
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Mitigating Antimicrobial Resistance through Strategic Design of Multimodal Antibacterial Agents Based on 1,2,3-Triazole with Click Chemistry - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E482AF8AEEDF530582AF0039F38F5F.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="acsbmcau">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371489/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="ACS Bio &amp; Med Chem Au">
<meta name="citation_title" content="Mitigating Antimicrobial Resistance through Strategic Design of Multimodal Antibacterial Agents Based on 1,2,3-Triazole with Click Chemistry">
<meta name="citation_author" content="Shabin N Chathangad">
<meta name="citation_author_institution" content="Department of Chemistry, Indian Institute of Technology Palakkad, Kerala 678 623, India">
<meta name="citation_author" content="Vishnu N Vijayan">
<meta name="citation_author_institution" content="Department of Chemistry, Indian Institute of Technology Palakkad, Kerala 678 623, India">
<meta name="citation_author" content="Jissy Anna George">
<meta name="citation_author_institution" content="Physical &amp; Chemical Biology Laboratory and Department of Biological Sciences &amp; Engineering, Indian Institute of Technology Palakkad, Kerala 678 623, India">
<meta name="citation_author" content="Sushabhan Sadhukhan">
<meta name="citation_author_institution" content="Department of Chemistry, Indian Institute of Technology Palakkad, Kerala 678 623, India">
<meta name="citation_author_institution" content="Physical &amp; Chemical Biology Laboratory and Department of Biological Sciences &amp; Engineering, Indian Institute of Technology Palakkad, Kerala 678 623, India">
<meta name="citation_publication_date" content="2025 Mar 17">
<meta name="citation_volume" content="5">
<meta name="citation_issue" content="4">
<meta name="citation_firstpage" content="486">
<meta name="citation_doi" content="10.1021/acsbiomedchemau.4c00132">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371489/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371489/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371489/pdf/bg4c00132.pdf">
<meta name="description" content="Drug-resistant bacterial infections impose a major threat to human health, as current antibiotic treatments are becoming increasingly ineffective. Priority has been given to the development of alternative medications to curb the development of ...">
<meta name="og:title" content="Mitigating Antimicrobial Resistance through Strategic Design of Multimodal Antibacterial Agents Based on 1,2,3-Triazole with Click Chemistry">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Drug-resistant bacterial infections impose a major threat to human health, as current antibiotic treatments are becoming increasingly ineffective. Priority has been given to the development of alternative medications to curb the development of ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371489/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12371489">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1021/acsbiomedchemau.4c00132"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/bg4c00132.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371489%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12371489/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12371489/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371489/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-acsbmcau.png" alt="ACS Bio &amp; Med Chem Au logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to ACS Bio &amp; Med Chem Au" title="Link to ACS Bio &amp; Med Chem Au" shape="default" href="https://pubs.acs.org/journal/abmcb8" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">ACS Bio Med Chem Au</button></div>. 2025 Mar 17;5(4):486–504. doi: <a href="https://doi.org/10.1021/acsbiomedchemau.4c00132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1021/acsbiomedchemau.4c00132</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22ACS%20Bio%20Med%20Chem%20Au%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22ACS%20Bio%20Med%20Chem%20Au%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22ACS%20Bio%20Med%20Chem%20Au%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22ACS%20Bio%20Med%20Chem%20Au%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Mitigating
Antimicrobial Resistance through Strategic
Design of Multimodal Antibacterial Agents Based on 1,2,3-Triazole
with Click Chemistry</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chathangad%20SN%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Shabin N Chathangad</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Shabin N Chathangad</span></h3>
<div class="p">
<sup>†</sup>
Department
of Chemistry, Indian Institute of Technology
Palakkad, Kerala
678 623, India
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chathangad%20SN%22%5BAuthor%5D" class="usa-link"><span class="name western">Shabin N Chathangad</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vijayan%20VN%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Vishnu N Vijayan</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Vishnu N Vijayan</span></h3>
<div class="p">
<sup>†</sup>
Department
of Chemistry, Indian Institute of Technology
Palakkad, Kerala
678 623, India
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vijayan%20VN%22%5BAuthor%5D" class="usa-link"><span class="name western">Vishnu N Vijayan</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22George%20JA%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Jissy Anna George</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Jissy Anna George</span></h3>
<div class="p">
<sup>‡</sup>
Physical
&amp; Chemical Biology Laboratory and Department of Biological Sciences
&amp; Engineering, Indian Institute of Technology
Palakkad, Kerala
678 623, India
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22George%20JA%22%5BAuthor%5D" class="usa-link"><span class="name western">Jissy Anna George</span></a>
</div>
</div>
<sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sadhukhan%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Sushabhan Sadhukhan</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Sushabhan Sadhukhan</span></h3>
<div class="p">
<sup>†</sup>
Department
of Chemistry, Indian Institute of Technology
Palakkad, Kerala
678 623, India
</div>
<div class="p">
<sup>‡</sup>
Physical
&amp; Chemical Biology Laboratory and Department of Biological Sciences
&amp; Engineering, Indian Institute of Technology
Palakkad, Kerala
678 623, India
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sadhukhan%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sushabhan Sadhukhan</span></a>
</div>
</div>
<sup>†,</sup><sup>‡,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>†</sup>
Department
of Chemistry, Indian Institute of Technology
Palakkad, Kerala
678 623, India
</div>
<div id="aff2">
<sup>‡</sup>
Physical
&amp; Chemical Biology Laboratory and Department of Biological Sciences
&amp; Engineering, Indian Institute of Technology
Palakkad, Kerala
678 623, India
</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>*</sup><p class="display-inline">

<span>sushabhan@iitpkd.ac.in</span>.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 30; Accepted 2025 Feb 26; Revised 2025 Feb 18; Collection date 2025 Aug 20.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Authors. Published by American Chemical Society</div>
<p>This article is licensed under CC-BY-NC-ND 4.0</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12371489</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Drug-resistant bacterial infections impose a major threat
to human
health, as current antibiotic treatments are becoming increasingly
ineffective. Priority has been given to the development of alternative
medications to curb the development of resistance or agents that can
work on the resistance strains. Among various promising approaches,
1,2,3-triazole-based molecular hybrids have emerged as excellent candidates
owing to their ease of synthesis, high structural diversity, functional
tunability, and biocompatibility. The rapid advancement of biological
understanding of 1,2,3-triazole has been greatly aided by the discovery
of the Click reaction. Drugs with a single molecular target often
fail to kill the bacteria effectively, and even if they do, the bacteria
eventually become resistant by virtue of mutations or other mechanisms.
In this context, the 1,2,3-triazole group has been explored to design
novel molecular hybrids to combat antimicrobial resistance in an effective
manner. Different types of 1,2,3-triazole-based hybrids have been
developed that have shown inhibitory effects on critical bacterial
enzymes, the ability to produce intracellular reactive oxygen species,
and the ability to disrupt the cell membrane. Herein, we discuss the
strategic design principles of triazole-based hybrids, their antibacterial
potential, especially focusing on the drug resistance issue, and future
perspectives to critically assess their potential for multitargeting
antibacterial agents. The presented information can lead to the development
of novel multifaceted antibacterial agents in the future by means
of their unique chemical features to address the growing challenge
of drug resistance.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Antimicrobial resistance; 1,2,3-triazoles; Click reaction; antibacterial activity; mechanism
of action; enzyme inhibition; multimodal activity</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a4/12371489/49829140a287/bg4c00132_0009.jpg" loading="lazy" height="372" width="618" alt="graphic file with name bg4c00132_0009.jpg"></p></section><section class="abstract" id="abstract3"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a4/12371489/49829140a287/bg4c00132_0008.jpg" loading="lazy" id="tgr1" height="372" width="618" alt="graphic file with name bg4c00132_0008.jpg"></p></section><section id="sec1"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>The rapid emergence of
antimicrobial resistance (AMR) over the
past few decades has raised questions regarding the efficacy of existing
medications. It is estimated that bacterial AMR resulted in 4.95 million
deaths across the globe in 2019. The number
is expected to rise to 10 million within the next 25 years if no effective
measures are implemented. In the coming years, the death rate due
to AMR could match that of the SARS-CoV-2 (COVID-19) pandemic, which
has also been associated with a large number of secondary bacterial
infections. There has been a massive use
of antibiotics to treat these bacterial infections or as a precaution
during the pandemic period, which may have exacerbated the AMR crisis.
Unfortunately, current drug development cannot match the pace of AMR
in the very near future. At present, only
1% of the antimicrobial drugs in development are entering clinical
trials, with relatively few targeting resistant bacteria. Considering
the fact that most of the antibiotics approved in the last 40 years
are derived from the already existing chemical structures drives us
to explore novel strategies by chemical modifications and derivatization.
</p>
<p>Bacteria develop various mechanisms of
resistance to antibiotics,
of which some are intrinsic, where they use existing genes to survive.
The other type is called “acquired”, where they gain
new genetic material that provides new capacities to evade the action
of antibiotics. In 2017, the World Health
Organization (WHO) identified antibiotic resistant pathogens as a
significant global health threat, categorizing them into three priority
groups: medium, high, and critical. Among these, ESKAPE pathogens
fall into the “critical group”, consisting of <em>Enterococcus faecium</em> (<em>E. faecium</em>), <em>Staphylococcus aureus</em> (<em>S. aureus</em>), <em>Klebsiella pneumoniae</em> (<em>K. pneumoniae</em>), <em>Acinetobacter baumannii</em> (<em>A. baumannii</em>), <em>Pseudomonas aeruginosa</em> (<em>P. aeruginosa</em>),
and <em>Enterobacter</em> species.<em>
,
</em> These
microbes are widely recognized for their ability to evade traditional
antibiotics using various advanced mechanisms such as inactivation of antibiotics by either irreversible modification
or degradation by enzymes (β-lactamases, chloramphenicol acetyltransferases, and aminoglycoside modifying enzymes), the use of efflux pumps to expel drugs from the bacterial
cell, alterations in cell membrane permeability to prevent antibiotic
uptake, and structural modifications of antibiotic target sites, making
it difficult for drugs to bind effectively. For example, <em>Staphylococcus aureus</em> (<em>S.
aureus)</em>, a Gram-positive bacterium, employs the mecA gene to impart methicillin resistance through the
alteration of penicillin-binding proteins, whereas <em>K. pneumoniae</em>, a Gram-negative bacterium, acquires carbapenem resistance via carbapenemases
and extended-spectrum β-lactamases (ESBLs).
<em>P. aeruginosa</em> can resist β-lactams
via β-lactamase and metallo β-lactamase. In this manner, bacteria developed resistance to several
antibiotics such as aminoglycosides (gentamicin,
streptomycin, kanamycin), β-lactams (penicillins, cephalosporins, cephamycins, carbapenems, monobactams),
glycopeptides (vancomycin), macrolides (azithromycin, erythromycin), quinolones and
fluoroquinolones (ciprofloxacin). Additionally,
to prevent the entry of foreign molecules in to the cell an extensive
outer lipid layer and a polysaccharide capsule coat were produced
by certain bacteria such as Gram-positive mycobacteria. Recently, porin structure modification has also
been observed as an important contributor to resistance development.
For example, modification of the nonselective porin OmpK36 through
a selected insertion of Gly115-Asp116 into loop 3 of the porin has
caused significant constriction and increased tolerance to the antibiotic
carbapenems in <em>Klebsiella pneumoniae</em>. Similarly, multiple mutations in OmpC affect
the permeability of antibiotics such as cefotaxime, gentamicin or
imipenem in multidrug resistant <em>E. coli</em>. These resistance mechanisms hamper the treatment
of diseases, such as pneumonia and bloodstream infections, highlighting
the need for novel therapeutic approaches.</p>
<p>Heterocyclic scaffolds
are omnipresent as the common cores in a
wide range of active pharmaceuticals and thus naturally have caught
the significant attention of medicinal chemists over the decades.
Among various heterocyclic scaffolds, nitrogen-containing ones hold
particular importance due to their widespread occurrence in nature.
These structures serve as integral subunits in various natural products,
including vitamins, hormones, antibiotics, etc. Analysis of the U.S.
Food and Drug Administration (FDA) databases has shown that approximately
60% of unique small-molecule drugs contain nitrogen-based heterocycles,
underscoring their structural importance in drug design and discovery. Of these, triazoles featuring a five-membered
ring of two carbon atoms and three nitrogen atoms have been recognized
as an important scaffold due to their unique physicochemical properties.<em>
,
</em> The name triazole was first coined by J. A. Bladin in 1885. Since then, its chemistry and biology have undergone
tremendous advancement, facilitated by efficient synthesis methods
and applications. Triazoles act as versatile alternatives to a range
of aromatic rings and functional groups. These properties render it
an attractive heterocycle for drug design, offering a less lipophilic
alternative to phenyl rings and serving as a substitute for other
heterocycles such as homologous azines. Triazole demonstrates unique
physicochemical properties, characterized by its weak basicity, diverse
dipole moments, and dual capabilities as both a hydrogen bond donor
and acceptor, which are critical in mediating drug-target interactions.
The intrinsic polarity of triazole contributes to a reduced logP value,
indicating potential enhancements in water solubility. The presence of nitrogen atoms with lone pairs
that are capable of metal coordination also makes triazole a valuable
scaffold for designing inhibitors. The ease of electrophilic substitutions
on the triazole ring leads to the development of novel scaffolds with
improved therapeutic effects.</p>
<p>1,2,3-Triazoles are five membered
heterocyclic compounds with a
6π electron ring system composed of two carbon and three nitrogen
atoms. Several methods for the synthesis of 1,2,3-triazoles have been
reported in the literature. However, Click chemistry made it considerably
easier to synthesize 1,2,3-triazoles allowing researchers to create
hybrids of choice with the desired functionalities. Sharpless established
the notion of Click chemistry in 2001 to alleviate the problems and
obstacles associated with conventional synthetic techniques. The concept of Click chemistry focuses on efficiency
and selectivity in terms of both regio and stereoselectivity. The Click technique paves the way to the discovery
of lead compounds and allows for fast exploration of chemical space.
It improves optimization through an efficient structure–activity
relationship (SAR) by providing various scaffolds. 1,2,3-Triazoles can bind with biomolecular targets like
enzymes, receptors, and proteins through various noncovalent interactions
such as hydrogen bonding, van der Waals interactions, etc. Due to its similar dipole moments, size, and
hydrogen-bond acceptor properties, the 1,2,3-triazole structure has
gained attention in drug discovery as a bioisostere for amides.<em>
,
</em> These physiochemical properties of the 1,2,3-triazole ring attracted
researchers for the development of novel scaffolds with various therapeutic
applications such as antibacterial,<em>
,
</em> anticancer and fungicidal activity. Several 1,2,3-triazole-containing drugs including seviteronel,
cefatrizine, tazobactam, rufinamide, daridorexant, mubritinib, and
suvorexant (<a href="#fig1" class="usa-link">Figure 
</a>) have already been approved by the FDA for clinical use in anticancer,
antibacterial, and antiepileptic therapies. These approvals highlight
the growing clinical significance of 1,2,3-triazoles in modern medicine.
</p>
<figure class="fig xbox font-sm" id="fig1"><h3 class="obj_head">1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371489_bg4c00132_0001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a4/12371489/59b1a38319b0/bg4c00132_0001.jpg" loading="lazy" id="gr1" height="339" width="738" alt="1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Chemical structures of some of the FDA approved 1,2,3-triazole-containing
marketed drugs.</p></figcaption></figure><p>Molecular hybrids generated by a combination of
two or more active
pharmacophores have emerged as a promising alternative to traditional
therapeutics, offering increased molecular diversity through the combination
of multiple subunits. The concept of designing molecular hybrids for
therapeutic purpose was first introduced by Fink et al. in 1996 where
they tried to design a single molecular framework to inhibit both
acetylcholine esterase and monoamine oxidase for treating Alzheimer’s
disease. Since then, there has been a
sharp upsurge in research output from both academia and industries
on various molecular hybrids to target complex multifaceted diseases
such as cancer, diabetes, Alzheimer’s, microbial infections,<em>
,
</em> etc. Among various
molecular hybrids designed so far, 1,2,3-triazole-based ones have
attracted significant attention due to their facile synthesis which
involves readily available or custom-synthesized alkyne and azide
components. Additionally, these compounds
demonstrate high biocompatibility and show considerable potential
in combating antibiotic-resistant bacteria. The antibacterial activity of 1,2,3-triazoles hybrids highly depends
on their molecular composition. The presence of lone pairs on the
nitrogen atom of 1,2,3-triazoles confers a coordination effect that is most likely observed with certain metalloproteins
as well as free metal ions present in bacteria, resulting in the inhibition
of metalloenzyme activities and thus reduces their biological functions,
depriving the availability of essential nutrients and inhibiting
their growth. The 1,2,3-triazole-based
hybrids have been reported to inhibit several critical bacterial enzymes
such as DNA gyrase, dihydrofolate reductase, sterol 14-α-demethylase causing bacterial cell death. It is observed that 1,2,3-triazole-based
hybrid molecules can target both Gram-positive and Gram-negative strains
by generating reactive oxygen species (ROS), thus affecting the metabolic
activity and disrupting membrane integrity. It also interacts with
the DNA polymerase enzyme responsible for the replication of chromosomal
DNA, affecting the survival of bacterial cells by disrupting their
cell division. Moreover, the molecular
hybridization of 1,2,3-triazole with existing antibiotics resulted
in more potent antibacterial drugs that can operate as a framework
to improve antibacterial properties more effectively than combination
treatment. The incorporation of a 1,2,3-triazole ring improves the
overall stability of the molecule and also makes it less susceptible
to bacterial resistance due to the multimodal action. Furthermore,
triazole hybrids have been shown to inhibit biofilm formation and
make the bacteria more susceptible to antibiotics. Thus, 1,2,3-triazole can be an excellent candidate for
developing antibacterial agents with multiple targets. In this Perspective,
we aim to analyze the structural and functional aspects of recently
reported 1,2,3-triazole hybrid molecules and their primary modes of
action. Additionally, we examine the role of 1,2,3-triazole as a pharmacophoric
unit in enhancing antibacterial activity and explore how 1,2,3-triazole
structures may contribute to combating the development of antimicrobial
resistance. Finally, we discuss the limitations and challenges associated
with 1,2,3-triazole-containing hybrid compounds with the goal of providing
a clear understanding of their potential and current constraints.
The multifaceted processes by which these chemicals exert their effects,
together with their structural diversity, open up new possibilities
for the generation of successful treatments.</p></section><section id="sec2"><h2 class="pmc_sec_title">2. Chemical Properties and Synthesis of 1,2,3-Triazole-Based
Molecular Hybrids</h2>
<p>1,2,3-Triazoles serve as versatile linkers
that connect two bioactive
moieties as well as function as a robust pharmacophore capable of
binding to various biological targets. This feature has been frequently used in medicinal chemistry in
the development of hit compounds, particularly for bidentate inhibitors.
In hybrid drug design, the triazole ring is often used to form homodimers
or heterodimers, which are made up of two identical or distinct pharmacophores,
respectively. In heterodimers, it connects
two pharmacophoric units that may simultaneously target multiple sites
or pathways. In the case of bidentate inhibitors, the triazole linker
is crucial to enable the molecule to interact with two distinct binding
sites on a target protein.<em>
,
</em> This dual engagement
often results in a stronger binding affinity and improved selectivity,
making these inhibitors more effective in modulating the activity
of their target proteins.</p>
<p>In a five-membered ring structure,
triazoles can exist in two isomeric
forms, 1,2,3- and 1,2,4-triazoles, based on the arrangement of nitrogen
atoms in the ring, and there are two tautomeric forms for each of
them (<a href="#fig2" class="usa-link">Figure 
</a>a). 
For 1,2,3-triazoles, it can be 1H-1,2,3-triazole and 2H-1,2,3-triazole
whereas the 4H-1,2,3-triazole is generally less stable due to its
nonaromatic character. For 1,2,4-triazoles, the tautomeric forms can
be 1H-1,2,4-triazole and 4H-1,2,4-triazole. The structural aspects
of 1,2,3-triazoles enable them to mimic various functional groups,
particularly amide bonds, making 1,2,3-triazoles widely used as bioisosteres
in drug design to create novel active compounds. Amide bonds are susceptible
to hydrolysis in the presence of endogenous peptidases/proteases,
and thus have a poor pharmacokinetic profile.<em>
,
</em> Therefore, in drug designing, amides have often been replaced by
triazoles, which offer better metabolic stability. Despite variation
in the dipole moment and substituent spacing, their structural characteristics
enable efficient mimicry and overlap with amide-binding groups. Amides
and triazoles are similar in several key aspects including substituent
distances (3.8–3.9 Å for amides and 5.0–5.1 Å
for 1,2,3-triazoles), dipole moments (approximately 4 D for amides
and 5 D for 1,2,3-triazoles), and hydrogen bond donor/acceptor capacities
(<a href="#fig2" class="usa-link">Figure 
</a>b). Substituted 1,2,3-triazoles can be of two types,
1,4-disubstituted and 1,5-disubstituted. 1,4-Disubstituted 1,2,3-triazoles
are excellent <em>Z-trans</em>-amide isosteres: The C-4 atom
serves as an electrophilic site; the C–H bond functions as
a hydrogen bond donor, and the lone pair of electrons on <em>N-2</em> and <em>N-3</em> acts as a hydrogen bond acceptor. On the
other hand, 1,5-disubstituted 1,2,3-triazoles effectively mimic <em>E-cis</em>-amides through the optimal spatial overlap of their
substituents. However, there are some polarity differences due to
the difference between the carbonyl group of amides and electronegative
nitrogen atoms of the triazole ring. Trans amides are naturally occurring,
whereas cis-amides are sterically unfavorable due to substituent repulsion.
This steric barrier is responsible for the higher utilization of 1,4-disubstituted
triazoles over their 1,5-disubstituted counterparts, despite the emergence
of ruthenium-based catalysts to synthesize the 1,5-regioisomer. This isosteric replacement is not only limited
to amides but also to other groups such as phenyl, trans olefins as well as for carboxylic acids and esters upon
proper substitutions.</p>
<figure class="fig xbox font-sm" id="fig2"><h3 class="obj_head">2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a4/12371489/608e476b421d/bg4c00132_0002.jpg" loading="lazy" id="gr2" height="2008" width="3417" alt="2"></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(a) Isomeric forms of the triazole nucleus and their tautomerization,
(b) 1,2,3-triazoles as nonclassical bioisosteres for amides, and (c)
synthesis of 1,2,3-triazole before and after the advent of Click chemistry.</p></figcaption></figure><p>1,2,3-Triazoles are planar molecules capable of
experiencing strong
dipole moments up to 5.2–5.6 D depending on the substitution
patterns. The 1,2,3-triazole ring often effectively interacts with
the target rather than just functioning as a linker because of its
capacity to engage through a variety of strong intermolecular interactions
such as hydrogen bonding, π–π stacking interactions,
etc., by virtue of its high dipole moment. Its structural and electronic
features can dramatically increase the compound’s biological
activity by directly influencing target interactions. 1,2,3-triazoles typically interact with hydrophobic residues
in binding pockets of the proteins, especially with tryptophan (Trp)
residues. Their planar, aromatic structure allows for edge-face and
face–face stacking interactions. The superior stability exhibited by the 1,2,3-triazole ring against
metabolic degradation made it an important scaffold in drug development.
They are often resistant toward both acidic and basic hydrolysis,
oxidative, and reductive conditions. In a comprehensive metabolic
study, Massarotti et al. reported that the 1,4-disubstituted 1,2,3-triazoles
exhibited unexpected stability against enzymatic degradation as compared
to the 1,5 disubstituted 1,2,3-triazoles highlighting the prolonged
availability of the former for therapeutic action with no significant
toxicity. The favorable spatial arrangement
of 1,5-substituted 1,2,3-triazoles toward enzymatic degradation (e.g.,
cytochrome P450-mediated oxidation) could be one of the reasons for
this distinct metabolic stability of these two isomers. Additionally,
it has been reported that 1,5-disubstituted 1,2,3-triazoles can undergo
oxidation to form triazole N-oxide when incubated with rat liver microsomes.
However, N-oxide formation was not observed for 1,4-disubstituted
1,2,3-triazoles, further establishing their superior metabolic stability.<em>
,
</em>
</p>
<p>Since the advent of the Click chemistry concept in 2001 by
Sharpless,
Kolb and Finn, it stands out as the most efficient, simple and eco-friendly
method for the synthesis of 1,2,3-triazoles. This approach is based on the copper­(I)-catalyzed azide–alkyne
cycloaddition (CuAAC) reaction that offers a highly selective and
straightforward route for the synthesis of 1,4 disubstituted 1,2,3-triazole
compared to earlier efforts (<a href="#fig2" class="usa-link">Figure 
</a>c). By combining an azide and an alkyne under mild
conditions with a copper­(I) catalyst, Click chemistry facilitates
the formation of 1,4-disubstituted 1,2,3-triazoles with high yield
and purity that has been widely explored for making various library
of molecules for drug discovery. Subsequently, Fokin and co-workers
developed a ruthenium catalyzed azide alkyne Click reaction (RuAAC)
using Cp*RuCl­(PPh<sub>3</sub>)<sub>2</sub> complex for the selective
synthesis of 1,5 disubstituted 1,2,3-triazoles. In CuAAC, two copper­(I) atoms facilitate the formation
of 1,4-substituted 1,2,3-triazoles, where the terminal nitrogen of
the azide attacking the substituted carbon of the sigma-bonded alkyne. In RuAAC, a single metal complex is involved,
where the first carbon nitrogen bond is formed when the terminal nitrogen
attacks the more electronegative and sterically demanding carbon of
the pi-coordinated alkyne, selectively producing the 1,5-substituted
isomer. Apart from metal catalyzed Click
reaction, a metal free strategy has also been reported in 2016 for
the synthesis of 1,5-disubstituted triazole where primary amines,
enolizable ketones, and 4-nitrophenyl azide are heated together in
the presence of acetic acid as a catalyst. Organocatalytic 3 + 2 cycloaddition
has also been reported for the synthesis of 1,5 disubstituted 1,2,3-triazoles
using organic catalysts such as 1,8-diazabicyclo [5.4.0] undec-7-ene
(DBU). Other methods used for the synthesis
of 1,2,3-triazoles include ionic liquids as catalysts, microwave and ultrasound-assisted
synthesis, etc.</p></section><section id="sec3"><h2 class="pmc_sec_title">3. Antibacterial Activity of 1,2,3-Triazole-Based
Hybrid Compounds</h2>
<p>Bacteria continue to develop resistance
to antibiotics available
on the market, which is a serious public
health problem and this demands new antibiotics that would be effective
against resistant strains, yet avoid the development of resistance.
Designing new alternative medicines requires an innovative and modular
approach to address the issue of resistance development. Currently,
most existing antibiotics follow a one-drug, one-target model, making
them highly susceptible to target modifications, such as mutations.
A multitargeting technique would be advantageous, because if one encounters
resistance, the other will still work. In this context, we observe
that 1,2,3-triazole is a simple and efficient molecule that can be
used to combine several distinct mechanisms of action in a single
molecule. 1,2,3-triazole hybrids are effective against a broad spectrum
of microorganisms, including drug-resistant pathogens. They function
through various modes of action (<a href="#tbl1" class="usa-link">Table 
</a>), which are covered in detail in this perspective.
These mechanisms include the inhibition of important bacterial enzymes,
the production of intracellular ROS, and the rupture of the phospholipid
bilayer of the bacterial cell. The strategic combination of multiple
modes of action in a single triazole-based compound could result in
effective antibacterial agents. In the following section, we present
an in-depth overview of various triazole-based hybrids that have demonstrated
notable antibacterial activity with a particular focus on their effectiveness
against resistant strains and the primary mode of action through which
they exert their action.</p>
<section class="tw xbox font-sm" id="tbl1"><h3 class="obj_head">1. Antibacterial Activity of the 1,2,3-Triazole
Hybrids Discussed and Their Major Mode of Action<sup></sup>
.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">Compound</th>
<th align="center" colspan="1" rowspan="1">Antibacterial
activity</th>
<th align="center" colspan="1" rowspan="1">Mode of action</th>
<th align="center" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>1</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme
inhibition (DNA gyrase)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 0.0016 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>B. subtilis</em>, 0.0016 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. epidermidis</em>, 0.0032 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>P. aeruginosa</em>, 0.0032 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>2</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (DNA gyrase)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 25 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>K. pneumoniae</em>, 100 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>B. subtilis</em>, 125 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. pyogenes</em>, 100 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>, 100 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>3</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (DNA gyrase)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 25 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>K. pneumoniae</em>, 100 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>P. vulgaris</em>, 100 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>, 200 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>4</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (DNA gyrase,
sterol 14α-demethylase)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>B. subtilis</em>, 6.2 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>, 12.5 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 6.2 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>P. aeruginosa</em>, 12.5 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>5</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (DNA gyrase)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>, 0.195 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>K. pneumoniae</em>, 0.195 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>6</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (DNA gyrase)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>: 0.391 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>7</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (DNA gyrase)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. faecalis</em>, 0.018 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>8</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (DNA polymerase)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">MRSA, 1.2–2.4 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>9</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme
inhibition (DHFR)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>, 10 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 36 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>K. pneumoniae</em>, 70 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>P. putida</em>, 60 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>10</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>Disk diameter in mm</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (DHFR)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 19 mm</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>, 16 mm</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<strong>Well diameter in mm</strong>
</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 21 mm</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>, 18 mm</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>11</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (cysteine synthase)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 1.6 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>12</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (Inh A, CYP121)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>M. tuberculosis</em>, 1.6 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 50 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>, 50 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>P. aeruginosa</em>, 100 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>13</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme inhibition (MurB)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em> C-18:0.65 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em> ″Viotko″ strains:
3.75 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>14</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme
inhibition (MurB)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 0.15 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>B. subtilis</em>, 0.02
μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>15</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Enzyme
inhibition (transpeptidases)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>P. aeruginosa</em>, 1.25 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>16</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Ribosomes (50s subunit)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">MRSA, 0.25 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>17</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Ribosomes (50s subunit)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">MRSA, 16 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>18</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Ribosomes (50s subunit)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">VRSA, 16 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>19</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Membrane disruption</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">MRSA, 4 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. faecalis</em>, 4 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. pneumoniae</em>, 4 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>C. difficile</em>, 4 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>20</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Membrane
disruption</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">MRSA: 4 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. faecalis-</em>8 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. pneumoniae-</em>8
μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>C. difficile-</em>16 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>21</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Membrane disruption</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">MRSA, 4 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. faecalis</em>, 4 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. pneumoniae</em>, 4 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>C. difficile</em>, 8 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>22</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">Membrane disruption</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>, 4 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E.
faecalis</em>, 16 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. agalactiae</em>, 8
μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 8 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>P.
aeruginosa</em>, 8 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>23</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
<sub>
<strong>50</strong>
</sub>
</td>
<td align="left" colspan="1" rowspan="1">Membrane disruption</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. pneumoniae</em>, 62.53 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. faecalis</em>, 36.66 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 15.28 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>K. pneumoniae</em>, 261 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>P. aeruginosa</em>, 134.7 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. enterica</em>, 402 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>24</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">ROS generation</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, 134 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>25</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">ROS generation</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>S. aureus</em>, 7.8 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>B. subtilis</em>, 7.8 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>M. luteus</em>, 3.9 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>K. planticola</em>, 15.6 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>E. coli</em>, &gt;250 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>P. aeruginosa</em>, &gt;250 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>26</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>MIC</strong>
</td>
<td align="left" colspan="1" rowspan="1">ROS generation</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>K. pneumoniae</em>, 2 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>27</strong>
</td>
<td align="left" colspan="1" rowspan="1">
<strong>EC</strong>
<sub>
<strong>50</strong>
</sub>
</td>
<td align="left" colspan="1" rowspan="1">ROS
generation</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>Xac</em>, 2.87 μg/mL</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t1fn1">
<sup>a</sup><p class="display-inline">
<em>M. luteus-Micrococcus luteus,
S. pyogenes-Streptococcus pyogenes, P. vulgaris-Proteus vulgaris,
M. tuberculosis-Mycobacterium tuberculosis, C. difficile-Clostridioides
difficile, S agalactiae-Streptococcus agalactiae, S. enterica-Salmonella
enterica, S. pneumoniae-Streptococcus pneumoniae, K. planticola-Klebsiella
planticola, Xac-X. axonopodis pv citri</em>
</p>
</div></div></section><section id="sec3.1"><h3 class="pmc_sec_title">3.1. 1,2,3-Triazole Hybrids That Target Critical
Bacterial Enzymes</h3>
<p>One of the primary mechanisms of action
attributed to 1,2,3-triazole hybrids is the inhibition of the critical
enzymes required for bacterial survival. Here, we discuss some of
those enzymes that are targeted by 1,2,3-triazole containing hybrids
and validated by experimental analysis or computational studies. Enzymes
or proteins are essential for both the survival and proliferation
of bacteria and the generation of antibiotic resistance. Targeting
these enzymes can disrupt essential metabolic processes, leading to
inhibition of bacterial growth. The enzyme DNA gyrase is one such
target that plays a key role in bacterial cells by introducing negative
supercoils to DNA, which is essential for DNA replication, transcription,
etc. It is an important and clinically
validated target of many antibiotics due to its critical function.
A library of novel dehydroacetic acid (DHA) chalcone-1,2,3-triazole
hybrids were designed and synthesized by Lal and co-workers in 2018,
as potent antibacterial agents against a variety of pathogenic bacteria
such as <em>Staphylococcus epidermidis (S. epidermidis), Bacillus
subtilis (B. subtilis), Escherichia coli (E. coli) and P. aeruginosa.</em>
 Chalcone represents an important class
of natural product, flavonoids, that has large number of replaceable
hydrogens that attracted synthetic chemists to introduce structural
diversity. Structurally, chalcones are α,β-unsaturated
aromatic ketones and display a wide range of pharmaceutical and biological
activities including anticancer, antidiabetic, anti-inflammatory,
and antibacterial. The DHA-chalcone alkyne and substituted benzyl
azide derivatives were Clicked to obtain a library of compounds. They
demonstrated antibacterial activity comparable to standard antibiotic
ciprofloxacin, which exhibited a minimum inhibitory concentration
(MIC) of 0.0015 μg/mL. In the synthesized library, compound <strong>1</strong> (<a href="#fig3" class="usa-link">Figure 
</a>) was found to be the most effective against <em>E. coli</em> and <em>B. subtilis</em> with an MIC value of 0.0016 μg/mL.
Molecular docking analysis further indicated that compound <strong>1</strong> effectively binds to the active sites of DNA gyrase through hydrogen
bonding, hydrophobic interaction, and electrostatic interactions.
The SAR studies revealed that the attachment of substituted benzyl
groups through the triazole ring increased antibacterial efficacy,
highlighting the importance of the 1,2,3-triazole unit. Recently,
a novel series of 1,2,3-triazole hybrids was designed and synthesized
by Mokariya et al. using an indole scaffold which exhibited excellent
antibacterial activity against both Gram-positive and Gram-negative
bacterial strains. They synthesized different derivatives by changing
the substituents such as Cl, F, NO<sub>2</sub>, Me, COOH, etc. on
the benzene ring attached to the 1,2,3-triazole group. The most potent
compound in their library, compound <strong>2</strong> (<a href="#fig3" class="usa-link">Figure 
</a>) with a meta-chloro substitution
on benzene ring attached to the triazole exhibited an MIC of 25 μg/mL
against <em>E. coli</em>. Compound <strong>2</strong> was also
found to interact with the active site of DNA gyrase in the molecular
docking study. Similarly, Suryapeta et
al. synthesized 1,4-disubstituted 1,2,3-triazole derivatives with
an indole-triazole-peptide conjugate. In their library, compound <strong>3</strong> (<a href="#fig3" class="usa-link">Figure 
</a>) exhibited the most potent activity against four different bacterial
strains tested, including drug-resistant <em>S. aureus</em> (MIC = 200 μg/mL) and <em>K. pneumonia</em> (MIC =
100 μg/mL). They observed that the activity changes according
to the nature and position of the R group on the benzene ring linked
to the 1,2,3-triazole core. When docked with DNA gyrase, compound <strong>3</strong> exhibited strong interactions with the target protein. In another study by Yadav and co-workers, the
design and synthesis of indole-chalcone linked 1,2,3-triazole hybrids
was demonstrated that exhibited strong antibacterial properties against
Gram-positive bacteria, Gram-negative bacteria, and fungal strains.
From the SAR analysis, they identified the most potent compound, compound <strong>4</strong> (<a href="#fig3" class="usa-link">Figure 
</a>), with an MIC of 6.2 μg/mL against <em>B. subtilis</em> and <em>E. coli</em>. The bromine substitution on the benzene
ring imparted better activity as compared to the chlorine substituent. <em>In-silico</em> studies revealed that the reported compounds interact
with the bacterial DNA gyrase enzyme through hydrophobic interactions,
leading to antibacterial activity. Furthermore, <em>in-silico</em> studies with sterol 14α-demethylase (CYP51), a cytochrome
P450 enzyme, which is an important enzyme in sterol biosynthesis and
a primary drug target for antifungal azoles, showed that the triazole-containing
compound exhibited π–π stacked interactions and
other hydrophobic interactions, resulting in overall inhibition of
the enzyme’s functioning and potential antimicrobial effects.
</p>
<figure class="fig xbox font-sm" id="fig3"><h4 class="obj_head">3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371489_bg4c00132_0003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a4/12371489/eb7f4682943b/bg4c00132_0003.jpg" loading="lazy" id="gr3" height="833" width="680" alt="3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Chemical structures of potent 1,2,3-triazole hybrids that
have
been reported to inhibit critical bacterial enzymes with their respective
MICs against the tested bacterial strains.</p></figcaption></figure><p>In another report, Patel et al. synthesized a library
of ciprofloxacin-conjugated
1,2,3-triazoles, where the C-3 carboxylic group of ciprofloxacin was
linked to various substituted 1,2,3-triazole rings and other variations
were further introduced in the piperazine moiety. The antibacterial efficacy of the synthesized compounds
was evaluated against various bacterial strains. Most of the reported
compounds demonstrated strong antibacterial activity, particularly
against strains such as <em>E. coli</em>, <em>S. aureus</em>, and clinical isolates of <em>A. baumannii</em>. MIC data
indicated that the nature, type, and position of the substituents
on the benzene ring significantly influenced the antibacterial efficacy.
The SAR studies showed that compounds with acetyl and benzoyl groups
on the piperazine moiety exhibited enhanced activity, especially against <em>S. aureus</em>, <em>E. coli</em>, and <em>A. baumannii</em>. However, compound <strong>5</strong> (<a href="#fig3" class="usa-link">Figure 
</a>) with an unsubstituted piperazine moiety
showed excellent antibacterial activity against <em>S. aureus</em> with MIC of 0.195 μg/mL, which is 32 times more effective
than the standard drug ciprofloxacin, having MIC of 6.25 μg/mL. <em>In-silico</em> studies such as molecular docking and molecular
dynamics simulations revealed a strong interaction of the active compounds
with the DNA gyrase enzyme. Further, the same has been experimentally
validated via an <em>in vitro</em> DNA gyrase inhibition assay.
This assay suggested that compound <strong>6</strong> (MIC 0.391 μg/mL
against <em>S. aureus</em>) (<a href="#fig3" class="usa-link">Figure 
</a>) having a bromine substituent on the benzene
ring exhibited the highest inhibition of the DNA gyrase enzyme, and
the inhibition was better than the unmodified ciprofloxacin used as
a positive control.</p>
<p>Further, a series of 2-quinolone-1,2,3-triazole-α-amino
phosphonates
was synthesized by Gadali et al. leveraging the structural similarity
of α-amino phosphonates to α-amino acids, peptides, and
natural phosphates. The study detailed
the synthesis of novel compounds through a molecular hybridization
approach, combining α-aminophosphonate, 1,2,3-triazole, and
4-methyl-2-quinolone moieties in a single scaffold. Four bacterial
strains, <em>E. coli</em>, <em>P. aeruginosa</em>, <em>Enterococcus faecalis</em> (<em>E. faecalis</em>), and <em>S. aureus</em> were used to evaluate the antibacterial activity
of the synthesized compounds. The chloro-substituted hybrid, compound <strong>7</strong> (<a href="#fig3" class="usa-link">Figure 
</a>) showed an MIC of 0.018 μg/mL which is 8.7-fold and 10-fold
better than the standard antibiotics, ampicillin and rifampicin, respectively
against <em>E. faecalis</em>. Derivatives that had 2-bromo
and 4-iodo phenyl substitutions on the benzene ring showed MIC values
of 0.036 μg/mL against <em>E. faecalis.</em> Molecular
docking analysis of compound <strong>7</strong> with bacterial DNA gyrase
demonstrated strong interactions such as hydrogen bonding and hydrophobic
contacts, which contributed to the inhibition of DNA gyrase activity.</p>
<p>Methicillin resistant <em>Staphylococcus aureus</em> (MRSA)
is one of the most dangerous superbugs that cause deleterious effects
such as sepsis and endocarditis in humans. Recently, Tang et al. synthesized triazolyl pterostilbene derivatives
and tested against MRSA. A Click reaction
was performed with propargylated sterostilbenes and selected azides
in the presence of sodium ascorbate and copper sulfate to yield a
library of hybrids. Among them, significantly low MIC values (1.2–2.4
μg/mL) were exhibited by Compound <strong>8</strong> (<a href="#fig3" class="usa-link">Figure 
</a>) as compared to pterostilbene
(41–161 μg/mL) indicating a great enhancement in anti-MRSA
activity. The SAR studies showed that the presence of a carboxylic
acid functionality and its spacing from triazole played a key role
in the antibacterial activity of the compounds. The compound showed
antibacterial properties by inhibiting the replication of bacterial
DNA. The mechanism of action was analyzed via experimental as well
as molecular docking analysis; the DNA replication test showed the
ability of the compounds to inhibit DNA polymerase, and the reduction
of PCR products in a dose-dependent manner confirmed the target of
the compounds as DNA polymerase. The <em>in-silico</em> studies
also indicated that the triazole group and the oxygen that connect
to the pterostilbene scaffold formed hydrogen bonds with Lys 450 and
Arg 435, respectively. These findings support the experimental validation
and suggest a potential interaction between the triazole group and
DNA polymerase enzyme, which plays a crucial role in chromosomal
DNA replication.</p>
<p>Aarjane et al. have designed and synthesized
novel 1,2,3-triazoles
from acridone, another nitrogen containing heterocycle with a wide
pharmacological application from antimicrobial to anticancer.<em>
,
</em> The synthesis was started with the alkyne functionalization of acridone
using propargyl bromide on the acridone skeleton which were presynthesized
using an Ullman condensation reaction 2-bromobenzoic acid and aniline
derivatives. The final compound was synthesized by using a Click reaction
with aromatic azide derivatives. The antibacterial activity of the
synthesized 1,2,3-triazole compounds were evaluated against <em>S. aureus</em> and <em>Pseudomonas putida (P. putida)</em>, <em>K. pneumoniae</em>, and <em>E. coli</em>. It
was found that, <em>S. aureus</em> was most sensitive to the
synthesized compounds. The SAR studies showed that compounds which
feature an <em>O</em>-methylphenyl group on the acridone-1,2,3-triazole
skeleton, demonstrated the highest antibacterial activity against <em>S. aureus</em> whereas carboxylic acid functionalization decreased
the activity. Compound <strong>9</strong> (<a href="#fig3" class="usa-link">Figure 
</a>) exhibited the most potent activity with
an MIC of 10 μg/mL against <em>S. aureus</em> (<a href="#tbl1" class="usa-link">Table 
</a>). The mechanism of
action of these compounds was revealed to be through inhibition of
the dihydrofolate reductase (DHFR) enzyme, which plays an important
role in thymidylate biosynthesis and cell proliferation. Molecular
docking studies revealed effective binding of <em>O</em>-methylated
derivatives into the active site of DHFR.</p>
<p>In 2022, Malah et
al. synthesized a library of ten isatin-1,2,3-triazole
hybrids through a Cu­(I)-catalyzed cycloaddition of N-propargylated
isatin with various azide derivatives. The N-propargylated isatins were prepared by reacting 1H-indole-2,3-dione
with propargyl bromide in an alkaline DMF solution. The antimicrobial
activity of the final compounds was evaluated against different pathogenic
microorganisms, including <em>E. coli, S. aureus, C. albicans</em>, and <em>A. niger</em>, and it was observed that the activity
was highly dependent on the substituents on the <em>N</em>-phenyl group. The compounds showed antibacterial effects through
different mechanisms such as reduction of ATP production in bacterial
cells, inhibition of DHFR, which is an essential cytoplasmic protease
with NADPH as a cofactor involved in the reduction of dihydrofolate
to tetrahydrofolate thereby playing a crucial role in DNA synthesis,
DNA translation, RNA transcription, protein replication, and controlling
cell proliferation. Compound <strong>10</strong> (<a href="#fig3" class="usa-link">Figure 
</a>) exhibited the most potent activity in the
library with zone of inhibition (ZOI) (disk diameter in mm) in <em>E. coli, S. aureus, C. albicans, A. niger</em> as 19 ± 0.08,
16 ± 0.28, 14 ± 0.09, and 12 ± 0.11 respectively. Polar
substituents enhanced the activity, whereas nonpolar groups reduced
the efficacy. The inhibition of DHFR was found to be the key mechanism
of action, using molecular docking studies. Similarly, in 2020, Wallace
et al. demonstrated the antimetabolite action of 1,2,3-triazole-thioacetamide
hybrids. Their lead compound <strong>11</strong> exhibited a very low MIC of 1.6 μg/mL against <em>E. coli</em>, and the mechanism was found to be inhibition of the cysteine synthase
A (CysK). CysK present in bacteria plays an important role in several
fundamental pathways such as cysteine biosynthesis, sulfur assimilation,
and homocysteine biosynthesis. Inhibition of these critical pathways
disrupts sulfur metabolism and redox homeostasis in bacteria, resulting
in elevated levels of intracellular oxidative stress and affect their
resistance development against antibiotics.
</p>
<p>Reddyrajula et al. synthesized 36 novel phenothiazine incorporated
1,2,3-triazole hybrids and evaluated their activity against <em>M. tuberculosis</em>. Compared to the tuberculosis standard drug,
pyrazinamide, more than half of the synthesized compounds exhibited
superior antibacterial activity. Interestingly, these compounds were
inactive against other bacteria such as <em>S. aureus, P. aeruginosa,</em> and <em>E. coli,</em> indicating their specificity toward <em>M. tuberculosis.</em> Compound <strong>12</strong> (<a href="#fig3" class="usa-link">Figure 
</a>) exhibited the lowest MIC
of 1.6 μg/mL against <em>M. tuberculosis</em>. To get
an insight into its mechanism of action, they demonstrated molecular
docking studies with two target enzymes, namely, enoyl reductase (Inh
A) and CYP121. A strong enzyme-ligand binding affinity was observed
as a result of hydrogen bonding and pi-pi stacking interactions.
</p>
<p>In 2019, Lipeeva et al. reported the antibacterial
efficacy of
1,2,3-triazole-coumarin hybrids made from plant-derived coumarin.
These hybrids exhibited greater potency against <em>S. aureus</em> compared to standard antibiotics, ceftriaxonum and streptomycin. In particular, hybrid <strong>13</strong> (<a href="#fig3" class="usa-link">Figure 
</a>) (MIC: 0.65 and
3.75 μg/mL) showed substantial activity against <em>S. aureus</em> C-18 and <em>S. aureus</em> “Viotko” strains,
indicating its potency in treating <em>S. aureus</em> infections.
The SAR analysis showed that carboxylic acid at the para-position
of the phenyl ring was essential for excellent activity against S. <em>aureus</em>. Molecular docking studies further indicated a strong
interaction of compound <strong>13</strong> with UDP-N-acetylenolpyruvylglucosamine
reductase (MurB) protein, suggesting a potential enzyme inhibition
leading to the observed antibacterial activity. MurB is an essential
enzyme present in bacteria that plays a major role in the synthesis
of cell wall precursor (uridine diphosphate N-acetyl muramic acid
(UNAM)). Thus, targeting this enzyme results in disruption of cell
wall biosynthesis leading to inhibition of bacterial growth. Adding
a furocoumarin moiety in the hybrids significantly improved their
efficacy against <em>E. coli</em> and <em>B. subtilis</em>, as observed in the coumarin-1,2,3-triazole-furocoumarin hybrid <strong>14</strong> (<a href="#fig3" class="usa-link">Figure 
</a>). Compound <strong>14</strong> exhibited
MICs of 0.15 μg/mL and 0.02 μg/mL, respectively, against <em>E. coli</em> and <em>B. subtilis</em> which are significantly
improved as compared to the standard antibiotic streptomycin with
MICs of 1 μg/mL and 2 μg/mL against <em>E. coli</em> and <em>B. subtilis</em>, respectively. Further studies
revealed that the linker between the 1,2,3-triazole and coumarin moieties,
as well as its position on the coumarin ring, had a significant impact
on the activity.
</p>
<p>β-Lactam
antibiotics are a large class of antibiotics that
includes penicillins, cephalosporins, nocardicins, carbapenems and
monobactams. The azetidine-2-one ring
system is the key to biological activities in β-lactam antibiotics.
The primary mode of action of β-lactams to kill bacteria is
inhibition of transpeptidases, which form peptidoglycan by cross-linking
the peptides. The hybridization of 1,2,3-triazole
with the β-lactam motif has gained significant interest among
medicinal chemists, as it may have the potential to overcome drug
resistance.<em>
,
</em> For example, in 2020, Kaur et
al. reported triazole β-lactam conjugates using Click chemistry.
Compound <strong>15</strong> (<a href="#fig4" class="usa-link">Figure 
</a>) containing 3-nitro or 3-chloro substituted benzene
reported in their library exhibited an MIC of 1.25 μg/mL against <em>B. subtilis</em> and <em>P. aeruginosa</em>. In addition to focusing on the different essential
proteins and enzymes required for bacterial survival, antibacterial
drugs have been created that target the ribosome itself, which is
the precise cellular organelle that makes proteins. Since protein
biosynthesis is a fundamental process in all living organisms, the
ribosome has become a key target for a wide variety of antibiotics. To address the challenges associated with these
antibacterial agents, such as low bioavailability, resistance development
and toxicity, researchers have explored the hybridization of antibiotics
with 1,2,3-triazoles. Pleuromutilin,
first isolated in 1951 from <em>Pleurotus mutilus,</em> functions
by inhibiting bacterial protein synthesis through interaction with
the 23S rRNA of the 50S ribosomal subunit. Several pleuromutilin hybrids have been developed for enhanced antibacterial
action, showing a weak tendency to induce cross-resistance. However,
these hybrids often suffer from poor bioavailability and CYP450 inhibition. To address these limitations, 1,2,3-triazole-pleuromutilin
hybrids have been developed. In 2021, Zhang et al. reported the antibacterial
activity of synthesized pleuromutilin analogs containing substituted
1,2,3-triazole moieties against MRSA. Their most potent hybrid, compound <strong>16</strong> featuring a tertiary
amine group, demonstrated a 8-fold improvement in the MIC (0.25 μg/mL)
against MRSA whereas pleuromutilin alone exhibited an MIC of 2 μg/mL.
Similarly, macrolide antibiotics such as clarithromycin, erythromycin,
and azithromycin are a key group of drugs used to treat bacterial
infections. Several studies have demonstrated
that these antibiotics can bind to some specific nucleotide residues,
such as A2058 and A2059 on the domain V of 23s rRNA present on the
50S subunit of the bacterial ribosome inhibiting the elongation of
peptide chains and thereby selectively blocking bacterial protein
synthesis. In 2021, Qin et al. reported
1,2,3-triazole azithromycin hybrids showing potent activity against
various drug-resistant strains such as MRSA and penicillin-resistant <em>S. aureus</em> (PRSA). Interestingly,
compound <strong>17</strong> (<a href="#fig4" class="usa-link">Figure 
</a>), upon the introduction of a pentyl group to the 1,2,3-triazole
ring exhibited the most potent antibacterial activity against MRSA
with an MIC of 16 μg/mL whereas the standard drug azithromycin
showed MIC &gt; 256 μg/mL. Molecular docking analyses revealed
that hybrid <strong>17</strong> has the potential to interact with the
A752 base of the 23S rRNA within the bacterial ribosome, likely through
a combination of hydrophobic and electrostatic interactions and contribute
to exceptional antibacterial activity. Oxazolidinone class of antibiotics
are known to attach 50S ribosomal subunit and inhibit the formation
of the 70S initiation complex by blocking the assembly of the N-formyl-methionyl-tRNA,
ribosome, and mRNA ternary complex. Resistance
to oxazolidinone antibiotics occurs mainly due to mutation in 23S
rRNA. In 2014, Phetsang et al. reported azide functionalized analogue
of oxazolidinone antibiotic linezolid retaining its antibacterial
activity. Further Click-mediated hybridization of azido linezolid
led to the creation of a library of compounds showing excellent antibacterial
activity against a number of drug-resistant Gram-positive bacteria.
The most potent hybrid, compound <strong>18</strong> (<a href="#fig4" class="usa-link">Figure 
</a>) with a 7-nitrobenzofuran
moiety showed promising antibacterial activity against VRSA with an
MIC value of 16 μg/mL whereas the standard antibiotic vancomycin
showed an MIC &gt; 64 μg/mL.
<em>In-silico</em> studies and crystal structure analysis revealed
that azide-functionalization promoted fitting of the compound in 50S
ribosomal subunit similar to that of oxazolidinones and contributes
to the antibacterial efficacy.</p>
<figure class="fig xbox font-sm" id="fig4"><h4 class="obj_head">4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371489_bg4c00132_0004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a4/12371489/bbbbd2ecd758/bg4c00132_0004.jpg" loading="lazy" id="gr4" height="596" width="704" alt="4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Representative compounds containing 1,2,3-triazole
hybridized with
antibiotics along with their respective MICs against the tested bacterial
strains.</p></figcaption></figure></section><section id="sec3.2"><h3 class="pmc_sec_title">3.2. 1,2,3-Triazole Hybrids That Disrupt the Bacterial
Cell Membrane</h3>
<p>The cell membrane is an essential component
of bacteria because it provides protection, resistance, and integrity
to the cell by regulating the entry and exit of substances. Cell membrane
disruption is one of the primary mechanisms by which antibiotics function.
It has advantages over other mechanisms as the possibility of resistance
development is comparatively low, as they completely destroy the bacteria
other than suppressing their replication or cell division. Cell membrane
targeting substituents can be attached to 1,2,3-triazole to develop
an efficient antibacterial agent. In this regard, Tague and co-workers
developed cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles. They have synthesized 43 compounds in three
distinct classes using CuAAC. The cationic biaryl amphiphile, <strong>19</strong> (<a href="#fig5" class="usa-link">Figure 
</a>) was identified as the most effective agent with an MIC of 4 μg/mL
against MRSA. The SAR studies suggested that the ratio of cationic
residues to hydrophobic residues within the peptidomimetic amphiphiles
has a strong influence on their antimicrobial activity, hemolytic
activity, and thus membrane selectivity.</p>
<figure class="fig xbox font-sm" id="fig5"><h4 class="obj_head">5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371489_bg4c00132_0005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a4/12371489/184ce92974f9/bg4c00132_0005.jpg" loading="lazy" id="gr5" height="513" width="720" alt="5"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Representative 1,2,3-triazole
hybrids that function through bacterial
cell membrane disruption along with their respective MICs against
the tested bacterial strains.</p></figcaption></figure><p>Antibacterial agents derived from basic amino acids,
such as lysine
and arginine, have shown the ability to disrupt the bacterial membrane.
In 2019, Tague and colleagues synthesized a series of 1,2,3-triazole-arginine
hybrids. In their synthesized library, compound <strong>20</strong> (<a href="#fig5" class="usa-link">Figure 
</a>) with ethylbenzene
substituent showed excellent activity against a variety of bacterial
strains such as MRSA clinical isolates, vancomycin-resistant <em>S. aureus</em> (VRSA) and Vancomycin-resistant <em>E. faecalis</em> (VRE), etc. with MIC values as low as 4 μg/mL. Compound <strong>21</strong> (<a href="#fig5" class="usa-link">Figure 
</a>) with a cyclohexyl substituent also showed
promising antibacterial activity against MRSA with an MIC value of
4 μg/mL. The obtained MIC values
were comparable with that of the standard antibiotic vancomycin (MIC
of 1–32 μg/mL) against all these strains. Cytoplasmic
membrane depolarization and disruption of membrane potential were
found to be the key mechanism of bacterial inactivation.</p>
<p>In
2017, Bakka et al. reported a library of 29 1,4-substituted
1,2,3-triazoles containing amphiphilic antimicrobial peptides (AMPs)
that can disrupt the bacterial cell membrane. The AMPs’ cationic charge can be drawn to the bacteria’s
negatively charged cell membrane, whereupon the hydrophobic portion
enters the phospholipid bilayer and disrupts the membrane. The hypothesis
behind the incorporation of triazoles into AMPs was to bypass its
limitations such as poor bioavailability and metabolic stability.
Click chemistry allowed them to easily connect the hydrophilic and
lipophilic parts through the triazole ring. Compound <strong>22</strong> (<a href="#fig5" class="usa-link">Figure 
</a>) with a
guanidium substituent exhibited the most potent antibacterial activity
with an MIC of 4 μg/mL against <em>S. aureus</em>. Similar
to conjugation with AMPs, Aneja et al. designed and synthesized 1,2,3-triazole
analogues of natural bioactive precursors for potential antibacterial
activity against resistant bacterial strains using Click reaction. Carvacrol, naphthoquinone, and 8-hydroxyquinoline
were used as precursors for modification. The most potent compound <strong>23</strong> (<a href="#fig5" class="usa-link">Figure 
</a>) exhibited significant antibacterial activity against <em>S.
pneumoniae</em> (MIC<sub>50</sub>= 62.53 μg/mL. where MIC<sub>50</sub> is the concentration that inhibits 50% bacterial growth), <em>E. faecalis</em> (MIC<sub>50</sub>= 36.66 μg/mL,), and <em>E. coli</em> (MIC<sub>50</sub>= 15.28 μg/mL). The growth
kinetics on <em>S. pneumoniae</em> and <em>E. coli</em> treated with <strong>23</strong> exhibited an extended lag phase attesting
its bactericidal effect. Transmission electron microscopy studies
revealed morphological changes and damage to the cell membrane upon
treatment with these compounds. They were also found to inhibit the
biofilm formed by <em>S. pneumoniae</em> and <em>E. coli</em>. Together with the membrane disruption property, the added biofilm
inhibitory function can aid in preventing the development of bacterial
resistance to antibacterial drugs, making it a viable option against
MDR pathogens.</p></section><section id="sec3.3"><h3 class="pmc_sec_title">3.3. 1,2,3-Triazole Containing Hybrid Molecules
That Generate Intracellular ROS</h3>
<p>The production of ROS has
been found to be a significant contributor to the antibacterial activity
as well as efficacy against multidrug-resistant organisms. ROS include radical and nonradical oxygen containing
species such as hydroxyl radicals (OH<sup>•</sup>), superoxide
anion (O<sub>2</sub>
<sup>–</sup>), hydroxyl anions (OH<sup>–</sup>) singlet oxygen (<sup>1</sup>O<sub>2</sub>), peroxide
(O<sub>2</sub>
<sup>2–</sup>), and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Under normal conditions, ROS levels are tightly
regulated by the cellular antioxidant defense system. However, during oxidative stress, ROS levels
can exceed the cell’s capacity to neutralize them, leading
to toxicity. Compared to mammalian cells that are equipped with a
better antioxidant defense system, bacteria are prone to severe damage
in the presence of ROS. Apart from lipids, ROS also affects DNA by
forming cross-links, modification of the bases, and breaking the strands. Similarly, ROS oxidizes proteins, leading to
the alteration of its structure and loss of activity.
</p>
<p>Although the 1,2,3-triazole ring itself
may not directly contribute to ROS production, ROS generating structural
elements can be strategically integrated to the 1,2,3-triazole nucleus.
So far, there are only a few reports on the antibacterial activity
of ROS producing 1,2,3-triazole hybrids. However, significant studies
have been conducted on other biological applications of ROS generating
1,2,3-triazole hybrids, such as anticancer, antifungal, etc. This
implies that it is important to highlight the possibility of increasing
the usage of these compounds in antibacterial applications. In this
respect, Hayden et al. designed and synthesized several water-soluble
triazole phenazine derivatives. In their
library, the most potent molecule, compound <strong>24</strong> (<a href="#fig6" class="usa-link">Figure 
</a>) exhibited an MIC
of 134 μg/mL against <em>E. coli</em>. One putative
mode of action for its antibacterial effect is the incorporation of
the phenazine portion of the molecule into the cell membrane, affecting
membrane-associated cation transporters and compromising the membrane
structural integrity. This can interfere with cellular redox balance,
leading to the generation of ROS and ultimately to cytotoxicity. Additionally,
phenazine may intercalate with DNA, downregulating DNA-directed protein
expression and disrupting essential cellular processes. The toxicity
of phenazine is primarily attributed to the formation of radicals
within the phenazine structure, which then facilitates the reduction
of molecular oxygen, producing ROS.</p>
<figure class="fig xbox font-sm" id="fig6"><h4 class="obj_head">6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371489_bg4c00132_0006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a4/12371489/722a734b376b/bg4c00132_0006.jpg" loading="lazy" id="gr6" height="278" width="700" alt="6"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Chemical structures of some of the 1,2,3-triazole
hybrids that
generate intracellular ROS are represented along with their respective
MICs against tested bacterial strains.</p></figcaption></figure><p>Another class of ROS generating antibacterial 1,2,3-triazole
hybrids
has been reported by T. Vijai Kumar Reddy and co-workers using 1,2,3-triazole
analogues of short-chain C12-sphinganine in 2016. These compounds were able to target both Gram-positive
and Gram-negative strains with promising antibacterial efficacy. The
most potent compound <strong>25</strong> (<a href="#fig6" class="usa-link">Figure 
</a>), exhibited antimicrobial effects with
an MIC of 3.9 μg/mL against <em>M. luteus.</em> It also
showed antibiofilm action against the tested microorganisms such as <em>C. albicans</em>, <em>M. luteus,</em> and <em>S.
aureus</em>. These hybrids could generate elevated levels of intracellular
ROS such as superoxide anions and hydrogen peroxides as observed in
the fluorescence assay using DCFH-DA. In another report, Aljohani
et al. developed 1,2,3-triazole derivatives complexed with Zn that
exhibited antibacterial activity against <em>K. pneumoniae</em>. Among various hybrids reported, 1,2,3-triazole-sulfadiazine-ZnO
could target bacteria that were resistant to the known antibiotic,
carbapenem. Compound <strong>26</strong> (<a href="#fig6" class="usa-link">Figure 
</a>) showed antibacterial properties against <em>K. pneumoniae</em> with an MIC of 128 μg/mL, and its hybrid
with ZnO showed enhanced antibacterial properties with an MIC of 2
μg/mL. The primary mode of action for its antibacterial activity
was reported as the generation of ROS such as free radicals, superoxide
anions, and peroxides. The presence of zinc ions improved the antibacterial
properties through their penetration and interaction with nucleic
acids, resulting in the inactivation of the enzymes involved in the
electron transport chains and enhanced cytokine release. The molecular
docking studies conducted on metallo-β-lactamase, a diverse
group of enzymes involved in the hydrolysis of a wide range of β-lactam
antibiotics, demonstrated the potential for interaction with the enzyme
through hydrophobic interactions, resulting in potent inhibition.
Additionally, the <em>in vitro</em> enzymatic assay of synthesized
compounds against metallo-β-lactamase exhibited a similar inhibitory
trend.</p>
<p>In 2021, Huang et al. reported ROS generating 1,2,3-triazole
tailored
carbazoles as efficient antibacterial agents and tested against plant
pathogens such as <em>Xanthomonas oryzae pv oryzae</em> (<em>Xoo</em>), <em>Xac,</em> and <em>Pseudomonas syringae
pv actinidiae</em> (<em>Psa</em>). Compound <strong>27</strong> (<a href="#fig6" class="usa-link">Figure 
</a>) showed potent antibacterial activity against <em>Xac</em> with the lowest EC<sub>50</sub> value of 2.87 μg/mL.
The most potent compound in their library showed antibacterial activity
through the ROS generation mechanism, as experimentally studied by
the DCFH-DA assay. As previously mentioned, 1,2,3-triazole hybrids
have been explored for various other biomedical applications, leveraging
their ability to generate ROS. For example, in 2024, Souza et al.
reported a library of naphthoquinone based 1,2,3-triazole hybrids
that were shown to have ROS mediated anticancer property. Electron transfer from the quinonoid substructure
to molecular oxygen generates ROS that results in irreversible DNA
damage in the cells. The most potent compound exhibited the highly
elevated levels of ROS production in the synthesized library within
2 h of treatment at a concentration of 6 μM. Another such example
is reported by Guo et al., where the authors synthesized a series
of 28 cabotegravir derivatives incorporating a 1,2,3-triazole moiety. Electron microscopic analysis revealed that
their best compound exhibited a large accumulation of intracellular
ROS upon treatment with HuH-7 cells at varying concentrations, which
resulted in mitochondrial membrane damage. These studies suggest that
1,2,3-triazole hybrids can be engineered to effectively induce substantial
ROS generation, disrupt bacterial membranes, and inhibit key enzymes
making them potential candidates for combating multidrug resistant
bacteria.</p></section><section id="sec3.4"><h3 class="pmc_sec_title">3.4. Combination Therapy</h3>
<p>Combination therapy
is an emerging and promising strategy for treating diseases in which
two or more drugs are used in tandem to achieve better therapeutic
outcomes. This offers several advantages over conventional monotherapy,
including the multitargeting effect, which can improve treatment efficacy.
Combination therapy can also make cells sensitive to other treatments,
thus, enhancing the overall therapeutic outcome. Furthermore, it reduces
the possibility of drug resistance development and minimizes potential
toxicity by using lower doses of individual drugs. Metallo-β-lactamases (MBLs) are a diverse set of
enzymes that catalyze the hydrolysis of a broad range of β-lactam
antibiotics, rendering them ineffective and significantly contributing
to antimicrobial resistance. Muhammad and co-workers reported a series
of 1,2,3-triazoles in 2020, following a three-step reaction protocol
involving a Banert cascade reaction. The synthesized compounds were
found to inhibit different types of MBLs such as Verona integron-encoded
metallo-β-lactamase (VIM-2) and New Delhi metallo-βlactamase
(NDM-1) exhibiting an IC<sub>50</sub> value in nanomolar range. The
most effective compounds were then tested for synergistic effects
with Meropenem against 3 clinical bacterial strains. A 64- and 16-fold
improvement in MIC was observed when treated in combination against <em>P. aeruginosa</em> and <em>E. coli</em>, respectively,
compared to Meropenem alone. In a separate study, Rogers et al. reported
the synergistic effect of 2-aminoimidazole-triazole conjugate and
antibiotics toward the biofilm production/dispersion of <em>S.
aureu</em>s. Bacteria produce biofilms
to protect themselves from harsh conditions and antibiotics for their
survival. Due to this protective layer, most antibiotics become ineffective,
and treating infections becomes challenging. Therefore, creating drugs
with both antibacterial and biofilm-inhibiting properties is beneficial.
The 2-aminoimidazole-triazole conjugate showed potential to inhibit
and disperse the bacterial biofilms of several microorganisms. A 26-fold
enhancement in the activity was also observed when used in combination
with 0.1 μM novobiocin antibiotic. Similarly, Su and co-workers
evaluated 4,5-disubstituted-2-aminoimidazole–triazole conjugates
for the resensitization of antibiotics against multidrug resistant
bacteria such as MRSA and <em>A. baumannii</em>. They were
also found to disperse or inhibit biofilm formation, and desensitization
to the antibiotic oxacillin was observed to be of 2–4 fold. In another report, Negi et al. evaluated the
synergistic effects of metronidazole-triazole hybrids against MRSA
with oxacillin antibiotic displaying a 4-fold improvement in MIC values
compared to the monotreatment. These
findings clearly imply that 1,2,3-triazole scaffolds can be successfully
used to create hybrids that have a synergistic impact on making bacteria
more susceptible to antibiotic exposure.</p></section></section><section id="sec4"><h2 class="pmc_sec_title">4. Metabolic Stability and Biocompatibility</h2>
<p>Triazoles contain a stable heterocyclic structure which is resistant
to hydrolysis, oxidation and reduction. The triazole moiety is commonly metabolized via the phase II N-glucuronidation
process. It has been reported that aldehyde glucuronidation occurs
at the triazole nitrogen in liver microsomes, with the specific site
of glucuronidation varying between organisms. Triazoles have been widely explored in medicinal chemistry
to enhance metabolic stability and biocompatibility particularly in
the case of inhibitor development. For
example, Kuttruff et al. developed potent autotaxin (ATX) inhibitors
where they introduced a triazole group in their lead compound that
exhibited improved pharmacokinetics and safety of the compound. Substitution of benzimidazolone with benzotriazole,
not only enhances metabolic stability but also improves its potency.
Brequinar, a human dihydroorotate dehydrogenase (hDHODH) inhibitor,
was initially abandoned due to its high toxicity. Development of a 1,2,3-triazole based compound by Sainas
et al. in 2017 avoided toxicity toward Jurkat T cells, holding potential
for further research in autoimmune diseases. Replacing imidazoles with triazoles in antifungal agents has also
enhanced metabolic stability and therapeutic effects. Furthermore, five membered heterocyclic compounds
including triazole have been found to have better metabolic stability
compared to their six membered counterparts.
</p></section><section id="sec5"><h2 class="pmc_sec_title">5. Antibacterial Activity of 1,2,4-Triazole-Based
Hybrid Compounds</h2>
<p>Similar to 1,2,3-triazoles, researchers
have explored 1,2,4-triazole
based hybrids for antibacterial activity against antibiotic sensitive
as well as resistant organisms. 1,2,4-Triazole
also offers structural diversity for designing antibacterial agents
with low cytotoxicity and evading resistance development, although
the synthesis pathway is completely different from that of 1,2,3-triazoles
(Click reaction). The 1,2,4-triazoles have been extensively explored
for the development of small molecule inhibitors particularly as antifungal
agents and aromatase inhibitors. They majorly function by inhibiting the active
site of the enzymes belonging to the cytochrome P450 family. Letrozole and anastrozole (used for the treatment
of breast cancer), fluconazole (antifungal agent), rizatriptan (used
against migraines) are some examples of 1,2,4-triazole containing
compounds approved by the FDA for the clinical treatment. 1,2,4 triazole moiety has been hybridized with
other antibacterial pharmacophores to enhance the biological properties.
Some of the recently explored 1,2,4-triazole hybrids for antibacterial
activity include 1,2,4-triazole–azole, 1,2,4-triazole-coumarin,
1,2,4-triazole-β-lactam, 1,2,4-triazole-pyrimidine, 1,2,4- triazole-quinoline,
1,2,4-triazole-quinolone, and triazole quinazoline hybrids etc. A detailed accounts on the development of 1,2,4-triazole
based antibacterial hybrids can be found in several recently published
review articles.<em>
,−

</em>
</p></section><section id="sec6"><h2 class="pmc_sec_title">6. Conclusion and Future Outlook</h2>
<p>The emergence
of antimicrobial resistance continues to pose a threat
to our healthcare system, necessitating the development of novel classes
of antimicrobial drugs that are less likely to develop resistance.
In this perspective, we have discussed strategically designed 1,2,3-triazole
hybrids that could work via multiple mechanisms of action to treat
bacterial infections. The advantage of multifaceted therapy or multitargeting
antibacterial agents is its low propensity to develop resistance against
them. Compared to a one-drug, one-target approach that becomes ineffective
upon drug resistance, a one-drug multitarget approach offers multiple
modes of action for bactericidal effect. While small molecules that
target critical enzymes required for bacterial survival or replication
have been found effective in antibacterial drug development, these
enzyme inhibitors are prone to gain resistance by the virtue of mutation
or other mechanisms discussed earlier. In this regard, membrane-targeting
antibacterial drugs and/or those capable of producing considerable
amounts of ROS work through nonspecific interactions, making it difficult
for bacteria to build resistance to these treatments. In the past
decade, it has been shown how a 1,2,3-triazole ring can bring various
pharmacophores together to bring about multiple mechanisms of action
to combat bacterial infection. The 1,2,3-triazole ring can act as
a linker for two biologically active molecules, providing an opportunity
to fine-tune different functionalities in a single molecule and, hence,
diversifying their structural aspects. Moreover, 1,2,3-triazole hybrids
have been found to bind to different sites of key enzymes critical
for bacterial survival. The hydrogen bond acceptor/donor capabilities,
biocompatibility, and ease of synthesis make it an attractive class
of compounds. 1,2,3-triazole hybrids can be designed to target bacterial
cell membranes and for generating intracellular ROS which can cause
damage to different biomacromolecules such as lipids, nucleic acids,
and proteins. Targeting various bacterial survival mechanisms (<a href="#fig7" class="usa-link">Figure 
</a>) is essential to
lower the likelihood of drug resistance development, as if one is
rendered inactive, the others will continue to fight. Therefore, 1,2,3-triazole
hybridization offers a modular, simple, and readily synthesizable
method for developing multitarget antibacterial drugs. Nonetheless,
there are still a few aspects that require further attention, though.
Out of the box design of novel hybrids is warranted which would allow
engagement with multiple targets to eliminate pathogenic bacteria,
including drug-resistant strains. Molecular hybridization can really
be a game changer. Novel 1,2,3-triazole hybrids need to be designed
considering the diversity and biological activity of potent pharmacophores
capable of exhibiting bactericidal effects.</p>
<figure class="fig xbox font-sm" id="fig7"><h3 class="obj_head">7.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371489_bg4c00132_0007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5a4/12371489/e85fcbe2b5a9/bg4c00132_0007.jpg" loading="lazy" id="gr7" height="491" width="675" alt="7"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Design of multitargeting
antibacterial 1,2,3-triazole-based hybrids
using the Click reaction.</p></figcaption></figure><p>For the past few decades, 1,2,3-triazole hybrids
have been extensively
explored for various biological activities. The major advantage of
these heterocycles is their biocompatible nature emerging out of its
chemical stability, nonreactivity and relatively simple structure.
However, the cytotoxicity of these hybrids can vary, depending on
the substituents attached to the triazole nucleus. To minimize cytotoxicity
with selectivity, the hybrid design can be made in such a way as
to target unique bacterial proteins. Substituents with a positive
charge can interact with the negatively charged bacterial cell membrane,
providing selectivity over mammalian cells. This selectivity arises
because the outer leaflet of the bacterial cell membrane contains
a greater proportion of anionic phospholipids as compared to mammalian
cells. Furthermore, the introduction
of ROS generating functionalities can provide better killing efficiency
in bacterial cells compared to normal cells as the former lacks a
well-organized antioxidant defense system. Despite all of the aforementioned advantages of 1,2,3-triazoles,
there are concerns that warrant further consideration and investigation.
The low water solubility of 1,2,3-triazoles is well recognized and
can have a substantial effect on their pharmacokinetics and therapeutic
effectiveness. To address this challenge, design can be made in such
a way as to attach hydrophilic groups or polyethylene glycol linkers,
thereby improving the bioavailability of the triazole hybrids. Nevertheless,
in a short period of time, 1,2,3-triazole hybrids have witnessed massive
growth in their medicinal applications, particularly as anticancer
drugs, antibacterial agents, etc. Most of the 1,2,3-triazole hybrids
exhibited excellent antibacterial activity against drug-resistant
strains. Therefore, rational development of molecular hybrids with
the 1,2,3-triazole nucleus with other pharmacophores having antibacterial
activity is a promising strategy to design novel antibacterial lead
compounds.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This work was funded by the Indian Institute of
Technology Palakkad, India; the Council of Scientific &amp; Industrial
Research, India (02(0434)/21/EMR-II, 09/1282(12720)/2021-EMR-I) 
Science and Engineering Research Board (SERB), India (CRG/2023/002841)
and the Department of Science &amp; Technology (DST), New Delhi, India
(INSPIRE Fellowship 230243).</p></section><section id="NOTES-d14e1866-autogenerated"><p>The authors declare no
competing financial interest.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="ref1">
<cite>Murray C. J. L., Ikuta K. S., Sharara F., Swetschinski L., Aguilar G. R., Gray A., Han C., Bisignano C., Rao P., Wool E., Johnson S. C., Browne A. J., Chipeta M. G., Fell F., Hackett S., Haines-Woodhouse G., Hamadani B. H. K., Kumaran E. A. P., McManigal B., Achalapong S.. et al. Global Burden of Bacterial Antimicrobial Resistance
in 2019: A Systematic Analysis. Lancet. 2022;399:629–655. doi: 10.1016/S0140-6736(21)02724-0.</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)02724-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8841637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35065702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Global%20Burden%20of%20Bacterial%20Antimicrobial%20Resistance%20in%202019:%20A%20Systematic%20Analysis&amp;author=C.%20J.%20L.%20Murray&amp;author=K.%20S.%20Ikuta&amp;author=F.%20Sharara&amp;author=L.%20Swetschinski&amp;author=G.%20R.%20Aguilar&amp;volume=399&amp;publication_year=2022&amp;pages=629-655&amp;pmid=35065702&amp;doi=10.1016/S0140-6736(21)02724-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref2">
<cite>Krishnaprasad V. H., Kumar S.. Antimicrobial Resistance:
An Ultimate Challenge for 21st Century
Scientists, Healthcare Professionals, and Policymakers to Save Future
Generations. J. Med. Chem. 2024;67:15927–15930. doi: 10.1021/acs.jmedchem.4c02002.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.4c02002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39238216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Antimicrobial%20Resistance:%20An%20Ultimate%20Challenge%20for%2021st%20Century%20Scientists,%20Healthcare%20Professionals,%20and%20Policymakers%20to%20Save%20Future%20Generations&amp;author=V.%20H.%20Krishnaprasad&amp;author=S.%20Kumar&amp;volume=67&amp;publication_year=2024&amp;pages=15927-15930&amp;pmid=39238216&amp;doi=10.1021/acs.jmedchem.4c02002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref3">
<cite>Haldar J.. Confronting
the Rising Threat of Antimicrobial Resistance: A Global Health Imperative. ACS Infect. Dis. 2024;10:1–2. doi: 10.1021/acsinfecdis.3c00571.</cite> [<a href="https://doi.org/10.1021/acsinfecdis.3c00571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38112298/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Infect.%20Dis.&amp;title=Confronting%20the%20Rising%20Threat%20of%20Antimicrobial%20Resistance:%20A%20Global%20Health%20Imperative&amp;author=J.%20Haldar&amp;volume=10&amp;publication_year=2024&amp;pages=1-2&amp;pmid=38112298&amp;doi=10.1021/acsinfecdis.3c00571&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref4">
<cite>Freire-Moran L., Aronsson B., Manz C., Gyssens I. C., So A. D., Monnet D. L., Cars O.. ECDC-EMA Working Group.
Critical
Shortage of New Antibiotics in Development against Multidrug-Resistant
BacteriaTime to React Is Now. Drug Resist.
Updat. 2011;14:118–124. doi: 10.1016/j.drup.2011.02.003.</cite> [<a href="https://doi.org/10.1016/j.drup.2011.02.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21435939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Resist.%20Updat.&amp;title=ECDC-EMA%20Working%20Group.%20Critical%20Shortage%20of%20New%20Antibiotics%20in%20Development%20against%20Multidrug-Resistant%20Bacteria%EE%97%B8Time%20to%20React%20Is%20Now&amp;author=L.%20Freire-Moran&amp;author=B.%20Aronsson&amp;author=C.%20Manz&amp;author=I.%20C.%20Gyssens&amp;author=A.%20D.%20So&amp;volume=14&amp;publication_year=2011&amp;pages=118-124&amp;pmid=21435939&amp;doi=10.1016/j.drup.2011.02.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref5">
<cite>Darby E. M., Trampari E., Siasat P., Gaya M. S., Alav I., Webber M. A., Blair J. M. A.. Molecular Mechanisms of Antibiotic
Resistance Revisited. Nat. Rev. Microbiol. 2023;21:280–295. doi: 10.1038/s41579-022-00820-y.</cite> [<a href="https://doi.org/10.1038/s41579-022-00820-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36411397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Microbiol.&amp;title=Molecular%20Mechanisms%20of%20Antibiotic%20Resistance%20Revisited&amp;author=E.%20M.%20Darby&amp;author=E.%20Trampari&amp;author=P.%20Siasat&amp;author=M.%20S.%20Gaya&amp;author=I.%20Alav&amp;volume=21&amp;publication_year=2023&amp;pages=280-295&amp;pmid=36411397&amp;doi=10.1038/s41579-022-00820-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref6">
<cite>Rahn H. P., Liu X., Chosy M. B., Sun J., Cegelski L., Wender P. A.. Biguanide-Vancomycin
Conjugates Are Effective Broad-Spectrum Antibiotics against Actively
Growing and Biofilm-Associated Gram-Positive and Gram-Negative ESKAPE
Pathogens and Mycobacteria
. J. Am. Chem. Soc. 2024;146:22541–22552. doi: 10.1021/jacs.4c06520.</cite> [<a href="https://doi.org/10.1021/jacs.4c06520" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11624893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39088791/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Chem.%20Soc.&amp;title=Biguanide-Vancomycin%20Conjugates%20Are%20Effective%20Broad-Spectrum%20Antibiotics%20against%20Actively%20Growing%20and%20Biofilm-Associated%20Gram-Positive%20and%20Gram-Negative%20ESKAPE%20Pathogens%20and%20Mycobacteria&amp;author=H.%20P.%20Rahn&amp;author=X.%20Liu&amp;author=M.%20B.%20Chosy&amp;author=J.%20Sun&amp;author=L.%20Cegelski&amp;volume=146&amp;publication_year=2024&amp;pages=22541-22552&amp;pmid=39088791&amp;doi=10.1021/jacs.4c06520&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref7">
<cite>Luo Q., Lu P., Chen Y., Shen P., Zheng B., Ji J., Ying C., Liu Z., Xiao Y.. ESKAPE in China: Epidemiology
and Characteristics of Antibiotic Resistance. Emerg. Microbes Infect. 2024;13:2317915. doi: 10.1080/22221751.2024.2317915.</cite> [<a href="https://doi.org/10.1080/22221751.2024.2317915" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10896150/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38356197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Emerg.%20Microbes%20Infect.&amp;title=ESKAPE%20in%20China:%20Epidemiology%20and%20Characteristics%20of%20Antibiotic%20Resistance&amp;author=Q.%20Luo&amp;author=P.%20Lu&amp;author=Y.%20Chen&amp;author=P.%20Shen&amp;author=B.%20Zheng&amp;volume=13&amp;publication_year=2024&amp;pages=2317915&amp;pmid=38356197&amp;doi=10.1080/22221751.2024.2317915&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref8">
<cite>Denissen J., Reyneke B., Waso-Reyneke M., Havenga B., Barnard T., Khan S., Khan W.. Prevalence of ESKAPE Pathogens in
the Environment: Antibiotic Resistance Status, Community-Acquired
Infection and Risk to Human Health. Int. J.
Hyg. Environ. Health. 2022;244:114006. doi: 10.1016/j.ijheh.2022.114006.</cite> [<a href="https://doi.org/10.1016/j.ijheh.2022.114006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35841823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Hyg.%20Environ.%20Health&amp;title=Prevalence%20of%20ESKAPE%20Pathogens%20in%20the%20Environment:%20Antibiotic%20Resistance%20Status,%20Community-Acquired%20Infection%20and%20Risk%20to%20Human%20Health&amp;author=J.%20Denissen&amp;author=B.%20Reyneke&amp;author=M.%20Waso-Reyneke&amp;author=B.%20Havenga&amp;author=T.%20Barnard&amp;volume=244&amp;publication_year=2022&amp;pages=114006&amp;pmid=35841823&amp;doi=10.1016/j.ijheh.2022.114006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref9">
<cite>González-Bello C., Rodríguez D., Pernas M., Rodríguez Á., Colchón E.. β-Lactamase Inhibitors To Restore
the Efficacy of Antibiotics against Superbugs. J. Med. Chem. 2020;63:1859–1881. doi: 10.1021/acs.jmedchem.9b01279.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.9b01279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31663735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=%CE%B2-Lactamase%20Inhibitors%20To%20Restore%20the%20Efficacy%20of%20Antibiotics%20against%20Superbugs&amp;author=C.%20Gonz%C3%A1lez-Bello&amp;author=D.%20Rodr%C3%ADguez&amp;author=M.%20Pernas&amp;author=%C3%81.%20Rodr%C3%ADguez&amp;author=E.%20Colch%C3%B3n&amp;volume=63&amp;publication_year=2020&amp;pages=1859-1881&amp;pmid=31663735&amp;doi=10.1021/acs.jmedchem.9b01279&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref10">
<cite>Liao J., Qi Q., Kuang L., Zhou Y., Xiao Q., Liu T., Wang X., Guo L., Jiang Y.. Chloramphenicol Binding
Sites of Acinetobacter baumannii Chloramphenicol
Acetyltransferase CatB8. ACS Infect. Dis. 2024;10:870–878. doi: 10.1021/acsinfecdis.3c00359.</cite> [<a href="https://doi.org/10.1021/acsinfecdis.3c00359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38311919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Infect.%20Dis.&amp;title=Chloramphenicol%20Binding%20Sites%20of%20Acinetobacter%20baumannii%20Chloramphenicol%20Acetyltransferase%20CatB8&amp;author=J.%20Liao&amp;author=Q.%20Qi&amp;author=L.%20Kuang&amp;author=Y.%20Zhou&amp;author=Q.%20Xiao&amp;volume=10&amp;publication_year=2024&amp;pages=870-878&amp;pmid=38311919&amp;doi=10.1021/acsinfecdis.3c00359&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref11">
<cite>Kondo S., Hotta K.. Semisynthetic Aminoglycoside
Antibiotics: Development and Enzymatic
Modifications. J. Infect. Chemother. 1999;5:1–9. doi: 10.1007/s101560050001.</cite> [<a href="https://doi.org/10.1007/s101560050001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11810483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Infect.%20Chemother.&amp;title=Semisynthetic%20Aminoglycoside%20Antibiotics:%20Development%20and%20Enzymatic%20Modifications&amp;author=S.%20Kondo&amp;author=K.%20Hotta&amp;volume=5&amp;publication_year=1999&amp;pages=1-9&amp;pmid=11810483&amp;doi=10.1007/s101560050001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref12">
<cite>Lin Q., Deslouches B., Montelaro R. C., Di Y. P.. Prevention of ESKAPE
Pathogen Biofilm Formation by Antimicrobial Peptides WLBU2 and LL37. Int. J. Antimicrob. Agents. 2018;52:667–672. doi: 10.1016/j.ijantimicag.2018.04.019.</cite> [<a href="https://doi.org/10.1016/j.ijantimicag.2018.04.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6230315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29753132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Antimicrob.%20Agents&amp;title=Prevention%20of%20ESKAPE%20Pathogen%20Biofilm%20Formation%20by%20Antimicrobial%20Peptides%20WLBU2%20and%20LL37&amp;author=Q.%20Lin&amp;author=B.%20Deslouches&amp;author=R.%20C.%20Montelaro&amp;author=Y.%20P.%20Di&amp;volume=52&amp;publication_year=2018&amp;pages=667-672&amp;pmid=29753132&amp;doi=10.1016/j.ijantimicag.2018.04.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref13">
<cite>Wielders C. L. C., Fluit A. C., Brisse S., Verhoef J., Schmitz F. J.. MecA Gene
Is Widely Disseminated in Staphylococcus aureus Population. J. Clin. Microbiol. 2002;40:3970–3975. doi: 10.1128/JCM.40.11.3970-3975.2002.</cite> [<a href="https://doi.org/10.1128/JCM.40.11.3970-3975.2002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC139644/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12409360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Microbiol.&amp;title=MecA%20Gene%20Is%20Widely%20Disseminated%20in%20Staphylococcus%20aureus%20Population&amp;author=C.%20L.%20C.%20Wielders&amp;author=A.%20C.%20Fluit&amp;author=S.%20Brisse&amp;author=J.%20Verhoef&amp;author=F.%20J.%20Schmitz&amp;volume=40&amp;publication_year=2002&amp;pages=3970-3975&amp;pmid=12409360&amp;doi=10.1128/JCM.40.11.3970-3975.2002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref14">
<cite>Indrajith S., Mukhopadhyay A. K., Chowdhury G., Farraj D. A. Al, Alkufeidy R. M., Natesan S., Meghanathan V., Gopal S., Muthupandian S.. Molecular
Insights of Carbapenem Resistance Klebsiella pneumoniae Isolates with Focus on Multidrug Resistance from Clinical Samples. J. Infect. Public Health. 2021;14:131–138. doi: 10.1016/j.jiph.2020.09.018.</cite> [<a href="https://doi.org/10.1016/j.jiph.2020.09.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33234410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Infect.%20Public%20Health&amp;title=Molecular%20Insights%20of%20Carbapenem%20Resistance%20Klebsiella%20pneumoniae%20Isolates%20with%20Focus%20on%20Multidrug%20Resistance%20from%20Clinical%20Samples&amp;author=S.%20Indrajith&amp;author=A.%20K.%20Mukhopadhyay&amp;author=G.%20Chowdhury&amp;author=D.%20A.%20Al%20Farraj&amp;author=R.%20M.%20Alkufeidy&amp;volume=14&amp;publication_year=2021&amp;pages=131-138&amp;pmid=33234410&amp;doi=10.1016/j.jiph.2020.09.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref15">
<cite>Lin H., Feng C., Zhu T., Li A., Liu S., Zhang L., Li Q., Zhang X., Lin L., Lu J., Lin X., Li K., Zhang H., Xu T., Li C., Bao Q.. Molecular Mechanism of the β-Lactamase
Mediated
β-Lactam Antibiotic Resistance of Pseudomonas aeruginosa Isolated From a Chinese Teaching Hospital. Front. Microbiol. 2022;13:855961. doi: 10.3389/fmicb.2022.855961.</cite> [<a href="https://doi.org/10.3389/fmicb.2022.855961" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9096163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35572664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Microbiol.&amp;title=Molecular%20Mechanism%20of%20the%20%CE%B2-Lactamase%20Mediated%20%CE%B2-Lactam%20Antibiotic%20Resistance%20of%20Pseudomonas%20aeruginosa%20Isolated%20From%20a%20Chinese%20Teaching%20Hospital&amp;author=H.%20Lin&amp;author=C.%20Feng&amp;author=T.%20Zhu&amp;author=A.%20Li&amp;author=S.%20Liu&amp;volume=13&amp;publication_year=2022&amp;pages=855961&amp;pmid=35572664&amp;doi=10.3389/fmicb.2022.855961&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref16">
<cite>Ramirez M. S., Tolmasky M. E.. Aminoglycoside Modifying Enzymes. Drug Resist. Updat. 2010;13:151–171. doi: 10.1016/j.drup.2010.08.003.</cite> [<a href="https://doi.org/10.1016/j.drup.2010.08.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2992599/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20833577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Resist.%20Updat.&amp;title=Aminoglycoside%20Modifying%20Enzymes&amp;author=M.%20S.%20Ramirez&amp;author=M.%20E.%20Tolmasky&amp;volume=13&amp;publication_year=2010&amp;pages=151-171&amp;pmid=20833577&amp;doi=10.1016/j.drup.2010.08.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref17">
<cite>Zapun A., Contreras-Martel C., Vernet T.. Penicillin-Binding
Proteins and Beta-Lactam
Resistance. FEMS Microbiol. Rev. 2008;32:361–385. doi: 10.1111/j.1574-6976.2007.00095.x.</cite> [<a href="https://doi.org/10.1111/j.1574-6976.2007.00095.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18248419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEMS%20Microbiol.%20Rev.&amp;title=Penicillin-Binding%20Proteins%20and%20Beta-Lactam%20Resistance&amp;author=A.%20Zapun&amp;author=C.%20Contreras-Martel&amp;author=T.%20Vernet&amp;volume=32&amp;publication_year=2008&amp;pages=361-385&amp;pmid=18248419&amp;doi=10.1111/j.1574-6976.2007.00095.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref18">
<cite>Zeng D., Debabov D., Hartsell T. L., Cano R. J., Adams S., Schuyler J. A., McMillan R., Pace J. L.. Approved Glycopeptide
Antibacterial Drugs: Mechanism of Action and Resistance. Cold Spring Harb. Perspect. Med. 2016;6:a026989.  doi: 10.1101/cshperspect.a026989.</cite> [<a href="https://doi.org/10.1101/cshperspect.a026989" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5131748/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27663982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cold%20Spring%20Harb.%20Perspect.%20Med.&amp;title=Approved%20Glycopeptide%20Antibacterial%20Drugs:%20Mechanism%20of%20Action%20and%20Resistance&amp;author=D.%20Zeng&amp;author=D.%20Debabov&amp;author=T.%20L.%20Hartsell&amp;author=R.%20J.%20Cano&amp;author=S.%20Adams&amp;volume=6&amp;publication_year=2016&amp;pages=a026989&amp;pmid=27663982&amp;doi=10.1101/cshperspect.a026989&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref19">
<cite>Roberts M. C.. Update
on Macrolide-Lincosamide-Streptogramin, Ketolide, and Oxazolidinone
Resistance Genes. FEMS Microbiol. Lett. 2008;282:147–159. doi: 10.1111/j.1574-6968.2008.01145.x.</cite> [<a href="https://doi.org/10.1111/j.1574-6968.2008.01145.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18399991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEMS%20Microbiol.%20Lett.&amp;title=Update%20on%20Macrolide-Lincosamide-Streptogramin,%20Ketolide,%20and%20Oxazolidinone%20Resistance%20Genes&amp;author=M.%20C.%20Roberts&amp;volume=282&amp;publication_year=2008&amp;pages=147-159&amp;pmid=18399991&amp;doi=10.1111/j.1574-6968.2008.01145.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref20">
<cite>Correia S., Poeta P., Hébraud M., Capelo J. L., Igrejas G.. Mechanisms
of Quinolone Action and Resistance: Where Do We Stand? J. Med. Microbiol. 2017;66:551–559. doi: 10.1099/jmm.0.000475.</cite> [<a href="https://doi.org/10.1099/jmm.0.000475" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28504927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Microbiol.&amp;title=Mechanisms%20of%20Quinolone%20Action%20and%20Resistance:%20Where%20Do%20We%20Stand?&amp;author=S.%20Correia&amp;author=P.%20Poeta&amp;author=M.%20H%C3%A9braud&amp;author=J.%20L.%20Capelo&amp;author=G.%20Igrejas&amp;volume=66&amp;publication_year=2017&amp;pages=551-559&amp;pmid=28504927&amp;doi=10.1099/jmm.0.000475&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref21">
<cite>Draper P.. The Outer
Parts of the Mycobacterial Envelope as Permeability Barriers. Front. Biosci. 1998;3:D1253–1261. doi: 10.2741/A360.</cite> [<a href="https://doi.org/10.2741/A360" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9851911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Biosci.&amp;title=The%20Outer%20Parts%20of%20the%20Mycobacterial%20Envelope%20as%20Permeability%20Barriers&amp;author=P.%20Draper&amp;volume=3&amp;publication_year=1998&amp;pages=D1253-1261&amp;pmid=9851911&amp;doi=10.2741/A360&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref22">
<cite>Wong J. L. C., Romano M., Kerry L. E., Kwong H.-S., Low W.-W., Brett S. J., Clements A., Beis K., Frankel G.. OmpK36-Mediated
Carbapenem Resistance Attenuates ST258 Klebsiella pneumoniae in Vivo. Nat. Commun. 2019;10:3957. doi: 10.1038/s41467-019-11756-y.</cite> [<a href="https://doi.org/10.1038/s41467-019-11756-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6718652/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31477712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=OmpK36-Mediated%20Carbapenem%20Resistance%20Attenuates%20ST258%20Klebsiella%20pneumoniae%20in%20Vivo&amp;author=J.%20L.%20C.%20Wong&amp;author=M.%20Romano&amp;author=L.%20E.%20Kerry&amp;author=H.-S.%20Kwong&amp;author=W.-W.%20Low&amp;volume=10&amp;publication_year=2019&amp;pages=3957&amp;pmid=31477712&amp;doi=10.1038/s41467-019-11756-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref23">
<cite>Lou H., Chen M., Black S. S., Bushell S. R., Ceccarelli M., Mach T., Beis K., Low A. S., Bamford V. A., Booth I. R., Bayley H., Naismith J. H.. Altered Antibiotic
Transport in OmpC Mutants Isolated from a Series of Clinical Strains
of Multi-Drug Resistant E. coli
. PLoS One. 2011;6:e25825.  doi: 10.1371/journal.pone.0025825.</cite> [<a href="https://doi.org/10.1371/journal.pone.0025825" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3203869/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22053181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Altered%20Antibiotic%20Transport%20in%20OmpC%20Mutants%20Isolated%20from%20a%20Series%20of%20Clinical%20Strains%20of%20Multi-Drug%20Resistant%20E.%20coli&amp;author=H.%20Lou&amp;author=M.%20Chen&amp;author=S.%20S.%20Black&amp;author=S.%20R.%20Bushell&amp;author=M.%20Ceccarelli&amp;volume=6&amp;publication_year=2011&amp;pages=e25825&amp;pmid=22053181&amp;doi=10.1371/journal.pone.0025825&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref24">
<cite>Heravi M. M., Zadsirjan V.. Prescribed Drugs Containing Nitrogen Heterocycles:
An Overview. RSC Adv. 2020;10:44247–44311. doi: 10.1039/D0RA09198G.</cite> [<a href="https://doi.org/10.1039/D0RA09198G" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9092475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35557843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=RSC%20Adv.&amp;title=Prescribed%20Drugs%20Containing%20Nitrogen%20Heterocycles:%20An%20Overview&amp;author=M.%20M.%20Heravi&amp;author=V.%20Zadsirjan&amp;volume=10&amp;publication_year=2020&amp;pages=44247-44311&amp;pmid=35557843&amp;doi=10.1039/D0RA09198G&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref25">
<cite>Obaid R. J., Mughal E. U., Naeem N., Al-Rooqi M. M., Sadiq A., Jassas R. S., Moussa Z., Ahmed S. A.. Pharmacological
Significance of Nitrogen-Containing Five and Six-Membered Heterocyclic
Scaffolds as Potent Cholinesterase Inhibitors for Drug Discovery. Process Biochem. 2022;120:250–259. doi: 10.1016/j.procbio.2022.06.009.</cite> [<a href="https://doi.org/10.1016/j.procbio.2022.06.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Process%20Biochem.&amp;title=Pharmacological%20Significance%20of%20Nitrogen-Containing%20Five%20and%20Six-Membered%20Heterocyclic%20Scaffolds%20as%20Potent%20Cholinesterase%20Inhibitors%20for%20Drug%20Discovery&amp;author=R.%20J.%20Obaid&amp;author=E.%20U.%20Mughal&amp;author=N.%20Naeem&amp;author=M.%20M.%20Al-Rooqi&amp;author=A.%20Sadiq&amp;volume=120&amp;publication_year=2022&amp;pages=250-259&amp;doi=10.1016/j.procbio.2022.06.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref26">
<cite>Mermer A., Keles T., Sirin Y.. Recent Studies of Nitrogen
Containing
Heterocyclic Compounds as Novel Antiviral Agents: A Review. Bioorg. Chem. 2021;114:105076. doi: 10.1016/j.bioorg.2021.105076.</cite> [<a href="https://doi.org/10.1016/j.bioorg.2021.105076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34157555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Chem.&amp;title=Recent%20Studies%20of%20Nitrogen%20Containing%20Heterocyclic%20Compounds%20as%20Novel%20Antiviral%20Agents:%20A%20Review&amp;author=A.%20Mermer&amp;author=T.%20Keles&amp;author=Y.%20Sirin&amp;volume=114&amp;publication_year=2021&amp;pages=105076&amp;pmid=34157555&amp;doi=10.1016/j.bioorg.2021.105076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref27">
<cite>Bladin J. A.. Ueber von
Dicyanphenylhydrazin Abgeleitete Verbindungen. Ber. Dtsch. Chem. Ges. 1885;18:1544–1551. doi: 10.1002/cber.188501801335.</cite> [<a href="https://doi.org/10.1002/cber.188501801335" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ber.%20Dtsch.%20Chem.%20Ges.&amp;title=Ueber%20von%20Dicyanphenylhydrazin%20Abgeleitete%20Verbindungen&amp;author=J.%20A.%20Bladin&amp;volume=18&amp;publication_year=1885&amp;pages=1544-1551&amp;doi=10.1002/cber.188501801335&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref28">
<cite>Guan Q., Xing S., Wang L., Zhu J., Guo C., Xu C., Zhao Q., Wu Y., Chen Y., Sun H.. Triazoles
in Medicinal Chemistry: Physicochemical Properties, Bioisosterism,
and Application. J. Med. Chem. 2024;67:7788–7824. doi: 10.1021/acs.jmedchem.4c00652.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.4c00652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38699796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Triazoles%20in%20Medicinal%20Chemistry:%20Physicochemical%20Properties,%20Bioisosterism,%20and%20Application&amp;author=Q.%20Guan&amp;author=S.%20Xing&amp;author=L.%20Wang&amp;author=J.%20Zhu&amp;author=C.%20Guo&amp;volume=67&amp;publication_year=2024&amp;pages=7788-7824&amp;pmid=38699796&amp;doi=10.1021/acs.jmedchem.4c00652&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref29">
<cite>Kolb H. C., Finn M. G., Sharpless K. B.. Click Chemistry:
Diverse Chemical
Function from a Few Good Reactions. Angew. Chem.,
Int. Ed. Engl. 2001;40:2004–2021. doi: 10.1002/1521-3773(20010601)40:11&amp;#x0003c;2004::AID-ANIE2004&amp;#x0003e;3.0.CO;2-5.</cite> [<a href="https://doi.org/10.1002/1521-3773(20010601)40:11&amp;#x0003c;2004::AID-ANIE2004&amp;#x0003e;3.0.CO;2-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11433435/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Angew.%20Chem.,%20Int.%20Ed.%20Engl.&amp;title=Click%20Chemistry:%20Diverse%20Chemical%20Function%20from%20a%20Few%20Good%20Reactions&amp;author=H.%20C.%20Kolb&amp;author=M.%20G.%20Finn&amp;author=K.%20B.%20Sharpless&amp;volume=40&amp;publication_year=2001&amp;pages=2004-2021&amp;pmid=11433435&amp;doi=10.1002/1521-3773(20010601)40:11&amp;#x0003c;2004::AID-ANIE2004&amp;#x0003e;3.0.CO;2-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref30">
<cite>Chi T. C., Yang P. C., Hung S. K., Wu H. W., Wang H. C., Liu H. K., Liu L. W., Chou H. H.. Synthesis of Multisubstituted
1,2,3-Triazoles: Regioselective Formation and Reaction Mechanism. J. Org. Chem. 2024;89:5401–5408. doi: 10.1021/acs.joc.3c02836.</cite> [<a href="https://doi.org/10.1021/acs.joc.3c02836" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11040735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38546539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Org.%20Chem.&amp;title=Synthesis%20of%20Multisubstituted%201,2,3-Triazoles:%20Regioselective%20Formation%20and%20Reaction%20Mechanism&amp;author=T.%20C.%20Chi&amp;author=P.%20C.%20Yang&amp;author=S.%20K.%20Hung&amp;author=H.%20W.%20Wu&amp;author=H.%20C.%20Wang&amp;volume=89&amp;publication_year=2024&amp;pages=5401-5408&amp;pmid=38546539&amp;doi=10.1021/acs.joc.3c02836&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref31">
<cite>Matin M. M., Matin P., Rahman M. R., Ben Hadda T., Almalki F. A., Mahmud S., Ghoneim M. M., Alruwaily M., Alshehri S.. Triazoles and Their Derivatives: Chemistry, Synthesis,
and Therapeutic Applications. Front. Mol. Biosci. 2022;9:864286. doi: 10.3389/fmolb.2022.864286.</cite> [<a href="https://doi.org/10.3389/fmolb.2022.864286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9081720/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35547394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Mol.%20Biosci.&amp;title=Triazoles%20and%20Their%20Derivatives:%20Chemistry,%20Synthesis,%20and%20Therapeutic%20Applications&amp;author=M.%20M.%20Matin&amp;author=P.%20Matin&amp;author=M.%20R.%20Rahman&amp;author=T.%20Ben%20Hadda&amp;author=F.%20A.%20Almalki&amp;volume=9&amp;publication_year=2022&amp;pages=864286&amp;pmid=35547394&amp;doi=10.3389/fmolb.2022.864286&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref32">
<cite>Liang T., Sun X., Li W., Hou G., Gao F.. 1,2,3-Triazole-Containing
Compounds as Anti–Lung Cancer Agents: Current Developments,
Mechanisms of Action, and Structure–Activity Relationship. Front. Pharmacol. 2021;12:661173. doi: 10.3389/fphar.2021.661173.</cite> [<a href="https://doi.org/10.3389/fphar.2021.661173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8226129/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34177578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Pharmacol.&amp;title=1,2,3-Triazole-Containing%20Compounds%20as%20Anti%E2%80%93Lung%20Cancer%20Agents:%20Current%20Developments,%20Mechanisms%20of%20Action,%20and%20Structure%E2%80%93Activity%20Relationship&amp;author=T.%20Liang&amp;author=X.%20Sun&amp;author=W.%20Li&amp;author=G.%20Hou&amp;author=F.%20Gao&amp;volume=12&amp;publication_year=2021&amp;pages=661173&amp;pmid=34177578&amp;doi=10.3389/fphar.2021.661173&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref33">
<cite>Tron G. C., Pirali T., Billington R. A., Canonico P. L., Sorba G., Genazzani A. A.. Click Chemistry Reactions in Medicinal Chemistry: Applications
of the 1,3-Dipolar Cycloaddition between Azides and Alkynes. Med. Res. Rev. 2008;28:278–308. doi: 10.1002/med.20107.</cite> [<a href="https://doi.org/10.1002/med.20107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17763363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med.%20Res.%20Rev.&amp;title=Click%20Chemistry%20Reactions%20in%20Medicinal%20Chemistry:%20Applications%20of%20the%201,3-Dipolar%20Cycloaddition%20between%20Azides%20and%20Alkynes&amp;author=G.%20C.%20Tron&amp;author=T.%20Pirali&amp;author=R.%20A.%20Billington&amp;author=P.%20L.%20Canonico&amp;author=G.%20Sorba&amp;volume=28&amp;publication_year=2008&amp;pages=278-308&amp;pmid=17763363&amp;doi=10.1002/med.20107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref34">
<cite>Chemama M., Fonvielle M., Arthur M., Valéry J. M., Etheve Quelquejeu M.. Synthesis of Stable Aminoacyl TRNA Analogues Containing
Triazole as a Bioisoster of Esters. Chem.Eur.
J. 2009;15:1929–1938. doi: 10.1002/chem.200801563.</cite> [<a href="https://doi.org/10.1002/chem.200801563" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19035586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%EE%97%B8Eur.%20J.&amp;title=Synthesis%20of%20Stable%20Aminoacyl%20TRNA%20Analogues%20Containing%20Triazole%20as%20a%20Bioisoster%20of%20Esters&amp;author=M.%20Chemama&amp;author=M.%20Fonvielle&amp;author=M.%20Arthur&amp;author=J.%20M.%20Val%C3%A9ry&amp;author=M.%20Etheve%20Quelquejeu&amp;volume=15&amp;publication_year=2009&amp;pages=1929-1938&amp;pmid=19035586&amp;doi=10.1002/chem.200801563&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref35">
<cite>Fan Y.-L., Ke X., Liu M.. Coumarin–Triazole Hybrids and Their Biological
Activities. J. Heterocycl. Chem. 2018;55:791–802. doi: 10.1002/jhet.3112.</cite> [<a href="https://doi.org/10.1002/jhet.3112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Heterocycl.%20Chem.&amp;title=Coumarin%E2%80%93Triazole%20Hybrids%20and%20Their%20Biological%20Activities&amp;author=Y.-L.%20Fan&amp;author=X.%20Ke&amp;author=M.%20Liu&amp;volume=55&amp;publication_year=2018&amp;pages=791-802&amp;doi=10.1002/jhet.3112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref36">
<cite>Shiradkar M. R., Murahari K. K., Gangadasu H. R., Suresh T., Kalyan C. A., Panchal D., Kaur R., Burange P., Ghogare J., Mokale V., Raut M.. Synthesis
of New S-Derivatives of
Clubbed Triazolyl Thiazole as Anti-Mycobacterium Tuberculosis Agents. Bioorg. Med. Chem. 2007;15:3997–4008. doi: 10.1016/j.bmc.2007.04.003.</cite> [<a href="https://doi.org/10.1016/j.bmc.2007.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17442576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.&amp;title=Synthesis%20of%20New%20S-Derivatives%20of%20Clubbed%20Triazolyl%20Thiazole%20as%20Anti-Mycobacterium%20Tuberculosis%20Agents&amp;author=M.%20R.%20Shiradkar&amp;author=K.%20K.%20Murahari&amp;author=H.%20R.%20Gangadasu&amp;author=T.%20Suresh&amp;author=C.%20A.%20Kalyan&amp;volume=15&amp;publication_year=2007&amp;pages=3997-4008&amp;pmid=17442576&amp;doi=10.1016/j.bmc.2007.04.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref37">
<cite>Demchuk D. V., Samet A. V., Chernysheva N. B., Ushkarov V. I., Stashina G. A., Konyushkin L. D., Raihstat M. M., Firgang S. I., Philchenkov A. A., Zavelevich M. P., Kuiava L. M., Chekhun V. F., Blokhin D. Y., Kiselyov A. S., Semenova M. N., Semenov V. V.. Synthesis and Antiproliferative
Activity of Conformationally Restricted 1,2,3-Triazole Analogues of
Combretastatins in the Sea Urchin Embryo Model and against Human Cancer
Cell Lines. Bioorg. Med. Chem. 2014;22:738–755. doi: 10.1016/j.bmc.2013.12.015.</cite> [<a href="https://doi.org/10.1016/j.bmc.2013.12.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24387982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.&amp;title=Synthesis%20and%20Antiproliferative%20Activity%20of%20Conformationally%20Restricted%201,2,3-Triazole%20Analogues%20of%20Combretastatins%20in%20the%20Sea%20Urchin%20Embryo%20Model%20and%20against%20Human%20Cancer%20Cell%20Lines&amp;author=D.%20V.%20Demchuk&amp;author=A.%20V.%20Samet&amp;author=N.%20B.%20Chernysheva&amp;author=V.%20I.%20Ushkarov&amp;author=G.%20A.%20Stashina&amp;volume=22&amp;publication_year=2014&amp;pages=738-755&amp;pmid=24387982&amp;doi=10.1016/j.bmc.2013.12.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref38">
<cite>Güzeldemirci N.
U., Küçükbasmacı Ö.. Synthesis
and Antimicrobial Activity
Evaluation of New 1,2,4-Triazoles and 1,3,4-Thiadiazoles Bearing Imidazo­[2,1-b]­Thiazole
Moiety. Eur. J. Med. Chem. 2010;45:63–68. doi: 10.1016/j.ejmech.2009.09.024.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2009.09.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19939519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Synthesis%20and%20Antimicrobial%20Activity%20Evaluation%20of%20New%201,2,4-Triazoles%20and%201,3,4-Thiadiazoles%20Bearing%20Imidazo%C2%AD%5B2,1-b%5D%C2%ADThiazole%20Moiety&amp;author=N.%20U.%20G%C3%BCzeldemirci&amp;author=%C3%96.%20K%C3%BC%C3%A7%C3%BCkbasmac%C4%B1&amp;volume=45&amp;publication_year=2010&amp;pages=63-68&amp;pmid=19939519&amp;doi=10.1016/j.ejmech.2009.09.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref39">
<cite>Vaishnani M. J., Bijani S., Rahamathulla M., Baldaniya L., Jain V., Thajudeen K. Y., Ahmed M. M., Farhana S. A., Pasha I.. Biological Importance
and Synthesis of 1,2,3-Triazole Derivatives:
A Review. Green Chem. Lett. Rev. 2024;17:2307989. doi: 10.1080/17518253.2024.2307989.</cite> [<a href="https://doi.org/10.1080/17518253.2024.2307989" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Green%20Chem.%20Lett.%20Rev.&amp;title=Biological%20Importance%20and%20Synthesis%20of%201,2,3-Triazole%20Derivatives:%20A%20Review&amp;author=M.%20J.%20Vaishnani&amp;author=S.%20Bijani&amp;author=M.%20Rahamathulla&amp;author=L.%20Baldaniya&amp;author=V.%20Jain&amp;volume=17&amp;publication_year=2024&amp;pages=2307989&amp;doi=10.1080/17518253.2024.2307989&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref40">
<cite>Fink D. M., Palermo M. G., Bores G. M., Huger F. P., Kurys B. E., Merriman M. C., Olsen G. E., Petko W., O’Malley G. J.. Imino 1,2,3,4-Tetrahydrocyclopent­[b]­Indole
Carbamates as Dual Inhibitors of Acetylcholinesterase and Monoamine
Oxidase. Bioorg. Med. Chem. Lett. 1996;6:625–630. doi: 10.1016/0960-894X(96)00072-8.</cite> [<a href="https://doi.org/10.1016/0960-894X(96)00072-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.%20Lett.&amp;title=Imino%201,2,3,4-Tetrahydrocyclopent%C2%AD%5Bb%5D%C2%ADIndole%20Carbamates%20as%20Dual%20Inhibitors%20of%20Acetylcholinesterase%20and%20Monoamine%20Oxidase&amp;author=D.%20M.%20Fink&amp;author=M.%20G.%20Palermo&amp;author=G.%20M.%20Bores&amp;author=F.%20P.%20Huger&amp;author=B.%20E.%20Kurys&amp;volume=6&amp;publication_year=1996&amp;pages=625-630&amp;doi=10.1016/0960-894X(96)00072-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref41">
<cite>Nepali K., Sharma S., Sharma M., Bedi P. M. S., Dhar K. L.. Rational
Approaches, Design Strategies, Structure Activity Relationship and
Mechanistic Insights for Anticancer Hybrids. Eur. J. Med. Chem. 2014;77:422–487. doi: 10.1016/j.ejmech.2014.03.018.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2014.03.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24685980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Rational%20Approaches,%20Design%20Strategies,%20Structure%20Activity%20Relationship%20and%20Mechanistic%20Insights%20for%20Anticancer%20Hybrids&amp;author=K.%20Nepali&amp;author=S.%20Sharma&amp;author=M.%20Sharma&amp;author=P.%20M.%20S.%20Bedi&amp;author=K.%20L.%20Dhar&amp;volume=77&amp;publication_year=2014&amp;pages=422-487&amp;pmid=24685980&amp;doi=10.1016/j.ejmech.2014.03.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref42">
<cite>Huneif M. A., Alshehri D. B., Alshaibari K. S., Dammaj M. Z., Mahnashi M. H., Majid S. U., Javed M. A., Ahmad S., Rashid U., Sadiq A.. Design, Synthesis and
Bioevaluation of New Vanillin Hybrid as Multitarget
Inhibitor of α-Glucosidase, α-Amylase, PTP-1B and DPP4
for the Treatment of Type-II Diabetes. Biomed.
Pharmacother. 2022;150:113038. doi: 10.1016/j.biopha.2022.113038.</cite> [<a href="https://doi.org/10.1016/j.biopha.2022.113038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35658208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed.%20Pharmacother.&amp;title=Design,%20Synthesis%20and%20Bioevaluation%20of%20New%20Vanillin%20Hybrid%20as%20Multitarget%20Inhibitor%20of%20%CE%B1-Glucosidase,%20%CE%B1-Amylase,%20PTP-1B%20and%20DPP4%20for%20the%20Treatment%20of%20Type-II%20Diabetes&amp;author=M.%20A.%20Huneif&amp;author=D.%20B.%20Alshehri&amp;author=K.%20S.%20Alshaibari&amp;author=M.%20Z.%20Dammaj&amp;author=M.%20H.%20Mahnashi&amp;volume=150&amp;publication_year=2022&amp;pages=113038&amp;pmid=35658208&amp;doi=10.1016/j.biopha.2022.113038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref43">
<cite>Yakushiji F., Miyamoto Y., Kunoh Y., Okamoto R., Nakaminami H., Yamazaki Y., Noguchi N., Hayashi Y.. Novel Hybrid-Type Antimicrobial
Agents Targeting the Switch Region of Bacterial RNA Polymerase. ACS Med. Chem. Lett. 2013;4:220–224. doi: 10.1021/ml300350p.</cite> [<a href="https://doi.org/10.1021/ml300350p" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4027222/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24900654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Med.%20Chem.%20Lett.&amp;title=Novel%20Hybrid-Type%20Antimicrobial%20Agents%20Targeting%20the%20Switch%20Region%20of%20Bacterial%20RNA%20Polymerase&amp;author=F.%20Yakushiji&amp;author=Y.%20Miyamoto&amp;author=Y.%20Kunoh&amp;author=R.%20Okamoto&amp;author=H.%20Nakaminami&amp;volume=4&amp;publication_year=2013&amp;pages=220-224&amp;pmid=24900654&amp;doi=10.1021/ml300350p&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref44">
<cite>Sun H., Ansari M. F., Fang B., Zhou C.-H.. Natural Berberine-Hybridized
Benzimidazoles as Novel Unique Bactericides against Staphylococcus
aureus
. J. Agric. Food Chem. 2021;69:7831–7840. doi: 10.1021/acs.jafc.1c02545.</cite> [<a href="https://doi.org/10.1021/acs.jafc.1c02545" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34228443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Agric.%20Food%20Chem.&amp;title=Natural%20Berberine-Hybridized%20Benzimidazoles%20as%20Novel%20Unique%20Bactericides%20against%20Staphylococcus%20aureus&amp;author=H.%20Sun&amp;author=M.%20F.%20Ansari&amp;author=B.%20Fang&amp;author=C.-H.%20Zhou&amp;volume=69&amp;publication_year=2021&amp;pages=7831-7840&amp;pmid=34228443&amp;doi=10.1021/acs.jafc.1c02545&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref45">
<cite>Masood M. M.. Progress
in Synthetic Trends Followed for the Development of 1,2,3-Triazole
Derivatives: A Review. Polycycl. Aromat. Compd. 2024;44:4273–4304. doi: 10.1080/10406638.2023.2247119.</cite> [<a href="https://doi.org/10.1080/10406638.2023.2247119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Polycycl.%20Aromat.%20Compd.&amp;title=Progress%20in%20Synthetic%20Trends%20Followed%20for%20the%20Development%20of%201,2,3-Triazole%20Derivatives:%20A%20Review&amp;author=M.%20M.%20Masood&amp;volume=44&amp;publication_year=2024&amp;pages=4273-4304&amp;doi=10.1080/10406638.2023.2247119&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref46">
<cite>Gatadi S., Gour J., Shukla M., Kaul G., Das S., Dasgupta A., Malasala S., Borra R. S., Madhavi Y. V., Chopra S., Nanduri S.. Synthesis
of 1,2,3-Triazole Linked
4­(3H)-Quinazolinones as Potent Antibacterial Agents against Multidrug-Resistant Staphylococcus aureus
. Eur. J. Med.
Chem. 2018;157:1056–1067. doi: 10.1016/j.ejmech.2018.08.070.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2018.08.070" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30176536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Synthesis%20of%201,2,3-Triazole%20Linked%204%C2%AD(3H)-Quinazolinones%20as%20Potent%20Antibacterial%20Agents%20against%20Multidrug-Resistant%20Staphylococcus%20aureus&amp;author=S.%20Gatadi&amp;author=J.%20Gour&amp;author=M.%20Shukla&amp;author=G.%20Kaul&amp;author=S.%20Das&amp;volume=157&amp;publication_year=2018&amp;pages=1056-1067&amp;pmid=30176536&amp;doi=10.1016/j.ejmech.2018.08.070&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref47">
<cite>Struthers H., Spingler B., Mindt T. L., Schibli R.. Click-to-Chelate”:
Design and Incorporation of Triazole-Containing Metal-Chelating Systems
into Biomolecules of Diagnostic and Therapeutic Interest. Chem.Eur. J. 2008;14:6173–6183. doi: 10.1002/chem.200702024.</cite> [<a href="https://doi.org/10.1002/chem.200702024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18494020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%EE%97%B8Eur.%20J.&amp;title=Click-to-Chelate%E2%80%9D:%20Design%20and%20Incorporation%20of%20Triazole-Containing%20Metal-Chelating%20Systems%20into%20Biomolecules%20of%20Diagnostic%20and%20Therapeutic%20Interest&amp;author=H.%20Struthers&amp;author=B.%20Spingler&amp;author=T.%20L.%20Mindt&amp;author=R.%20Schibli&amp;volume=14&amp;publication_year=2008&amp;pages=6173-6183&amp;pmid=18494020&amp;doi=10.1002/chem.200702024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref48">
<cite>Hugenberg V., Riemann B., Hermann S., Schober O., Schäfers M., Szardenings K., Lebedev A., Gangadharmath U., Kolb H., Walsh J., Zhang W., Kopka K., Wagner S.. Inverse 1,2,3-Triazole-1-Yl-Ethyl Substituted Hydroxamates
as Highly Potent Matrix Metalloproteinase Inhibitors: (Radio) Synthesis,
in Vitro and First in Vivo Evaluation. J. Med.
Chem. 2013;56:6858–6870. doi: 10.1021/jm4006753.</cite> [<a href="https://doi.org/10.1021/jm4006753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23899323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Inverse%201,2,3-Triazole-1-Yl-Ethyl%20Substituted%20Hydroxamates%20as%20Highly%20Potent%20Matrix%20Metalloproteinase%20Inhibitors:%20(Radio)%20Synthesis,%20in%20Vitro%20and%20First%20in%20Vivo%20Evaluation&amp;author=V.%20Hugenberg&amp;author=B.%20Riemann&amp;author=S.%20Hermann&amp;author=O.%20Schober&amp;author=M.%20Sch%C3%A4fers&amp;volume=56&amp;publication_year=2013&amp;pages=6858-6870&amp;pmid=23899323&amp;doi=10.1021/jm4006753&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref49">
<cite>Patel U. K., Tiwari P., Tilak R., Joshi G., Kumar R., Agarwal A.. Synthesis of Ciprofloxacin-Linked
1,2,3-Triazole Conjugates
as Potent Antibacterial Agents Using Click Chemistry: Exploring Their
Function as DNA Gyrase Inhibitors via in Silico- and in Vitro-Based
Studies. RSC Adv. 2024;14:17051–17070. doi: 10.1039/D4RA01332H.</cite> [<a href="https://doi.org/10.1039/D4RA01332H" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11138863/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38818013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=RSC%20Adv.&amp;title=Synthesis%20of%20Ciprofloxacin-Linked%201,2,3-Triazole%20Conjugates%20as%20Potent%20Antibacterial%20Agents%20Using%20Click%20Chemistry:%20Exploring%20Their%20Function%20as%20DNA%20Gyrase%20Inhibitors%20via%20in%20Silico-%20and%20in%20Vitro-Based%20Studies&amp;author=U.%20K.%20Patel&amp;author=P.%20Tiwari&amp;author=R.%20Tilak&amp;author=G.%20Joshi&amp;author=R.%20Kumar&amp;volume=14&amp;publication_year=2024&amp;pages=17051-17070&amp;pmid=38818013&amp;doi=10.1039/D4RA01332H&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref50">
<cite>Sanduja M., Gupta J., Singh H., Pagare P. P., Rana A.. Uracil-Coumarin
Based Hybrid Molecules as Potent Anti-Cancer and Anti-Bacterial Agents. J. Saudi Chem. Soc. 2020;24:251–266. doi: 10.1016/j.jscs.2019.12.001.</cite> [<a href="https://doi.org/10.1016/j.jscs.2019.12.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Saudi%20Chem.%20Soc.&amp;title=Uracil-Coumarin%20Based%20Hybrid%20Molecules%20as%20Potent%20Anti-Cancer%20and%20Anti-Bacterial%20Agents&amp;author=M.%20Sanduja&amp;author=J.%20Gupta&amp;author=H.%20Singh&amp;author=P.%20P.%20Pagare&amp;author=A.%20Rana&amp;volume=24&amp;publication_year=2020&amp;pages=251-266&amp;doi=10.1016/j.jscs.2019.12.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref51">
<cite>Poonia N., Lal K., Kumar A.. Design, Synthesis,
Antimicrobial Evaluation and in
Silico Studies of Symmetrical Bis (Urea-1,2,3-Triazole) Hybrids. Res. Chem. Intermed. 2021;47:1087–1103. doi: 10.1007/s11164-020-04318-1.</cite> [<a href="https://doi.org/10.1007/s11164-020-04318-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Res.%20Chem.%20Intermed.&amp;title=Design,%20Synthesis,%20Antimicrobial%20Evaluation%20and%20in%20Silico%20Studies%20of%20Symmetrical%20Bis%20(Urea-1,2,3-Triazole)%20Hybrids&amp;author=N.%20Poonia&amp;author=K.%20Lal&amp;author=A.%20Kumar&amp;volume=47&amp;publication_year=2021&amp;pages=1087-1103&amp;doi=10.1007/s11164-020-04318-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref52">
<cite>Tang K. W., Yang S. C., Tseng C. H.. Design, Synthesis,
and Anti-Bacterial
Evaluation of Triazolyl-Pterostilbene Derivatives. Int. J. Mol. Sci. 2019;20:4564. doi: 10.3390/ijms20184564.</cite> [<a href="https://doi.org/10.3390/ijms20184564" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6769857/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31540106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Design,%20Synthesis,%20and%20Anti-Bacterial%20Evaluation%20of%20Triazolyl-Pterostilbene%20Derivatives&amp;author=K.%20W.%20Tang&amp;author=S.%20C.%20Yang&amp;author=C.%20H.%20Tseng&amp;volume=20&amp;publication_year=2019&amp;pages=4564&amp;pmid=31540106&amp;doi=10.3390/ijms20184564&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref53">
<cite>Gondru R., Kanugala S., Raj S., Kumar C. G., Pasupuleti M., Banothu J., Bavantula R.. 1,2,3-Triazole-Thiazole Hybrids:
Synthesis, in Vitro Antimicrobial Activity and Antibiofilm Studies. Bioorg. Med. Chem. Lett. 2021;33:127746. doi: 10.1016/j.bmcl.2020.127746.</cite> [<a href="https://doi.org/10.1016/j.bmcl.2020.127746" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33333162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.%20Lett.&amp;title=1,2,3-Triazole-Thiazole%20Hybrids:%20Synthesis,%20in%20Vitro%20Antimicrobial%20Activity%20and%20Antibiofilm%20Studies&amp;author=R.%20Gondru&amp;author=S.%20Kanugala&amp;author=S.%20Raj&amp;author=C.%20G.%20Kumar&amp;author=M.%20Pasupuleti&amp;volume=33&amp;publication_year=2021&amp;pages=127746&amp;pmid=33333162&amp;doi=10.1016/j.bmcl.2020.127746&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref54">
<cite>Zhang J., Chen S., Liu X., Yu X., Gu N., Li A.. Discovery of 1,2,3-Triazole-Based Pleuromutilin Derivatives
as Potent
Gram-Positive Antibacterial Agents. Bioorg.
Med. Chem. Lett. 2024;110:129878. doi: 10.1016/j.bmcl.2024.129878.</cite> [<a href="https://doi.org/10.1016/j.bmcl.2024.129878" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38977107/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.%20Lett.&amp;title=Discovery%20of%201,2,3-Triazole-Based%20Pleuromutilin%20Derivatives%20as%20Potent%20Gram-Positive%20Antibacterial%20Agents&amp;author=J.%20Zhang&amp;author=S.%20Chen&amp;author=X.%20Liu&amp;author=X.%20Yu&amp;author=N.%20Gu&amp;volume=110&amp;publication_year=2024&amp;pages=129878&amp;pmid=38977107&amp;doi=10.1016/j.bmcl.2024.129878&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref55">
<cite>Silverman S. M., Moses J. E., Sharpless K. B.. Reengineering Antibiotics to Combat
Bacterial Resistance: Click Chemistry [1,2,3]-Triazole Vancomycin
Dimers with Potent Activity against MRSA and VRE. Chem.Eur. J. 2017;23:79–83. doi: 10.1002/chem.201604765.</cite> [<a href="https://doi.org/10.1002/chem.201604765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27747932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%EE%97%B8Eur.%20J.&amp;title=Reengineering%20Antibiotics%20to%20Combat%20Bacterial%20Resistance:%20Click%20Chemistry%20%5B1,2,3%5D-Triazole%20Vancomycin%20Dimers%20with%20Potent%20Activity%20against%20MRSA%20and%20VRE&amp;author=S.%20M.%20Silverman&amp;author=J.%20E.%20Moses&amp;author=K.%20B.%20Sharpless&amp;volume=23&amp;publication_year=2017&amp;pages=79-83&amp;pmid=27747932&amp;doi=10.1002/chem.201604765&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref56">
<cite>Kumar S. V., Lo W. K. C., Brooks H. J. L., Crowley J. D.. Synthesis, Structure,
Stability and Antimicrobial Activity of a Ruthenium­(II) Helicate Derived
from a Bis-Bidentate “Click” Pyridyl-1,2,3-Triazole
Ligand. Inorg. Chim. Acta. 2015;425:1–6. doi: 10.1016/j.ica.2014.10.011.</cite> [<a href="https://doi.org/10.1016/j.ica.2014.10.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inorg.%20Chim.%20Acta&amp;title=Synthesis,%20Structure,%20Stability%20and%20Antimicrobial%20Activity%20of%20a%20Ruthenium%C2%AD(II)%20Helicate%20Derived%20from%20a%20Bis-Bidentate%20%E2%80%9CClick%E2%80%9D%20Pyridyl-1,2,3-Triazole%20Ligand&amp;author=S.%20V.%20Kumar&amp;author=W.%20K.%20C.%20Lo&amp;author=H.%20J.%20L.%20Brooks&amp;author=J.%20D.%20Crowley&amp;volume=425&amp;publication_year=2015&amp;pages=1-6&amp;doi=10.1016/j.ica.2014.10.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref57">
<cite>Lauko J., Kouwer P. H. J., Rowan A. E.. 1H-1,2,3-Triazole:
From Structure
to Function and Catalysis. J. Heterocycl. Chem. 2017;54:1677–1699. doi: 10.1002/jhet.2770.</cite> [<a href="https://doi.org/10.1002/jhet.2770" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Heterocycl.%20Chem.&amp;title=1H-1,2,3-Triazole:%20From%20Structure%20to%20Function%20and%20Catalysis&amp;author=J.%20Lauko&amp;author=P.%20H.%20J.%20Kouwer&amp;author=A.%20E.%20Rowan&amp;volume=54&amp;publication_year=2017&amp;pages=1677-1699&amp;doi=10.1002/jhet.2770&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref58">
<cite>Tyndall J. D. A., Nall T., Fairlie D. P.. Proteases
Universally Recognize Beta
Strands In Their Active Sites. Chem. Rev. 2005;105:973–1000. doi: 10.1021/cr040669e.</cite> [<a href="https://doi.org/10.1021/cr040669e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15755082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Rev.&amp;title=Proteases%20Universally%20Recognize%20Beta%20Strands%20In%20Their%20Active%20Sites&amp;author=J.%20D.%20A.%20Tyndall&amp;author=T.%20Nall&amp;author=D.%20P.%20Fairlie&amp;volume=105&amp;publication_year=2005&amp;pages=973-1000&amp;pmid=15755082&amp;doi=10.1021/cr040669e&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref59">
<cite>Kumari S., Carmona A. V., Tiwari A. K., Trippier P. C.. Amide Bond Bioisosteres:
Strategies, Synthesis, and Successes. J. Med.
Chem. 2020;63:12290–12358. doi: 10.1021/acs.jmedchem.0c00530.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.0c00530" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7666045/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32686940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Amide%20Bond%20Bioisosteres:%20Strategies,%20Synthesis,%20and%20Successes&amp;author=S.%20Kumari&amp;author=A.%20V.%20Carmona&amp;author=A.%20K.%20Tiwari&amp;author=P.%20C.%20Trippier&amp;volume=63&amp;publication_year=2020&amp;pages=12290-12358&amp;pmid=32686940&amp;doi=10.1021/acs.jmedchem.0c00530&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref60">
<cite>Massarotti A., Aprile S., Mercalli V., Del Grosso E., Grosa G., Sorba G., Tron G. C.. Are 1,4- and 1,5-Disubstituted
1,2,3-Triazoles Good Pharmacophoric Groups? ChemMedChem. 2014;9:2497–2508. doi: 10.1002/cmdc.201402233.</cite> [<a href="https://doi.org/10.1002/cmdc.201402233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25079879/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ChemMedChem.&amp;title=Are%201,4-%20and%201,5-Disubstituted%201,2,3-Triazoles%20Good%20Pharmacophoric%20Groups?&amp;author=A.%20Massarotti&amp;author=S.%20Aprile&amp;author=V.%20Mercalli&amp;author=E.%20Del%20Grosso&amp;author=G.%20Grosa&amp;volume=9&amp;publication_year=2014&amp;pages=2497-2508&amp;pmid=25079879&amp;doi=10.1002/cmdc.201402233&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref61">
<cite>Johansson J. R., Beke-Somfai T., Said Stålsmeden A., Kann N.. Ruthenium-Catalyzed
Azide Alkyne Cycloaddition Reaction: Scope, Mechanism, and Applications. Chem. Rev. 2016;116:14726–14768. doi: 10.1021/acs.chemrev.6b00466.</cite> [<a href="https://doi.org/10.1021/acs.chemrev.6b00466" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27960271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Rev.&amp;title=Ruthenium-Catalyzed%20Azide%20Alkyne%20Cycloaddition%20Reaction:%20Scope,%20Mechanism,%20and%20Applications&amp;author=J.%20R.%20Johansson&amp;author=T.%20Beke-Somfai&amp;author=A.%20Said%20St%C3%A5lsmeden&amp;author=N.%20Kann&amp;volume=116&amp;publication_year=2016&amp;pages=14726-14768&amp;pmid=27960271&amp;doi=10.1021/acs.chemrev.6b00466&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref62">
<cite>Bakunov S. A., Bakunova S. M., Wenzler T., Ghebru M., Werbovetz K. A., Brun R., Tidwell R. R.. Synthesis and Antiprotozoal
Activity
of Cationic 1,4-Diphenyl-1H-1,2,3-Triazoles. J. Med. Chem. 2010;53:254–272. doi: 10.1021/jm901178d.</cite> [<a href="https://doi.org/10.1021/jm901178d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3113660/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19928900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Synthesis%20and%20Antiprotozoal%20Activity%20of%20Cationic%201,4-Diphenyl-1H-1,2,3-Triazoles&amp;author=S.%20A.%20Bakunov&amp;author=S.%20M.%20Bakunova&amp;author=T.%20Wenzler&amp;author=M.%20Ghebru&amp;author=K.%20A.%20Werbovetz&amp;volume=53&amp;publication_year=2010&amp;pages=254-272&amp;pmid=19928900&amp;doi=10.1021/jm901178d&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref63">
<cite>Pippione A. C., Dosio F., Ducime A., Federico A., Martina K., Sainas S., Fro̷lund B., Gooyit M., Janda K. D., Boschi D., Lolli M. L.. Substituted 4-Hydroxy-1,2,3-Triazoles:
Synthesis, Characterization and First Drug Design Applications through
Bioisosteric Modulation and Scaffold Hopping Approaches. Med. Chem. Commun. 2015;6:1285–1292. doi: 10.1039/C5MD00182J.</cite> [<a href="https://doi.org/10.1039/C5MD00182J" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med.%20Chem.%20Commun.&amp;title=Substituted%204-Hydroxy-1,2,3-Triazoles:%20Synthesis,%20Characterization%20and%20First%20Drug%20Design%20Applications%20through%20Bioisosteric%20Modulation%20and%20Scaffold%20Hopping%20Approaches&amp;author=A.%20C.%20Pippione&amp;author=F.%20Dosio&amp;author=A.%20Ducime&amp;author=A.%20Federico&amp;author=K.%20Martina&amp;volume=6&amp;publication_year=2015&amp;pages=1285-1292&amp;doi=10.1039/C5MD00182J&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref64">
<cite>Nahrwold M., Bogner T., Eissler S., Verma S., Sewald N.. Clicktophycin-52”:
A Bioactive Cryptophycin-52 Triazole Analogue. Org. Lett. 2010;12:1064–1067. doi: 10.1021/ol1000473.</cite> [<a href="https://doi.org/10.1021/ol1000473" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20131817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Org.%20Lett.&amp;title=Clicktophycin-52%E2%80%9D:%20A%20Bioactive%20Cryptophycin-52%20Triazole%20Analogue&amp;author=M.%20Nahrwold&amp;author=T.%20Bogner&amp;author=S.%20Eissler&amp;author=S.%20Verma&amp;author=N.%20Sewald&amp;volume=12&amp;publication_year=2010&amp;pages=1064-1067&amp;pmid=20131817&amp;doi=10.1021/ol1000473&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref65">
<cite>Hou J., Liu X., Shen J., Zhao G., Wang P. G.. The Impact of Click
Chemistry in Medicinal Chemistry. Expert Opin.
Drug Discovery. 2012;7:489–501. doi: 10.1517/17460441.2012.682725.</cite> [<a href="https://doi.org/10.1517/17460441.2012.682725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22607210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin.%20Drug%20Discovery&amp;title=The%20Impact%20of%20Click%20Chemistry%20in%20Medicinal%20Chemistry&amp;author=J.%20Hou&amp;author=X.%20Liu&amp;author=J.%20Shen&amp;author=G.%20Zhao&amp;author=P.%20G.%20Wang&amp;volume=7&amp;publication_year=2012&amp;pages=489-501&amp;pmid=22607210&amp;doi=10.1517/17460441.2012.682725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref66">
<cite>Aprile S., Galli U., Tron G. C., Del Grosso E., Travelli C., Grosa G.. Data on Metabolic Stability, Aqueous
Solubility and CYP Inhibition of Novel Triazole-Based Nicotinamide
Phosphoribosyltransferase (NAMPT) Inhibitors. Data Br. 2020;28:105034. doi: 10.1016/j.dib.2019.105034.</cite> [<a href="https://doi.org/10.1016/j.dib.2019.105034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7093798/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32226807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Data%20Br.&amp;title=Data%20on%20Metabolic%20Stability,%20Aqueous%20Solubility%20and%20CYP%20Inhibition%20of%20Novel%20Triazole-Based%20Nicotinamide%20Phosphoribosyltransferase%20(NAMPT)%20Inhibitors&amp;author=S.%20Aprile&amp;author=U.%20Galli&amp;author=G.%20C.%20Tron&amp;author=E.%20Del%20Grosso&amp;author=C.%20Travelli&amp;volume=28&amp;publication_year=2020&amp;pages=105034&amp;pmid=32226807&amp;doi=10.1016/j.dib.2019.105034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref67">
<cite>Amorim A. C., Burke A. J.. What Is the Future
of Click Chemistry in Drug Discovery
and Development? Expert Opin. Drug Discovery. 2024;19:267–280. doi: 10.1080/17460441.2024.2302151.</cite> [<a href="https://doi.org/10.1080/17460441.2024.2302151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38214914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin.%20Drug%20Discovery&amp;title=What%20Is%20the%20Future%20of%20Click%20Chemistry%20in%20Drug%20Discovery%20and%20Development?&amp;author=A.%20C.%20Amorim&amp;author=A.%20J.%20Burke&amp;volume=19&amp;publication_year=2024&amp;pages=267-280&amp;pmid=38214914&amp;doi=10.1080/17460441.2024.2302151&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref68">
<cite>Boren B. C., Narayan S., Rasmussen L. K., Zhang L., Zhao H., Lin Z., Jia G., Fokin V. V.. Ruthenium-Catalyzed Azide–Alkyne
Cycloaddition: Scope and Mechanism. J. Am. Chem.
Soc. 2008;130:8923–8930. doi: 10.1021/ja0749993.</cite> [<a href="https://doi.org/10.1021/ja0749993" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18570425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Chem.%20Soc.&amp;title=Ruthenium-Catalyzed%20Azide%E2%80%93Alkyne%20Cycloaddition:%20Scope%20and%20Mechanism&amp;author=B.%20C.%20Boren&amp;author=S.%20Narayan&amp;author=L.%20K.%20Rasmussen&amp;author=L.%20Zhang&amp;author=H.%20Zhao&amp;volume=130&amp;publication_year=2008&amp;pages=8923-8930&amp;pmid=18570425&amp;doi=10.1021/ja0749993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref69">
<cite>Worrell B.
T., Malik J. A., Fokin V. V.. Direct Evidence of a Dinuclear Copper
Intermediate in Cu­(I)-Catalyzed Azide-Alkyne Cycloadditions. Science. 2013;340:457–460. doi: 10.1126/science.1229506.</cite> [<a href="https://doi.org/10.1126/science.1229506" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3651910/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23558174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science.&amp;title=Direct%20Evidence%20of%20a%20Dinuclear%20Copper%20Intermediate%20in%20Cu%C2%AD(I)-Catalyzed%20Azide-Alkyne%20Cycloadditions&amp;author=B.%20T.%20Worrell&amp;author=J.%20A.%20Malik&amp;author=V.%20V.%20Fokin&amp;volume=340&amp;publication_year=2013&amp;pages=457-460&amp;pmid=23558174&amp;doi=10.1126/science.1229506&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref70">
<cite>Zhou X., Xu X., Liu K., Gao H., Wang W., Li W.. Organocatalytic
1,3-Dipolar Cycloaddition Reaction of β-Keto Amides with Azides–Direct
Access to 1,4,5-Trisubstituted 1,2,3-Triazole-4-Carboxamides. Eur. J. Org. Chem. 2016;2016:1886–1890. doi: 10.1002/ejoc.201600157.</cite> [<a href="https://doi.org/10.1002/ejoc.201600157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Org.%20Chem.&amp;title=Organocatalytic%201,3-Dipolar%20Cycloaddition%20Reaction%20of%20%CE%B2-Keto%20Amides%20with%20Azides%E2%80%93Direct%20Access%20to%201,4,5-Trisubstituted%201,2,3-Triazole-4-Carboxamides&amp;author=X.%20Zhou&amp;author=X.%20Xu&amp;author=K.%20Liu&amp;author=H.%20Gao&amp;author=W.%20Wang&amp;volume=2016&amp;publication_year=2016&amp;pages=1886-1890&amp;doi=10.1002/ejoc.201600157&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref71">
<cite>Javaherian M., Kazemi F., Ghaemi M.. A Dicationic, Podand-like, Ionic
Liquid Water System Accelerated Copper-Catalyzed Azide-Alkyne Click
Reaction. Chin. Chem. Lett. 2014;25:1643–1647. doi: 10.1016/j.cclet.2014.09.005.</cite> [<a href="https://doi.org/10.1016/j.cclet.2014.09.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chin.%20Chem.%20Lett.&amp;title=A%20Dicationic,%20Podand-like,%20Ionic%20Liquid%20Water%20System%20Accelerated%20Copper-Catalyzed%20Azide-Alkyne%20Click%20Reaction&amp;author=M.%20Javaherian&amp;author=F.%20Kazemi&amp;author=M.%20Ghaemi&amp;volume=25&amp;publication_year=2014&amp;pages=1643-1647&amp;doi=10.1016/j.cclet.2014.09.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref72">
<cite>Dharavath R., Nagaraju N., Reddy M. R., Ashok D., Sarasija M., Vijjulatha M., T V., Jyothi K., Prashanthi G.. Microwave-Assisted
Synthesis, Biological Evaluation and Molecular Docking Studies of
New Coumarin-Based 1,2,3-Triazoles. RSC Adv. 2020;10:11615–11623. doi: 10.1039/D0RA01052A.</cite> [<a href="https://doi.org/10.1039/D0RA01052A" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9050871/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35496603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=RSC%20Adv.&amp;title=Microwave-Assisted%20Synthesis,%20Biological%20Evaluation%20and%20Molecular%20Docking%20Studies%20of%20New%20Coumarin-Based%201,2,3-Triazoles&amp;author=R.%20Dharavath&amp;author=N.%20Nagaraju&amp;author=M.%20R.%20Reddy&amp;author=D.%20Ashok&amp;author=M.%20Sarasija&amp;volume=10&amp;publication_year=2020&amp;pages=11615-11623&amp;pmid=35496603&amp;doi=10.1039/D0RA01052A&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref73">
<cite>Mady M. F., Awad G. E. A., Jo̷rgensen K. B.. Ultrasound-Assisted
Synthesis of
Novel 1,2,3-Triazoles Coupled Diaryl Sulfone Moieties by the CuAAC
Reaction, and Biological Evaluation of Them as Antioxidant and Antimicrobial
Agents. Eur. J. Med. Chem. 2014;84:433–443. doi: 10.1016/j.ejmech.2014.07.042.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2014.07.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25038485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Ultrasound-Assisted%20Synthesis%20of%20Novel%201,2,3-Triazoles%20Coupled%20Diaryl%20Sulfone%20Moieties%20by%20the%20CuAAC%20Reaction,%20and%20Biological%20Evaluation%20of%20Them%20as%20Antioxidant%20and%20Antimicrobial%20Agents&amp;author=M.%20F.%20Mady&amp;author=G.%20E.%20A.%20Awad&amp;author=K.%20B.%20Jo%CC%B7rgensen&amp;volume=84&amp;publication_year=2014&amp;pages=433-443&amp;pmid=25038485&amp;doi=10.1016/j.ejmech.2014.07.042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref74">
<cite>Dzuvor C. K. O.. Toward
Clinical Applications: Transforming Nonantibiotic Antibacterials into
Effective Next-Generation Supramolecular Therapeutics. ACS Nano. 2024;18:2564–2577. doi: 10.1021/acsnano.3c11045.</cite> [<a href="https://doi.org/10.1021/acsnano.3c11045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38227832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Toward%20Clinical%20Applications:%20Transforming%20Nonantibiotic%20Antibacterials%20into%20Effective%20Next-Generation%20Supramolecular%20Therapeutics&amp;author=C.%20K.%20O.%20Dzuvor&amp;volume=18&amp;publication_year=2024&amp;pages=2564-2577&amp;pmid=38227832&amp;doi=10.1021/acsnano.3c11045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref75">
<cite>Powell J. W., Mann C. A., Toth P. D., Nolan S., Steinert A., Ove C., Seffernick J. T., Wozniak D. J., Kebriaei R., Lindert S., Osheroff N., Yalowich J. C., Mitton-Fry M. J.. Development
of Novel Bacterial Topoisomerase Inhibitors Assisted by Computational
Screening. ACS Med. Chem. Lett. 2024;15:1287–1297. doi: 10.1021/acsmedchemlett.4c00162.</cite> [<a href="https://doi.org/10.1021/acsmedchemlett.4c00162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11318591/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39140037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Med.%20Chem.%20Lett.&amp;title=Development%20of%20Novel%20Bacterial%20Topoisomerase%20Inhibitors%20Assisted%20by%20Computational%20Screening&amp;author=J.%20W.%20Powell&amp;author=C.%20A.%20Mann&amp;author=P.%20D.%20Toth&amp;author=S.%20Nolan&amp;author=A.%20Steinert&amp;volume=15&amp;publication_year=2024&amp;pages=1287-1297&amp;pmid=39140037&amp;doi=10.1021/acsmedchemlett.4c00162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref76">
<cite>Lal K., Yadav P., Kumar A., Kumar A., Paul A. K.. Design,
Synthesis, Characterization, Antimicrobial Evaluation and Molecular
Modeling Studies of Some Dehydroacetic Acid-Chalcone-1,2,3-Triazole
Hybrids. Bioorg. Chem. 2018;77:236–244. doi: 10.1016/j.bioorg.2018.01.016.</cite> [<a href="https://doi.org/10.1016/j.bioorg.2018.01.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29421698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Chem.&amp;title=Design,%20Synthesis,%20Characterization,%20Antimicrobial%20Evaluation%20and%20Molecular%20Modeling%20Studies%20of%20Some%20Dehydroacetic%20Acid-Chalcone-1,2,3-Triazole%20Hybrids&amp;author=K.%20Lal&amp;author=P.%20Yadav&amp;author=A.%20Kumar&amp;author=A.%20Kumar&amp;author=A.%20K.%20Paul&amp;volume=77&amp;publication_year=2018&amp;pages=236-244&amp;pmid=29421698&amp;doi=10.1016/j.bioorg.2018.01.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref77">
<cite>Mokariya J. A., Patel R. C., Rajani D. P., Patel M. P.. Synthesis of Novel
Indole-Oxindole Clubbed 1,2,3-Triazole Hybrids: Antimicrobial Evaluation
and Molecular Docking Study. Res. Chem. Intermed. 2023;49:2933–2953. doi: 10.1007/s11164-023-05024-4.</cite> [<a href="https://doi.org/10.1007/s11164-023-05024-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Res.%20Chem.%20Intermed.&amp;title=Synthesis%20of%20Novel%20Indole-Oxindole%20Clubbed%201,2,3-Triazole%20Hybrids:%20Antimicrobial%20Evaluation%20and%20Molecular%20Docking%20Study&amp;author=J.%20A.%20Mokariya&amp;author=R.%20C.%20Patel&amp;author=D.%20P.%20Rajani&amp;author=M.%20P.%20Patel&amp;volume=49&amp;publication_year=2023&amp;pages=2933-2953&amp;doi=10.1007/s11164-023-05024-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref78">
<cite>Suryapeta S., Papigani N., Banothu V., Dubey P. K., Mukkanti K., Pal S.. Synthesis, Biological
Evaluation, and Docking Study of a Series of
1,4-Disubstituted 1,2,3-Triazole Derivatives with an Indole-Triazole-Peptide
Conjugate. J. Heterocycl. Chem. 2020;57:3126–3141. doi: 10.1002/jhet.4020.</cite> [<a href="https://doi.org/10.1002/jhet.4020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Heterocycl.%20Chem.&amp;title=Synthesis,%20Biological%20Evaluation,%20and%20Docking%20Study%20of%20a%20Series%20of%201,4-Disubstituted%201,2,3-Triazole%20Derivatives%20with%20an%20Indole-Triazole-Peptide%20Conjugate&amp;author=S.%20Suryapeta&amp;author=N.%20Papigani&amp;author=V.%20Banothu&amp;author=P.%20K.%20Dubey&amp;author=K.%20Mukkanti&amp;volume=57&amp;publication_year=2020&amp;pages=3126-3141&amp;doi=10.1002/jhet.4020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref79">
<cite>Yadav M., Lal K., Kumar A., Kumar A., Kumar D.. Indole-Chalcone Linked
1,2,3-Triazole Hybrids: Facile Synthesis, Antimicrobial Evaluation
and Docking Studies as Potential Antimicrobial Agents. J. Mol. Struct. 2022;1261:132867. doi: 10.1016/j.molstruc.2022.132867.</cite> [<a href="https://doi.org/10.1016/j.molstruc.2022.132867" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=Indole-Chalcone%20Linked%201,2,3-Triazole%20Hybrids:%20Facile%20Synthesis,%20Antimicrobial%20Evaluation%20and%20Docking%20Studies%20as%20Potential%20Antimicrobial%20Agents&amp;author=M.%20Yadav&amp;author=K.%20Lal&amp;author=A.%20Kumar&amp;author=A.%20Kumar&amp;author=D.%20Kumar&amp;volume=1261&amp;publication_year=2022&amp;pages=132867&amp;doi=10.1016/j.molstruc.2022.132867&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref80">
<cite>Gadali K. El, Rafya M., El Mansouri A., Maatallah M., Vanderlee A., Mehdi A., Neyts J., Jochmans D., De Jonghe S., Benkhalti F., Sanghvi Y. S., Taourirte M., Lazrek H. B.. Design, Synthesis, and Molecular Modeling Studies of
Novel 2-Quinolone-1,2,3-Triazole-α-Aminophosphonates Hybrids
as Dual Antiviral and Antibacterial Agents. Eur. J. Med. Chem. 2024;268:116235. doi: 10.1016/j.ejmech.2024.116235.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2024.116235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38377828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Design,%20Synthesis,%20and%20Molecular%20Modeling%20Studies%20of%20Novel%202-Quinolone-1,2,3-Triazole-%CE%B1-Aminophosphonates%20Hybrids%20as%20Dual%20Antiviral%20and%20Antibacterial%20Agents&amp;author=K.%20El%20Gadali&amp;author=M.%20Rafya&amp;author=A.%20El%20Mansouri&amp;author=M.%20Maatallah&amp;author=A.%20Vanderlee&amp;volume=268&amp;publication_year=2024&amp;pages=116235&amp;pmid=38377828&amp;doi=10.1016/j.ejmech.2024.116235&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref81">
<cite>Zhao Z., Yan R., Yi X., Li J., Rao J., Guo Z., Yang Y., Li W., Li Y.-Q., Chen C.. Bacteria-Activated
Theranostic Nanoprobes against Methicillin-Resistant Staphylococcus
aureus Infection. ACS Nano. 2017;11:4428–4438. doi: 10.1021/acsnano.7b00041.</cite> [<a href="https://doi.org/10.1021/acsnano.7b00041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28350437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Bacteria-Activated%20Theranostic%20Nanoprobes%20against%20Methicillin-Resistant%20Staphylococcus%20aureus%20Infection&amp;author=Z.%20Zhao&amp;author=R.%20Yan&amp;author=X.%20Yi&amp;author=J.%20Li&amp;author=J.%20Rao&amp;volume=11&amp;publication_year=2017&amp;pages=4428-4438&amp;pmid=28350437&amp;doi=10.1021/acsnano.7b00041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref82">
<cite>Aarjane M., Slassi S., Amine A.. Synthesis,
Antibacterial Evaluation
and Computational Studies of New Acridone-1,2,3-Triazole Hybrids. J. Mol. Struct. 2021;1241:130636. doi: 10.1016/j.molstruc.2021.130636.</cite> [<a href="https://doi.org/10.1016/j.molstruc.2021.130636" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=Synthesis,%20Antibacterial%20Evaluation%20and%20Computational%20Studies%20of%20New%20Acridone-1,2,3-Triazole%20Hybrids&amp;author=M.%20Aarjane&amp;author=S.%20Slassi&amp;author=A.%20Amine&amp;volume=1241&amp;publication_year=2021&amp;pages=130636&amp;doi=10.1016/j.molstruc.2021.130636&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref83">
<cite>Aarjane M., Slassi S., Tazi B., Amine A.. Synthesis and Biological
Evaluation of Novel Isoxazole Derivatives from Acridone. Arch. Pharm. 2021;354:2000261. doi: 10.1002/ardp.202000261.</cite> [<a href="https://doi.org/10.1002/ardp.202000261" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33289176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch.%20Pharm.&amp;title=Synthesis%20and%20Biological%20Evaluation%20of%20Novel%20Isoxazole%20Derivatives%20from%20Acridone&amp;author=M.%20Aarjane&amp;author=S.%20Slassi&amp;author=B.%20Tazi&amp;author=A.%20Amine&amp;volume=354&amp;publication_year=2021&amp;pages=2000261&amp;pmid=33289176&amp;doi=10.1002/ardp.202000261&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref84">
<cite>El
Malah T., Sharaf H., Hemdan B., Mageid R., Abdelrahman M. T., El-Manawaty M., Nour H.. Synthesis, in Vitro
Antimicrobial Evaluation, and Molecular Docking Studies of New Isatin-1,2,3-Triazole
Hybrids. J. Mol. Struct. 2022;1250:131855. doi: 10.1016/j.molstruc.2021.131855.</cite> [<a href="https://doi.org/10.1016/j.molstruc.2021.131855" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=Synthesis,%20in%20Vitro%20Antimicrobial%20Evaluation,%20and%20Molecular%20Docking%20Studies%20of%20New%20Isatin-1,2,3-Triazole%20Hybrids&amp;author=T.%20El%20Malah&amp;author=H.%20Sharaf&amp;author=B.%20Hemdan&amp;author=R.%20Mageid&amp;author=M.%20T.%20Abdelrahman&amp;volume=1250&amp;publication_year=2022&amp;pages=131855&amp;doi=10.1016/j.molstruc.2021.131855&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref85">
<cite>Wallace M. J., Dharuman S., Fernando D. M., Reeve S. M., Gee C. T., Yao J., Griffith E. C., Phelps G. A., Wright W. C., Elmore J. M., Lee R. B., Chen T., Lee R. E.. Discovery and Characterization
of the Antimetabolite Action of Thioacetamide-Linked 1,2,3-Triazoles
as Disruptors of Cysteine Biosynthesis in Gram-Negative Bacteria. ACS Infect. Dis. 2020;6:467–478. doi: 10.1021/acsinfecdis.9b00406.</cite> [<a href="https://doi.org/10.1021/acsinfecdis.9b00406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7477787/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31887254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Infect.%20Dis.&amp;title=Discovery%20and%20Characterization%20of%20the%20Antimetabolite%20Action%20of%20Thioacetamide-Linked%201,2,3-Triazoles%20as%20Disruptors%20of%20Cysteine%20Biosynthesis%20in%20Gram-Negative%20Bacteria&amp;author=M.%20J.%20Wallace&amp;author=S.%20Dharuman&amp;author=D.%20M.%20Fernando&amp;author=S.%20M.%20Reeve&amp;author=C.%20T.%20Gee&amp;volume=6&amp;publication_year=2020&amp;pages=467-478&amp;pmid=31887254&amp;doi=10.1021/acsinfecdis.9b00406&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref86">
<cite>Abd
El-Aleam R. H., George R. F., Georgey H. H., Abdel-Rahman H. M.. Bacterial
Virulence Factors: A Target for Heterocyclic Compounds to Combat Bacterial
Resistance. RSC Adv. 2021;11:36459–36482. doi: 10.1039/D1RA06238G.</cite> [<a href="https://doi.org/10.1039/D1RA06238G" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9043591/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35494393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=RSC%20Adv.&amp;title=Bacterial%20Virulence%20Factors:%20A%20Target%20for%20Heterocyclic%20Compounds%20to%20Combat%20Bacterial%20Resistance&amp;author=R.%20H.%20Abd%20El-Aleam&amp;author=R.%20F.%20George&amp;author=H.%20H.%20Georgey&amp;author=H.%20M.%20Abdel-Rahman&amp;volume=11&amp;publication_year=2021&amp;pages=36459-36482&amp;pmid=35494393&amp;doi=10.1039/D1RA06238G&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref87">
<cite>Reddyrajula R., Dalimba U., Kumar S. M.. Molecular
Hybridization Approach
for Phenothiazine Incorporated 1,2,3-Triazole Hybrids as Promising
Antimicrobial Agents: Design, Synthesis, Molecular Docking and in
Silico ADME Studies. Eur. J. Med. Chem. 2019;168:263–282. doi: 10.1016/j.ejmech.2019.02.010.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2019.02.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30822714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Molecular%20Hybridization%20Approach%20for%20Phenothiazine%20Incorporated%201,2,3-Triazole%20Hybrids%20as%20Promising%20Antimicrobial%20Agents:%20Design,%20Synthesis,%20Molecular%20Docking%20and%20in%20Silico%20ADME%20Studies&amp;author=R.%20Reddyrajula&amp;author=U.%20Dalimba&amp;author=S.%20M.%20Kumar&amp;volume=168&amp;publication_year=2019&amp;pages=263-282&amp;pmid=30822714&amp;doi=10.1016/j.ejmech.2019.02.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref88">
<cite>Lipeeva A. V., Zakharov D. O., Burova L. G., Frolova T. S., Baev D. S., Shirokikh I. V., Evstropov A. N., Sinitsyna O. I., Tolsikova T. G., Shults E. E.. Design, Synthesis and Antibacterial
Activity of Coumarin-1,2,3-Triazole Hybrids Obtained from Natural
Furocoumarin Peucedanin. Molecules. 2019;24:2126. doi: 10.3390/molecules24112126.</cite> [<a href="https://doi.org/10.3390/molecules24112126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6600338/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31195697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Design,%20Synthesis%20and%20Antibacterial%20Activity%20of%20Coumarin-1,2,3-Triazole%20Hybrids%20Obtained%20from%20Natural%20Furocoumarin%20Peucedanin&amp;author=A.%20V.%20Lipeeva&amp;author=D.%20O.%20Zakharov&amp;author=L.%20G.%20Burova&amp;author=T.%20S.%20Frolova&amp;author=D.%20S.%20Baev&amp;volume=24&amp;publication_year=2019&amp;pages=2126&amp;pmid=31195697&amp;doi=10.3390/molecules24112126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref89">
<cite>Zhang Z., Li K., Zhang G. Y., Tang Y. Z.. Synthesis and Biological Activities
of Novel Pleuromutilin Derivatives with a Substituted Triazole Moiety
as Potent Antibacterial Agents. Eur. J. Med.
Chem. 2020;204:112604. doi: 10.1016/j.ejmech.2020.112604.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2020.112604" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32731187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Synthesis%20and%20Biological%20Activities%20of%20Novel%20Pleuromutilin%20Derivatives%20with%20a%20Substituted%20Triazole%20Moiety%20as%20Potent%20Antibacterial%20Agents&amp;author=Z.%20Zhang&amp;author=K.%20Li&amp;author=G.%20Y.%20Zhang&amp;author=Y.%20Z.%20Tang&amp;volume=204&amp;publication_year=2020&amp;pages=112604&amp;pmid=32731187&amp;doi=10.1016/j.ejmech.2020.112604&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref90">
<cite>Qin Y., Xu L., Teng Y., Yang Y., Wang Y., Ma P.. Design, Synthesis
and Antibacterial Evaluation of Novel 3-O-Substituted 15-Membered
Azalides Possessing 1,2,3-Triazole Side Chains. Bioorg. Med. Chem. Lett. 2021;49:128330. doi: 10.1016/j.bmcl.2021.128330.</cite> [<a href="https://doi.org/10.1016/j.bmcl.2021.128330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34403726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.%20Lett.&amp;title=Design,%20Synthesis%20and%20Antibacterial%20Evaluation%20of%20Novel%203-O-Substituted%2015-Membered%20Azalides%20Possessing%201,2,3-Triazole%20Side%20Chains&amp;author=Y.%20Qin&amp;author=L.%20Xu&amp;author=Y.%20Teng&amp;author=Y.%20Yang&amp;author=Y.%20Wang&amp;volume=49&amp;publication_year=2021&amp;pages=128330&amp;pmid=34403726&amp;doi=10.1016/j.bmcl.2021.128330&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref91">
<cite>Phetsang W., Blaskovich M. A. T., Butler M. S., Huang J. X., Zuegg J., Mamidyala S. K., Ramu S., Kavanagh A. M., Cooper M. A.. An Azido-Oxazolidinone
Antibiotic for Live Bacterial Cell Imaging and Generation of Antibiotic
Variants. Bioorg. Med. Chem. 2014;22:4490–4498. doi: 10.1016/j.bmc.2014.05.054.</cite> [<a href="https://doi.org/10.1016/j.bmc.2014.05.054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4141890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25023540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.&amp;title=An%20Azido-Oxazolidinone%20Antibiotic%20for%20Live%20Bacterial%20Cell%20Imaging%20and%20Generation%20of%20Antibiotic%20Variants&amp;author=W.%20Phetsang&amp;author=M.%20A.%20T.%20Blaskovich&amp;author=M.%20S.%20Butler&amp;author=J.%20X.%20Huang&amp;author=J.%20Zuegg&amp;volume=22&amp;publication_year=2014&amp;pages=4490-4498&amp;pmid=25023540&amp;doi=10.1016/j.bmc.2014.05.054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref92">
<cite>Tague A. J., Putsathit P., Hammer K. A., Wales S. M., Knight D. R., Riley T. V., Keller P. A., Pyne S. G.. Cationic Biaryl
1,2,3-Triazolyl Peptidomimetic Amphiphiles: Synthesis, Antibacterial
Evaluation and Preliminary Mechanism of Action Studies. Eur. J. Med. Chem. 2019;168:386–404. doi: 10.1016/j.ejmech.2019.02.013.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2019.02.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30831407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Cationic%20Biaryl%201,2,3-Triazolyl%20Peptidomimetic%20Amphiphiles:%20Synthesis,%20Antibacterial%20Evaluation%20and%20Preliminary%20Mechanism%20of%20Action%20Studies&amp;author=A.%20J.%20Tague&amp;author=P.%20Putsathit&amp;author=K.%20A.%20Hammer&amp;author=S.%20M.%20Wales&amp;author=D.%20R.%20Knight&amp;volume=168&amp;publication_year=2019&amp;pages=386-404&amp;pmid=30831407&amp;doi=10.1016/j.ejmech.2019.02.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref93">
<cite>Tague A. J., Putsathit P., Hutton M. L., Hammer K. A., Wales S. M., Knight D. R., Riley T. V., Lyras D., Keller P. A., Pyne S. G.. Cationic Biaryl 1,2,3-Triazolyl Peptidomimetic
Amphiphiles
Targeting Clostridioides (Clostridium) Difficile: Synthesis, Antibacterial
Evaluation and an in Vivo C. difficile Infection
Model. Eur. J. Med. Chem. 2019;170:203–224. doi: 10.1016/j.ejmech.2019.02.068.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2019.02.068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30901686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Cationic%20Biaryl%201,2,3-Triazolyl%20Peptidomimetic%20Amphiphiles%20Targeting%20Clostridioides%20(Clostridium)%20Difficile:%20Synthesis,%20Antibacterial%20Evaluation%20and%20an%20in%20Vivo%20C.%20difficile%20Infection%20Model&amp;author=A.%20J.%20Tague&amp;author=P.%20Putsathit&amp;author=M.%20L.%20Hutton&amp;author=K.%20A.%20Hammer&amp;author=S.%20M.%20Wales&amp;volume=170&amp;publication_year=2019&amp;pages=203-224&amp;pmid=30901686&amp;doi=10.1016/j.ejmech.2019.02.068&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref94">
<cite>Bakka T. A., Stro̷m M. B., Andersen J. H., Gautun O. R.. Methyl Propiolate
and 3-Butynone: Starting Points for Synthesis of Amphiphilic 1,2,3-Triazole
Peptidomimetics for Antimicrobial Evaluation. Bioorg. Med. Chem. 2017;25:5380–5395. doi: 10.1016/j.bmc.2017.07.060.</cite> [<a href="https://doi.org/10.1016/j.bmc.2017.07.060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28797773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.&amp;title=Methyl%20Propiolate%20and%203-Butynone:%20Starting%20Points%20for%20Synthesis%20of%20Amphiphilic%201,2,3-Triazole%20Peptidomimetics%20for%20Antimicrobial%20Evaluation&amp;author=T.%20A.%20Bakka&amp;author=M.%20B.%20Stro%CC%B7m&amp;author=J.%20H.%20Andersen&amp;author=O.%20R.%20Gautun&amp;volume=25&amp;publication_year=2017&amp;pages=5380-5395&amp;pmid=28797773&amp;doi=10.1016/j.bmc.2017.07.060&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref95">
<cite>Aneja B., Azam M., Alam S., Perwez A., Maguire R., Yadava U., Kavanagh K., Daniliuc C. G., Rizvi M. M. A., Haq Q. M. R., Abid M.. Natural Product-Based
1,2,3-Triazole/Sulfonate
Analogues as Potential Chemotherapeutic Agents for Bacterial Infections. ACS Omega. 2018;3:6912–6930. doi: 10.1021/acsomega.8b00582.</cite> [<a href="https://doi.org/10.1021/acsomega.8b00582" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6044994/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30023966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Omega&amp;title=Natural%20Product-Based%201,2,3-Triazole/Sulfonate%20Analogues%20as%20Potential%20Chemotherapeutic%20Agents%20for%20Bacterial%20Infections&amp;author=B.%20Aneja&amp;author=M.%20Azam&amp;author=S.%20Alam&amp;author=A.%20Perwez&amp;author=R.%20Maguire&amp;volume=3&amp;publication_year=2018&amp;pages=6912-6930&amp;pmid=30023966&amp;doi=10.1021/acsomega.8b00582&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref96">
<cite>Hayden S. C., Bryant J. J., Mackey M. A., Höfer K., Lindner B. D., Nguyen V. P., Jäschke A., Bunz U. H. F.. Antimicrobial Activity of Water-Soluble Triazole Phenazine
Clickamers against E. coli
. Chem.Eur. J. 2014;20:719–723. doi: 10.1002/chem.201303353.</cite> [<a href="https://doi.org/10.1002/chem.201303353" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24339195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%EE%97%B8Eur.%20J.&amp;title=Antimicrobial%20Activity%20of%20Water-Soluble%20Triazole%20Phenazine%20Clickamers%20against%20E.%20coli&amp;author=S.%20C.%20Hayden&amp;author=J.%20J.%20Bryant&amp;author=M.%20A.%20Mackey&amp;author=K.%20H%C3%B6fer&amp;author=B.%20D.%20Lindner&amp;volume=20&amp;publication_year=2014&amp;pages=719-723&amp;pmid=24339195&amp;doi=10.1002/chem.201303353&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref97">
<cite>Vijai
Kumar Reddy T., Jyotsna A., Prabhavathi Devi B. L. A., Prasad R. B. N., Poornachandra Y., Ganesh Kumar C.. Design, Synthesis
and in Vitro Biological Evaluation of Short-Chain
C12-Sphinganine and Its 1,2,3-Triazole Analogs as Potential Antimicrobial
and Anti-Biofilm Agents. Eur. J. Med. Chem. 2016;118:98–106. doi: 10.1016/j.ejmech.2016.04.020.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2016.04.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27128176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Design,%20Synthesis%20and%20in%20Vitro%20Biological%20Evaluation%20of%20Short-Chain%20C12-Sphinganine%20and%20Its%201,2,3-Triazole%20Analogs%20as%20Potential%20Antimicrobial%20and%20Anti-Biofilm%20Agents&amp;author=T.%20Vijai%20Kumar%20Reddy&amp;author=A.%20Jyotsna&amp;author=B.%20L.%20A.%20Prabhavathi%20Devi&amp;author=R.%20B.%20N.%20Prasad&amp;author=Y.%20Poornachandra&amp;volume=118&amp;publication_year=2016&amp;pages=98-106&amp;pmid=27128176&amp;doi=10.1016/j.ejmech.2016.04.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref98">
<cite>Aljohani F. S., Rezki N., Aouad M. R., Hagar M., Bakr B. A., Shaaban M. M., Elwakil B. H.. Novel 1,2,3-Triazole-Sulphadiazine-ZnO
Hybrids as Potent Antimicrobial Agents against Carbapenem Resistant
Bacteria. Antibiotics. 2022;11:916. doi: 10.3390/antibiotics11070916.</cite> [<a href="https://doi.org/10.3390/antibiotics11070916" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9312158/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35884170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antibiotics&amp;title=Novel%201,2,3-Triazole-Sulphadiazine-ZnO%20Hybrids%20as%20Potent%20Antimicrobial%20Agents%20against%20Carbapenem%20Resistant%20Bacteria&amp;author=F.%20S.%20Aljohani&amp;author=N.%20Rezki&amp;author=M.%20R.%20Aouad&amp;author=M.%20Hagar&amp;author=B.%20A.%20Bakr&amp;volume=11&amp;publication_year=2022&amp;pages=916&amp;pmid=35884170&amp;doi=10.3390/antibiotics11070916&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref99">
<cite>Huang X., Liu H. W., Long Z. Q., Li Z. X., Zhu J. J., Wang P. Y., Qi P. Y., Liu L. W., Yang S.. Rational Optimization
of 1,2,3-Triazole-Tailored Carbazoles As Prospective Antibacterial
Alternatives with Significant In Vivo Control Efficiency and Unique
Mode of Action. J. Agric. Food Chem. 2021;69:4615–4627. doi: 10.1021/acs.jafc.1c00707.</cite> [<a href="https://doi.org/10.1021/acs.jafc.1c00707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33855856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Agric.%20Food%20Chem.&amp;title=Rational%20Optimization%20of%201,2,3-Triazole-Tailored%20Carbazoles%20As%20Prospective%20Antibacterial%20Alternatives%20with%20Significant%20In%20Vivo%20Control%20Efficiency%20and%20Unique%20Mode%20of%20Action&amp;author=X.%20Huang&amp;author=H.%20W.%20Liu&amp;author=Z.%20Q.%20Long&amp;author=Z.%20X.%20Li&amp;author=J.%20J.%20Zhu&amp;volume=69&amp;publication_year=2021&amp;pages=4615-4627&amp;pmid=33855856&amp;doi=10.1021/acs.jafc.1c00707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref100">
<cite>Dürckheimer W., Blumbach J., Lattrell R., Scheunemann K. H.. Recent
Developments in the Field of β-Lactam Antibiotics. Angew. Chem., Int. Ed. Engl. 1985;24:180–202. doi: 10.1002/anie.198501801.</cite> [<a href="https://doi.org/10.1002/anie.198501801" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Angew.%20Chem.,%20Int.%20Ed.%20Engl.&amp;title=Recent%20Developments%20in%20the%20Field%20of%20%CE%B2-Lactam%20Antibiotics&amp;author=W.%20D%C3%BCrckheimer&amp;author=J.%20Blumbach&amp;author=R.%20Lattrell&amp;author=K.%20H.%20Scheunemann&amp;volume=24&amp;publication_year=1985&amp;pages=180-202&amp;doi=10.1002/anie.198501801&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref101">
<cite>Smith P. W., Zuccotto F., Bates R. H., Martinez-Martinez M. S., Read K. D., Peet C., Epemolu O.. Pharmacokinetics
of
β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting
Oral Drugs in the Future. ACS Infect. Dis. 2018;4:1439–1447. doi: 10.1021/acsinfecdis.8b00160.</cite> [<a href="https://doi.org/10.1021/acsinfecdis.8b00160" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6189874/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30141902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Infect.%20Dis.&amp;title=Pharmacokinetics%20of%20%CE%B2-Lactam%20Antibiotics:%20Clues%20from%20the%20Past%20To%20Help%20Discover%20Long-Acting%20Oral%20Drugs%20in%20the%20Future&amp;author=P.%20W.%20Smith&amp;author=F.%20Zuccotto&amp;author=R.%20H.%20Bates&amp;author=M.%20S.%20Martinez-Martinez&amp;author=K.%20D.%20Read&amp;volume=4&amp;publication_year=2018&amp;pages=1439-1447&amp;pmid=30141902&amp;doi=10.1021/acsinfecdis.8b00160&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref102">
<cite>Kumar K., Carrère-Kremer S., Kremer L., Guérardel Y., Biot C., Kumar V.. Azide-Alkyne
Cycloaddition
En Route towards 1H-1,2,3-Triazole-Tethered β-Lactam-Ferrocene
and β-Lactam-Ferrocenylchalcone Conjugates: Synthesis and in
Vitro Anti-Tubercular Evaluation. Dalton Trans. 2013;42:1492–1500. doi: 10.1039/C2DT32148C.</cite> [<a href="https://doi.org/10.1039/C2DT32148C" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23108229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dalton%20Trans.&amp;title=Azide-Alkyne%20Cycloaddition%20En%20Route%20towards%201H-1,2,3-Triazole-Tethered%20%CE%B2-Lactam-Ferrocene%20and%20%CE%B2-Lactam-Ferrocenylchalcone%20Conjugates:%20Synthesis%20and%20in%20Vitro%20Anti-Tubercular%20Evaluation&amp;author=K.%20Kumar&amp;author=S.%20Carr%C3%A8re-Kremer&amp;author=L.%20Kremer&amp;author=Y.%20Gu%C3%A9rardel&amp;author=C.%20Biot&amp;volume=42&amp;publication_year=2013&amp;pages=1492-1500&amp;pmid=23108229&amp;doi=10.1039/C2DT32148C&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref103">
<cite>Kaur R., Singh R., Kumar A., Kaur S., Priyadarshi N., Singhal N. K., Singh K.. 1,2,3-Triazole
β-Lactam
Conjugates as Antimicrobial Agents. Heliyon. 2020;6:e04241.  doi: 10.1016/j.heliyon.2020.e04241.</cite> [<a href="https://doi.org/10.1016/j.heliyon.2020.e04241" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7327255/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32637684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heliyon&amp;title=1,2,3-Triazole%20%CE%B2-Lactam%20Conjugates%20as%20Antimicrobial%20Agents&amp;author=R.%20Kaur&amp;author=R.%20Singh&amp;author=A.%20Kumar&amp;author=S.%20Kaur&amp;author=N.%20Priyadarshi&amp;volume=6&amp;publication_year=2020&amp;pages=e04241&amp;pmid=32637684&amp;doi=10.1016/j.heliyon.2020.e04241&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref104">
<cite>Wilson D. N.. Ribosome-Targeting Antibiotics and
Mechanisms of Bacterial
Resistance. Nat. Rev. Microbiol. 2014;12:35–48. doi: 10.1038/nrmicro3155.</cite> [<a href="https://doi.org/10.1038/nrmicro3155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24336183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Microbiol.&amp;title=Ribosome-Targeting%20Antibiotics%20and%20Mechanisms%20of%20Bacterial%20Resistance&amp;author=D.%20N.%20Wilson&amp;volume=12&amp;publication_year=2014&amp;pages=35-48&amp;pmid=24336183&amp;doi=10.1038/nrmicro3155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref105">
<cite>Deng C., Yan H., Wang J., Liu K., Liu B. S., Shi Y. M.. 1,2,3-Triazole-Containing Hybrids
with Potential Antibacterial Activity against ESKAPE Pathogens. Eur. J. Med. Chem. 2022;244:114888. doi: 10.1016/j.ejmech.2022.114888.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2022.114888" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36334453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=1,2,3-Triazole-Containing%20Hybrids%20with%20Potential%20Antibacterial%20Activity%20against%20ESKAPE%20Pathogens&amp;author=C.%20Deng&amp;author=H.%20Yan&amp;author=J.%20Wang&amp;author=K.%20Liu&amp;author=B.%20S.%20Liu&amp;volume=244&amp;publication_year=2022&amp;pages=114888&amp;pmid=36334453&amp;doi=10.1016/j.ejmech.2022.114888&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref106">
<cite>Li K., Lin C., Hu Y.-H., Wang J., Jin Z., Zeng Z.-L., Tang Y.-Z.. Design, Synthesis, Biological Evaluation,
and Molecular Docking Studies of Pleuromutilin Derivatives Containing
Thiazole. ACS Infect. Dis. 2024;10:1980–1989. doi: 10.1021/acsinfecdis.3c00718.</cite> [<a href="https://doi.org/10.1021/acsinfecdis.3c00718" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38703116/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Infect.%20Dis.&amp;title=Design,%20Synthesis,%20Biological%20Evaluation,%20and%20Molecular%20Docking%20Studies%20of%20Pleuromutilin%20Derivatives%20Containing%20Thiazole&amp;author=K.%20Li&amp;author=C.%20Lin&amp;author=Y.-H.%20Hu&amp;author=J.%20Wang&amp;author=Z.%20Jin&amp;volume=10&amp;publication_year=2024&amp;pages=1980-1989&amp;pmid=38703116&amp;doi=10.1021/acsinfecdis.3c00718&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref107">
<cite>Stresser D. M., Broudy M. I., Ho T., Cargill C. E., Blanchard A. P., Sharma R., Dandeneau A. A., Goodwin J. J., Turner S. D., Erve J. C. L., Patten C. J., Dehal S. S., Crespi C. L.. Highly Selective Inhibition of Human
CYP3Aa in Vitro by Azamulin and Evidence That Inhibition Is Irreversible. Drug Metab. Dispos. 2004;32:105–112. doi: 10.1124/dmd.32.1.105.</cite> [<a href="https://doi.org/10.1124/dmd.32.1.105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14709627/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Metab.%20Dispos.&amp;title=Highly%20Selective%20Inhibition%20of%20Human%20CYP3Aa%20in%20Vitro%20by%20Azamulin%20and%20Evidence%20That%20Inhibition%20Is%20Irreversible&amp;author=D.%20M.%20Stresser&amp;author=M.%20I.%20Broudy&amp;author=T.%20Ho&amp;author=C.%20E.%20Cargill&amp;author=A.%20P.%20Blanchard&amp;volume=32&amp;publication_year=2004&amp;pages=105-112&amp;pmid=14709627&amp;doi=10.1124/dmd.32.1.105&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref108">
<cite>Lohsen S., Stephens D. S.. Current Macrolide Antibiotics and
Their Mechanisms of Action. Antibiotic Drug
Resistance. 2019:97–117. doi: 10.1002/9781119282549.ch5.</cite> [<a href="https://doi.org/10.1002/9781119282549.ch5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antibiotic%20Drug%20Resistance&amp;title=Current%20Macrolide%20Antibiotics%20and%20Their%20Mechanisms%20of%20Action&amp;author=S.%20Lohsen&amp;author=D.%20S.%20Stephens&amp;publication_year=2019&amp;pages=97-117&amp;doi=10.1002/9781119282549.ch5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref109">
<cite>Gaynor M., Mankin A. S.. Macrolide Antibiotics:
Binding Site,
Mechanism of Action, Resistance. Current Topics
in Medicinal Chemistry. 2003;3:949–960. doi: 10.2174/1568026033452159.</cite> [<a href="https://doi.org/10.2174/1568026033452159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12678831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Topics%20in%20Medicinal%20Chemistry.&amp;title=Macrolide%20Antibiotics:%20Binding%20Site,%20Mechanism%20of%20Action,%20Resistance&amp;author=M.%20Gaynor&amp;author=A.%20S.%20Mankin&amp;volume=3&amp;publication_year=2003&amp;pages=949-960&amp;pmid=12678831&amp;doi=10.2174/1568026033452159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref110">
<cite>Qin Y., Xu L., Teng Y., Yang Y., Wang Y., Ma P.. Design, Synthesis and Antibacterial
Evaluation of Novel 3-O-Substituted
15-Membered Azalides Possessing 1,2,3-Triazole Side Chains. Bioorg. Med. Chem. Lett. 2021;49:128330. doi: 10.1016/j.bmcl.2021.128330.</cite> [<a href="https://doi.org/10.1016/j.bmcl.2021.128330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34403726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.%20Lett.&amp;title=Design,%20Synthesis%20and%20Antibacterial%20Evaluation%20of%20Novel%203-O-Substituted%2015-Membered%20Azalides%20Possessing%201,2,3-Triazole%20Side%20Chains&amp;author=Y.%20Qin&amp;author=L.%20Xu&amp;author=Y.%20Teng&amp;author=Y.%20Yang&amp;author=Y.%20Wang&amp;volume=49&amp;publication_year=2021&amp;pages=128330&amp;pmid=34403726&amp;doi=10.1016/j.bmcl.2021.128330&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref111">
<cite>Bozdogan B., Appelbaum P. C.. Oxazolidinones: Activity, Mode of
Action, and Mechanism of Resistance. Int. J.
Antimicrob. Agents. 2004;23:113–119. doi: 10.1016/j.ijantimicag.2003.11.003.</cite> [<a href="https://doi.org/10.1016/j.ijantimicag.2003.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15013035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Antimicrob.%20Agents&amp;title=Oxazolidinones:%20Activity,%20Mode%20of%20Action,%20and%20Mechanism%20of%20Resistance&amp;author=B.%20Bozdogan&amp;author=P.%20C.%20Appelbaum&amp;volume=23&amp;publication_year=2004&amp;pages=113-119&amp;pmid=15013035&amp;doi=10.1016/j.ijantimicag.2003.11.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref112">
<cite>Phetsang W., Blaskovich M. A. T., Butler M. S., Huang J. X., Zuegg J., Mamidyala S. K., Ramu S., Kavanagh A. M., Cooper M. A.. An Azido-Oxazolidinone
Antibiotic for Live Bacterial
Cell Imaging and Generation of Antibiotic Variants. Bioorg. Med. Chem. 2014;22:4490–4498. doi: 10.1016/j.bmc.2014.05.054.</cite> [<a href="https://doi.org/10.1016/j.bmc.2014.05.054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4141890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25023540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.&amp;title=An%20Azido-Oxazolidinone%20Antibiotic%20for%20Live%20Bacterial%20Cell%20Imaging%20and%20Generation%20of%20Antibiotic%20Variants&amp;author=W.%20Phetsang&amp;author=M.%20A.%20T.%20Blaskovich&amp;author=M.%20S.%20Butler&amp;author=J.%20X.%20Huang&amp;author=J.%20Zuegg&amp;volume=22&amp;publication_year=2014&amp;pages=4490-4498&amp;pmid=25023540&amp;doi=10.1016/j.bmc.2014.05.054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref113">
<cite>Khodade V. S., Sharath Chandra M., Banerjee A., Lahiri S., Pulipeta M., Rangarajan R., Chakrapani H.. Bioreductively
Activated Reactive Oxygen Species (ROS) Generators as MRSA Inhibitors. ACS Med. Chem. Lett. 2014;5:777–781. doi: 10.1021/ml5001118.</cite> [<a href="https://doi.org/10.1021/ml5001118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4094247/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25050164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Med.%20Chem.%20Lett.&amp;title=Bioreductively%20Activated%20Reactive%20Oxygen%20Species%20(ROS)%20Generators%20as%20MRSA%20Inhibitors&amp;author=V.%20S.%20Khodade&amp;author=M.%20Sharath%20Chandra&amp;author=A.%20Banerjee&amp;author=S.%20Lahiri&amp;author=M.%20Pulipeta&amp;volume=5&amp;publication_year=2014&amp;pages=777-781&amp;pmid=25050164&amp;doi=10.1021/ml5001118&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref114">
<cite>Weng C., Shen L., Teo J. W., Lim Z. C., Loh B. S., Ang W. H.. Targeted Antibacterial Strategy Based
on Reactive Oxygen Species Generated from Dioxygen Reduction Using
an Organoruthenium Complex. JACS Au. 2021;1:1348–1354. doi: 10.1021/jacsau.1c00262.</cite> [<a href="https://doi.org/10.1021/jacsau.1c00262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8479771/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34604844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACS%20Au&amp;title=Targeted%20Antibacterial%20Strategy%20Based%20on%20Reactive%20Oxygen%20Species%20Generated%20from%20Dioxygen%20Reduction%20Using%20an%20Organoruthenium%20Complex&amp;author=C.%20Weng&amp;author=L.%20Shen&amp;author=J.%20W.%20Teo&amp;author=Z.%20C.%20Lim&amp;author=B.%20S.%20Loh&amp;volume=1&amp;publication_year=2021&amp;pages=1348-1354&amp;pmid=34604844&amp;doi=10.1021/jacsau.1c00262&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref115">
<cite>Yu T. W., Anderson D.. Reactive Oxygen Species-Induced
DNA
Damage and Its Modification: A Chemical Investigation. Mutat. Res. Mol. Mech. Mutagen. 1997;379:201–210. doi: 10.1016/S0027-5107(97)00141-3.</cite> [<a href="https://doi.org/10.1016/S0027-5107(97)00141-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9357549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mutat.%20Res.%20Mol.%20Mech.%20Mutagen.&amp;title=Reactive%20Oxygen%20Species-Induced%20DNA%20Damage%20and%20Its%20Modification:%20A%20Chemical%20Investigation&amp;author=T.%20W.%20Yu&amp;author=D.%20Anderson&amp;volume=379&amp;publication_year=1997&amp;pages=201-210&amp;pmid=9357549&amp;doi=10.1016/S0027-5107(97)00141-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref116">
<cite>Cabiscol E., Tamarit J., Ros J.. Oxidative
Stress in
Bacteria and Protein Damage by Reactive Oxygen Species. Int. Microbiol. 2000;3:3–8.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10963327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20Microbiol.&amp;title=Oxidative%20Stress%20in%20Bacteria%20and%20Protein%20Damage%20by%20Reactive%20Oxygen%20Species&amp;author=E.%20Cabiscol&amp;author=J.%20Tamarit&amp;author=J.%20Ros&amp;volume=3&amp;publication_year=2000&amp;pages=3-8&amp;pmid=10963327&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref117">
<cite>de Souza A. S., Dias D. S., Ribeiro R. C. B., Costa D. C. S., de
Moraes M. G., Pinho D. R., Masset M. E. G., Marins L. M., Valle S. P., de Carvalho C. J. C., de Carvalho G. S. G., Mello A. L. N., Sola-Penna M., Palmeira-Mello M. V., Conceição R. A., Rodrigues C. R., Souza A. M. T., Forezi L. da S. M., Zancan P., Ferreira V. F., da Silva F. de C.. Novel Naphthoquinone-1H-1,2,3-Triazole Hybrids: Design,
Synthesis and Evaluation as Inductors of ROS-Mediated Apoptosis in
the MCF-7 Cells. Bioorg. Med. Chem. 2024;102:117671. doi: 10.1016/j.bmc.2024.117671.</cite> [<a href="https://doi.org/10.1016/j.bmc.2024.117671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38452407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.&amp;title=Novel%20Naphthoquinone-1H-1,2,3-Triazole%20Hybrids:%20Design,%20Synthesis%20and%20Evaluation%20as%20Inductors%20of%20ROS-Mediated%20Apoptosis%20in%20the%20MCF-7%20Cells&amp;author=A.%20S.%20de%20Souza&amp;author=D.%20S.%20Dias&amp;author=R.%20C.%20B.%20Ribeiro&amp;author=D.%20C.%20S.%20Costa&amp;author=M.%20G.%20de%20Moraes&amp;volume=102&amp;publication_year=2024&amp;pages=117671&amp;pmid=38452407&amp;doi=10.1016/j.bmc.2024.117671&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref118">
<cite>Guo Y., Hou J., Wu H., Chen Y., Liu G., Wang D., Wang H., Mao L., Li S., Wang T.. Synthesis and Discovery of Novel
1,2,3-Triazole Based Cabotegravir
Derivatives with Potent Anticancer Activity. J. Mol. Struct. 2024;1298:137042. doi: 10.1016/j.molstruc.2023.137042.</cite> [<a href="https://doi.org/10.1016/j.molstruc.2023.137042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=Synthesis%20and%20Discovery%20of%20Novel%201,2,3-Triazole%20Based%20Cabotegravir%20Derivatives%20with%20Potent%20Anticancer%20Activity&amp;author=Y.%20Guo&amp;author=J.%20Hou&amp;author=H.%20Wu&amp;author=Y.%20Chen&amp;author=G.%20Liu&amp;volume=1298&amp;publication_year=2024&amp;pages=137042&amp;doi=10.1016/j.molstruc.2023.137042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref119">
<cite>Zhu M., Tse M. W., Weller J., Chen J., Blainey P. C.. The Future
of Antibiotics Begins with Discovering New Combinations. Ann. N.Y. Acad. Sci. 2021;1496:82–96. doi: 10.1111/nyas.14649.</cite> [<a href="https://doi.org/10.1111/nyas.14649" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8290516/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34212403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20N.Y.%20Acad.%20Sci.&amp;title=The%20Future%20of%20Antibiotics%20Begins%20with%20Discovering%20New%20Combinations&amp;author=M.%20Zhu&amp;author=M.%20W.%20Tse&amp;author=J.%20Weller&amp;author=J.%20Chen&amp;author=P.%20C.%20Blainey&amp;volume=1496&amp;publication_year=2021&amp;pages=82-96&amp;pmid=34212403&amp;doi=10.1111/nyas.14649&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref120">
<cite>Rogers S. A., Huigens R. W., Cavanagh J., Melander C.. Synergistic
Effects between Conventional Antibiotics and 2-Aminoimidazole-Derived
Antibiofilm Agents. Antimicrob. Agents Chemother. 2010;54:2112–2118. doi: 10.1128/AAC.01418-09.</cite> [<a href="https://doi.org/10.1128/AAC.01418-09" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2863642/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20211901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob.%20Agents%20Chemother.&amp;title=Synergistic%20Effects%20between%20Conventional%20Antibiotics%20and%202-Aminoimidazole-Derived%20Antibiofilm%20Agents&amp;author=S.%20A.%20Rogers&amp;author=R.%20W.%20Huigens&amp;author=J.%20Cavanagh&amp;author=C.%20Melander&amp;volume=54&amp;publication_year=2010&amp;pages=2112-2118&amp;pmid=20211901&amp;doi=10.1128/AAC.01418-09&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref121">
<cite>Su Z., Peng L., Worthington R. J., Melander C.. Evaluation of 4,5-Disubstituted-2-Aminoimidazole-Triazole
Conjugates for Antibiofilm/Antibiotic Resensitization Activity against
MRSA and Acinetobacter baumannii
. ChemMedChem. 2011;6:2243–2251. doi: 10.1002/cmdc.201100316.</cite> [<a href="https://doi.org/10.1002/cmdc.201100316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21928438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ChemMedChem.&amp;title=Evaluation%20of%204,5-Disubstituted-2-Aminoimidazole-Triazole%20Conjugates%20for%20Antibiofilm/Antibiotic%20Resensitization%20Activity%20against%20MRSA%20and%20Acinetobacter%20baumannii&amp;author=Z.%20Su&amp;author=L.%20Peng&amp;author=R.%20J.%20Worthington&amp;author=C.%20Melander&amp;volume=6&amp;publication_year=2011&amp;pages=2243-2251&amp;pmid=21928438&amp;doi=10.1002/cmdc.201100316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref122">
<cite>Negi B., Kumar D., Kumbukgolla W., Jayaweera S., Ponnan P., Singh R., Agarwal S., Rawat D. S.. Anti-Methicillin Resistant Staphylococcus aureus Activity, Synergism with Oxacillin and Molecular Docking Studies
of Metronidazole-Triazole Hybrids. Eur. J. Med.
Chem. 2016;115:426–437. doi: 10.1016/j.ejmech.2016.03.041.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2016.03.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27046397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Anti-Methicillin%20Resistant%20Staphylococcus%20aureus%20Activity,%20Synergism%20with%20Oxacillin%20and%20Molecular%20Docking%20Studies%20of%20Metronidazole-Triazole%20Hybrids&amp;author=B.%20Negi&amp;author=D.%20Kumar&amp;author=W.%20Kumbukgolla&amp;author=S.%20Jayaweera&amp;author=P.%20Ponnan&amp;volume=115&amp;publication_year=2016&amp;pages=426-437&amp;pmid=27046397&amp;doi=10.1016/j.ejmech.2016.03.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref123">
<cite>Xu Z., Zhao S.-J., Liu Y.. 1,2,3-Triazole-Containing Hybrids
as Potential Anticancer Agents: Current Developments, Action Mechanisms
and Structure-Activity Relationships. Eur. J.
Med. Chem. 2019;183:111700. doi: 10.1016/j.ejmech.2019.111700.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2019.111700" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31546197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=1,2,3-Triazole-Containing%20Hybrids%20as%20Potential%20Anticancer%20Agents:%20Current%20Developments,%20Action%20Mechanisms%20and%20Structure-Activity%20Relationships&amp;author=Z.%20Xu&amp;author=S.-J.%20Zhao&amp;author=Y.%20Liu&amp;volume=183&amp;publication_year=2019&amp;pages=111700&amp;pmid=31546197&amp;doi=10.1016/j.ejmech.2019.111700&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref124">
<cite>Machinist J. M., Bopp B. A., Anderson D. J., Granneman G. R., Sonders R. C., Tolman K., Buchi K., Rollins D.. Metabolism
of 14C-Estazolam in Dogs and Humans. Xenobiotica. 1986;16:11–20. doi: 10.3109/00498258609043501.</cite> [<a href="https://doi.org/10.3109/00498258609043501" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2868576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Xenobiotica&amp;title=Metabolism%20of%2014C-Estazolam%20in%20Dogs%20and%20Humans&amp;author=J.%20M.%20Machinist&amp;author=B.%20A.%20Bopp&amp;author=D.%20J.%20Anderson&amp;author=G.%20R.%20Granneman&amp;author=R.%20C.%20Sonders&amp;volume=16&amp;publication_year=1986&amp;pages=11-20&amp;pmid=2868576&amp;doi=10.3109/00498258609043501&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref125">
<cite>Kuttruff C. A., Ferrara M., Bretschneider T., Hoerer S., Handschuh S., Nosse B., Romig H., Nicklin P., Roth G. J.. Discovery of BI-2545: A Novel Autotaxin
Inhibitor That Significantly Reduces LPA Levels in Vivo. ACS Med. Chem. Lett. 2017;8:1252–1257. doi: 10.1021/acsmedchemlett.7b00312.</cite> [<a href="https://doi.org/10.1021/acsmedchemlett.7b00312" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5733304/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29259743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Med.%20Chem.%20Lett.&amp;title=Discovery%20of%20BI-2545:%20A%20Novel%20Autotaxin%20Inhibitor%20That%20Significantly%20Reduces%20LPA%20Levels%20in%20Vivo&amp;author=C.%20A.%20Kuttruff&amp;author=M.%20Ferrara&amp;author=T.%20Bretschneider&amp;author=S.%20Hoerer&amp;author=S.%20Handschuh&amp;volume=8&amp;publication_year=2017&amp;pages=1252-1257&amp;pmid=29259743&amp;doi=10.1021/acsmedchemlett.7b00312&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref126">
<cite>Leban J., Vitt D.. Human Dihydroorotate
Dehydrogenase
Inhibitors, a Novel Approach for the Treatment of Autoimmune and Inflammatory
Diseases. Arzneimittelforschung. 2011;61:66–72. doi: 10.1055/s-0031-1296169.</cite> [<a href="https://doi.org/10.1055/s-0031-1296169" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21355448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arzneimittelforschung.&amp;title=Human%20Dihydroorotate%20Dehydrogenase%20Inhibitors,%20a%20Novel%20Approach%20for%20the%20Treatment%20of%20Autoimmune%20and%20Inflammatory%20Diseases&amp;author=J.%20Leban&amp;author=D.%20Vitt&amp;volume=61&amp;publication_year=2011&amp;pages=66-72&amp;pmid=21355448&amp;doi=10.1055/s-0031-1296169&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref127">
<cite>Sainas S., Pippione A. C., Giorgis M., Lupino E., Goyal P., Ramondetti C., Buccinnà B., Piccinini M., Braga R. C., Andrade C. H., Andersson M., Moritzer A.-C., Friemann R., Mensa S., Al-Kadaraghi S., Boschi D., Lolli M. L.. Design, Synthesis,
Biological Evaluation
and X-Ray Structural Studies of Potent Human Dihydroorotate Dehydrogenase
Inhibitors Based on Hydroxylated Azole Scaffolds. Eur. J. Med. Chem. 2017;129:287–302. doi: 10.1016/j.ejmech.2017.02.017.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2017.02.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28235702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Design,%20Synthesis,%20Biological%20Evaluation%20and%20X-Ray%20Structural%20Studies%20of%20Potent%20Human%20Dihydroorotate%20Dehydrogenase%20Inhibitors%20Based%20on%20Hydroxylated%20Azole%20Scaffolds&amp;author=S.%20Sainas&amp;author=A.%20C.%20Pippione&amp;author=M.%20Giorgis&amp;author=E.%20Lupino&amp;author=P.%20Goyal&amp;volume=129&amp;publication_year=2017&amp;pages=287-302&amp;pmid=28235702&amp;doi=10.1016/j.ejmech.2017.02.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref128">
<cite>Lass-Flörl C.. Triazole Antifungal Agents in Invasive
Fungal Infections:
A Comparative Review. Drugs. 2011;71:2405–2419. doi: 10.2165/11596540-000000000-00000.</cite> [<a href="https://doi.org/10.2165/11596540-000000000-00000" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22141384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Triazole%20Antifungal%20Agents%20in%20Invasive%20Fungal%20Infections:%20A%20Comparative%20Review&amp;author=C.%20Lass-Fl%C3%B6rl&amp;volume=71&amp;publication_year=2011&amp;pages=2405-2419&amp;pmid=22141384&amp;doi=10.2165/11596540-000000000-00000&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref129">
<cite>Gao F., Wang T., Xiao J., Huang G.. Antibacterial Activity
Study of 1,2,4-Triazole Derivatives. Eur. J.
Med. Chem. 2019;173:274–281. doi: 10.1016/j.ejmech.2019.04.043.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2019.04.043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31009913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Antibacterial%20Activity%20Study%20of%201,2,4-Triazole%20Derivatives&amp;author=F.%20Gao&amp;author=T.%20Wang&amp;author=J.%20Xiao&amp;author=G.%20Huang&amp;volume=173&amp;publication_year=2019&amp;pages=274-281&amp;pmid=31009913&amp;doi=10.1016/j.ejmech.2019.04.043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref130">
<cite>Xu J., Cao Y., Zhang J., Yu S., Zou Y., Chai X., Wu Q., Zhang D., Jiang Y., Sun Q.. Design, Synthesis and
Antifungal Activities of Novel 1,2,4-Triazole
Derivatives. Eur. J. Med. Chem. 2011;46:3142–3148. doi: 10.1016/j.ejmech.2011.02.042.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2011.02.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21420761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Design,%20Synthesis%20and%20Antifungal%20Activities%20of%20Novel%201,2,4-Triazole%20Derivatives&amp;author=J.%20Xu&amp;author=Y.%20Cao&amp;author=J.%20Zhang&amp;author=S.%20Yu&amp;author=Y.%20Zou&amp;volume=46&amp;publication_year=2011&amp;pages=3142-3148&amp;pmid=21420761&amp;doi=10.1016/j.ejmech.2011.02.042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref131">
<cite>Moody D. E., Walsh S. L., Rollins D. E., Neff J. A., Huang W.. Ketoconazole, a Cytochrome P450 3A4
Inhibitor, Markedly Increases
Concentrations of Levo-Acetyl-Alpha-Methadol in Opioid-Naive Individuals. Clin. Pharmacol. Ther. 2004;76:154–166. doi: 10.1016/j.clpt.2004.04.004.</cite> [<a href="https://doi.org/10.1016/j.clpt.2004.04.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15289792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Pharmacol.%20Ther.&amp;title=Ketoconazole,%20a%20Cytochrome%20P450%203A4%20Inhibitor,%20Markedly%20Increases%20Concentrations%20of%20Levo-Acetyl-Alpha-Methadol%20in%20Opioid-Naive%20Individuals&amp;author=D.%20E.%20Moody&amp;author=S.%20L.%20Walsh&amp;author=D.%20E.%20Rollins&amp;author=J.%20A.%20Neff&amp;author=W.%20Huang&amp;volume=76&amp;publication_year=2004&amp;pages=154-166&amp;pmid=15289792&amp;doi=10.1016/j.clpt.2004.04.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref132">
<cite>Cao Y., Lu H.. Advances in the Application of 1,2,4-Triazole-Containing
Hybrids as Anti-Tuberculosis Agents. Future
Med. Chem. 2021;13:2107–2124. doi: 10.4155/fmc-2020-0295.</cite> [<a href="https://doi.org/10.4155/fmc-2020-0295" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34698509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Future%20Med.%20Chem.&amp;title=Advances%20in%20the%20Application%20of%201,2,4-Triazole-Containing%20Hybrids%20as%20Anti-Tuberculosis%20Agents&amp;author=Y.%20Cao&amp;author=H.%20Lu&amp;volume=13&amp;publication_year=2021&amp;pages=2107-2124&amp;pmid=34698509&amp;doi=10.4155/fmc-2020-0295&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref133">
<cite>Zhang J., Wang S., Ba Y., Xu Z.. 1,2,4-Triazole-Quinoline/Quinolone
Hybrids as Potential Anti-Bacterial Agents. Eur. J. Med. Chem. 2019;174:1–8. doi: 10.1016/j.ejmech.2019.04.033.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2019.04.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31015103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=1,2,4-Triazole-Quinoline/Quinolone%20Hybrids%20as%20Potential%20Anti-Bacterial%20Agents&amp;author=J.%20Zhang&amp;author=S.%20Wang&amp;author=Y.%20Ba&amp;author=Z.%20Xu&amp;volume=174&amp;publication_year=2019&amp;pages=1-8&amp;pmid=31015103&amp;doi=10.1016/j.ejmech.2019.04.033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref134">
<cite>Li J., Zhang J.. The Antibacterial Activity of 1,2,3-Triazole-
and 1,2,4-Triazole-Containing
Hybrids against Staphylococcus aureus: An Updated
Review (2020 - Present) Current Topics in Medicinal
Chemistry. 2022;22:41–63. doi: 10.2174/1568026621666211111160332.</cite> [<a href="https://doi.org/10.2174/1568026621666211111160332" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34766892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Topics%20in%20Medicinal%20Chemistry.&amp;title=The%20Antibacterial%20Activity%20of%201,2,3-Triazole-%20and%201,2,4-Triazole-Containing%20Hybrids%20against%20Staphylococcus%20aureus:%20An%20Updated%20Review%20(2020%20-%20Present)&amp;author=J.%20Li&amp;author=J.%20Zhang&amp;volume=22&amp;publication_year=2022&amp;pages=41-63&amp;pmid=34766892&amp;doi=10.2174/1568026621666211111160332&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref135">
<cite>Wimley W. C.. Describing
the Mechanism of Antimicrobial Peptide Action
with the Interfacial Activity Model. ACS Chem.
Biol. 2010;5:905–917. doi: 10.1021/cb1001558.</cite> [<a href="https://doi.org/10.1021/cb1001558" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2955829/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20698568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Chem.%20Biol.&amp;title=Describing%20the%20Mechanism%20of%20Antimicrobial%20Peptide%20Action%20with%20the%20Interfacial%20Activity%20Model&amp;author=W.%20C.%20Wimley&amp;volume=5&amp;publication_year=2010&amp;pages=905-917&amp;pmid=20698568&amp;doi=10.1021/cb1001558&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref136">
<cite>Imlay J.
A.. The Molecular Mechanisms
and Physiological Consequences
of Oxidative Stress: Lessons from a Model Bacterium. Nat. Rev. Microbiol. 2013;11:443–454. doi: 10.1038/nrmicro3032.</cite> [<a href="https://doi.org/10.1038/nrmicro3032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4018742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23712352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Microbiol.&amp;title=The%20Molecular%20Mechanisms%20and%20Physiological%20Consequences%20of%20Oxidative%20Stress:%20Lessons%20from%20a%20Model%20Bacterium&amp;author=J.%20A.%20Imlay&amp;volume=11&amp;publication_year=2013&amp;pages=443-454&amp;pmid=23712352&amp;doi=10.1038/nrmicro3032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from ACS Bio &amp; Med Chem Au are provided here courtesy of <strong>American Chemical Society</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1021/acsbiomedchemau.4c00132"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/bg4c00132.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (4.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12371489/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12371489/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371489%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371489/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12371489/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12371489/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12371489/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12371489/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12371489/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="qW6aJlIMfsiBPbyZGZsTp95CfLgi9fUiV8Jt0TIKqjVTSFseStUUR72vDerh75v4">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
